Ensembl_ID	Gene_symbol	logFC	FDR	Comparison	LncBook ID	Type	Conservation	miRNA	GWAS	nearest PC	Top correlated gene
ENSG00000269246	ENSG00000269246	-2.829254829771	0.00408553863313981	M1_vs_M0	HSALNG0125993	overlap_antisense,overlap_sense,anti_sense	Not conserved	hsa-miR-6089	Eotaxin measurement,Lung adenocarcinoma,Serum alanine aminotransferase measurement,Physical activity,-	GMFG	BAD
ENSG00000228221	LINC00578	-6.85693462390205	5.742752114742971e-9	M1_vs_M0	HSALNG0030898	integenic	Not conserved	hsa-miR-4505	NA	KCNMB2	BAD
ENSG00000272695	GAS6-DT	-1.84249474600479	1.77905864167674e-6	M1_vs_M0	HSALNG0099631	integenic	Q50	hsa-miR-1268b	NA	TMEM255B	NDUFAF7
ENSG00000290994	FAM86C2P	-1.46363947615146	9.7572458262546e-4	M1_vs_M0	HSALNG0085186	integenic	Not conserved	hsa-miR-619-5p	Hair colour measurement,Bmi-adjusted waist circumference,Bmi-adjusted waist circumference; Bmi-adjusted hip circumference,Bmi-adjusted hip circumference,Body height,Interleukin 18 measurement,Qrs duration,Sex interaction measurement,-	ALDH3B2	UPF1
ENSG00000236393	ENSG00000236393	-6.95563591643919	8.64714928517373e-10	M1_vs_M0	HSALNG0137402	integenic	Q75	NA	Mean platelet volume	ATP6AP2	THSD7A
ENSG00000203392	ENSG00000203392	-1.96664764134891	0.00454303757603524	M1_vs_M0	HSALNG0107312	anti_sense	Not conserved	NA	NA	SNX33	CROT
ENSG00000272823	ENSG00000272823	1.64983005088092	3.16810717851765e-8	M1_vs_M0	HSALNG0010765	anti_sense	Q90	hsa-miR-23a-5p,hsa-miR-6735-3p	Heart failure,Body height,Heel bone mineral density,Apolipoprotein b measurement,Urate measurement,Serum albumin measurement,Monocyte count,Neutrophil percentage of leukocytes,Leukocyte count,Granulocyte percentage of myeloid white cells; Monocyte percentage of leukocytes,Eosinophil count; Basophil count,Lymphocyte count,Neutrophil count,Fetal hemoglobin measurement,C-reactive protein measurement; Vital capacity,C-reactive protein measurement; Total cholesterol measurement,-	RAB3GAP2	ITGA2B
ENSG00000251136	RIPK2-DT	4.25440328226819	4.27786008170103e-276	M1_vs_M0	HSALNG0066822	integenic	Q50	NA	Human papilloma virus infection; Oropharynx cancer,-	NBN	DBF4
ENSG00000277851	LINC02391	-2.51296411560493	0.0242890560718721	M1_vs_M0	HSALNG0143695	integenic	Not conserved	NA	Smoking behaviour measurement	BTG1	POMT2
ENSG00000229271	ENSG00000229271	1.82398240164028	0.0108527623092098	M1_vs_M0	HSALNG0024495	sense	Not conserved	NA	Response to opioid,-	DAZL	VTA1
ENSG00000253227	ENSG00000253227	-4.08291005466079	2.91608413572397e-5	M1_vs_M0	HSALNG0068255	integenic	Not conserved	hsa-miR-619-5p,hsa-miR-1285-5p	NA	FER1L6	IFFO1
ENSG00000225963	ENSG00000225963	1.16781468099605	5.31825560806393e-5	M1_vs_M0	HSALNG0022854	anti_sense	Q50	hsa-miR-6089,hsa-miR-6763-5p	Subcutaneous adipose tissue measurement,Metabolic rate measurement,Serum non-albumin protein measurement,Obsessive-compulsive disorder; Obsessive-compulsive symptom measurement,-	SP140	SLC6A13
ENSG00000254102	BHLHE22-AS1	-2.72188154249135	3.3159665796427e-40	M1_vs_M0	HSALNG0065796	anti_sense	Q50	NA	Risk-taking behaviour,Systolic blood pressure,-	CYP7B1	TSPAN9
ENSG00000286162	ENSG00000286162	2.22545216534922	1.17224984485463e-30	M1_vs_M0	HSALNG0069800	integenic	Q50	NA	NA	PLGRKT	PPP5C
ENSG00000234311	ENSG00000234311	-3.62954926894227	5.72018803486409e-29	M1_vs_M0	HSALNG0081788	integenic	Q90	hsa-miR-574-5p,hsa-miR-6852-5p	Heel bone mineral density,Myopathy; Response to simvastatin,-	STK32C	EXTL3
ENSG00000254242	ENSG00000254242	-3.10069094046599	0.0161816612153929	M1_vs_M0	HSALNG0063740	integenic	Not conserved	hsa-miR-619-5p	Platelet count,Mean platelet volume	SH2D4A	SNAI2
ENSG00000288940	ENSG00000288940	-6.69493048388105	9.36339850240447e-8	M1_vs_M0	HSALNG0148071	integenic	Q90	hsa-miR-4268,hsa-miR-6089	-	PCDH7	VRK2
ENSG00000224478	ENSG00000224478	3.72715015451634	5.64192010939538e-7	M1_vs_M0	HSALNG0054727	integenic	Not conserved	hsa-miR-6089	Psoriasis vulgaris,Nicotine dependence symptom count; Depressive symptom measurement	FNDC1	SLC39A9
ENSG00000241886	ENSG00000241886	3.52413456401419	3.36224923020113e-8	M1_vs_M0	HSALNG0137207	sense	Q90	NA	-	GK	SLC39A9
ENSG00000248202	LINC02234	-4.40182968155971	8.69123765116153e-7	M1_vs_M0	HSALNG0043678	integenic	Q75	NA	Pr interval,Estradiol measurement,Loneliness measurement,Ovarian serous carcinoma; Ovarian carcinoma; Progression free survival,-	LNPEP	ANK1
ENSG00000233828	MIR4280HG	-6.60668230037788	3.2148038744347998e-24	M1_vs_M0	HSALNG0043286	integenic	Q50	hsa-miR-6503-3p	NA	CCNH	LRRC7
ENSG00000269399	ENSG00000269399	-1.42469806771474	3.2153624306253e-4	M1_vs_M0	HSALNG0124446	anti_sense	Not conserved	hsa-miR-6089	Eosinophil count,Leukocyte count	C19orf44	FBXO42
ENSG00000257595	LINC02356	-3.60537881109649	7.133222319402189e-11	M1_vs_M0	HSALNG0094035	integenic	Q75	hsa-miR-30b-3p,hsa-miR-3194-5p	Platelet count,Lean body mass,Eosinophil count; Neutrophil percentage of leukocytes; Lymphocyte percentage of leukocytes,Parental genotype effect measurement; Eosinophil count; Protein measurement; Intraocular pressure measurement; Systolic blood pressure; C-x-c motif chemokine 10 measurement; Hba1c measurement; Monokine induced by gamma interferon measurement; Preeclampsia; Rheumatoid arthritis; Peripheral arterial disease; Vitiligo,Triglyceride measurement; Epilepsy; Alcohol dependence measurement; Alcohol consumption measurement,Lymphocyte count,Diastolic blood pressure; Smoking status measurement; Systolic blood pressure,-	SH2B3	CLEC16A
ENSG00000255410	ENSG00000255410	-1.86929381418665	0.0257162721704021	M1_vs_M0	HSALNG0082460	anti_sense	Q90	hsa-miR-3620-5p,hsa-miR-4492,hsa-miR-1587,hsa-miR-4644,hsa-miR-6124	Platelet crit,Hemoglobin measurement,-	ILK	MTREX
ENSG00000275830	ENSG00000275830	-4.71279214343824	7.784629834369031e-15	M1_vs_M0	HSALNG0099354	integenic	Not conserved	hsa-miR-4472	Erosive tooth wear measurement,Cup-to-disc ratio measurement,Sleep duration,Igfbp-3 measurement,Diastolic blood pressure change measurement; Response to diuretic,-	COL4A1	RIPOR1
ENSG00000231889	TRAF3IP2-AS1	1.28163170895622	2.7151155380935e-4	M1_vs_M0	HSALNG0052788	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-4463,hsa-miR-6812-3p,hsa-miR-6886-3p,hsa-miR-10392-3p	Psoriatic arthritis,Abnormality of refraction,Triglyceride measurement; High density lipoprotein cholesterol measurement; Smoking behavior,Ulcerative colitis; Crohn's disease; Inflammatory bowel disease,Manic episode measurement; Depressive episode measurement,Non-melanoma skin carcinoma,Esophageal varices,Inflammatory bowel disease,C-reactive protein measurement,Attention deficit hyperactivity disorder; Antisocial behaviour measurement; Substance abuse,Psoriasis; Psoriatic arthritis; Psoriasis vulgaris,-,Balding measurement	MFSD4B	PHF23
ENSG00000221883	ARIH2OS	1.25702852994146	7.4668565331827e-4	M1_vs_M0	HSALNG0025886	anti_sense,sense	Q50	hsa-miR-619-5p,hsa-miR-6089	Platelet crit,-	SLC25A20	TNC
ENSG00000288156	ENSG00000288156	-1.61508058893551	1.7640412623677194e-43	M1_vs_M0	HSALNG0123151	intronic_sense	Not conserved	NA	-	NA	AIFM2
ENSG00000250159	PKD2L2-DT	-1.41944749903825	0.00530375614200574	M1_vs_M0	HSALNG0045129	integenic	Not conserved	NA	NA	FAM13B	RETSAT
ENSG00000281005	LINC00921	-2.65499659758085	3.4401313255529e-20	M1_vs_M0	HSALNG0109143	sense	Not conserved	hsa-miR-3925-3p	NA	NA	ARHGAP6
ENSG00000237484	LINC01684	2.36106141790465	1.0288672550606999e-44	M1_vs_M0	HSALNG0147058	integenic	Not conserved	NA	-	JAM2	TNFRSF9
ENSG00000260641	TSPAN5-DT	-2.29758642745385	0.0182890516156744	M1_vs_M0	HSALNG0035964	integenic	Q50	hsa-miR-6090,hsa-miR-6769b-5p,hsa-miR-7704	Alcohol use disorder measurement,-	RAP1GDS1	ARHGEF5
ENSG00000253522	MIR3142HG	3.95660583352922	1.6168463305967299e-114	M1_vs_M0	HSALNG0046249	integenic	Not conserved	NA	NA	PTTG1	NFE2L3
ENSG00000236453	ENSG00000236453	2.53165921478155	1.35818023253571e-10	M1_vs_M0	HSALNG0059602	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-3622b-5p	Eye colour measurement,Brcax breast cancer,Asparaginase hypersensitivity,Aging,Athletic endurance measurement,Circadian rhythm,-	GNG11	MAPK9
ENSG00000275202	ENSG00000275202	-1.47442189157046	6.28139250056856e-7	M1_vs_M0	HSALNG0097019	anti_sense	Q75	hsa-miR-4268,hsa-miR-4280,hsa-miR-3960,hsa-miR-4707-5p	-	CAB39L	RRP12
ENSG00000288928	ENSG00000288928	2.48488151538278	0.00851245523841898	M1_vs_M0	NA	NA	NA	NA	NA	HIF1A	LY75
ENSG00000223768	LINC00205	-1.50141661795675	6.80941314760172e-50	M1_vs_M0	HSALNG0133618	integenic	Q50	hsa-miR-92b-5p,hsa-miR-619-5p,hsa-miR-1205,hsa-miR-3692-5p,hsa-miR-3934-5p,hsa-miR-4472,hsa-miR-4505,hsa-miR-6751-3p,hsa-miR-6803-5p	Systemic lupus erythematosus,Bmi-adjusted waist-hip ratio,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio,Bmi-adjusted waist circumference,-	ADARB1	HDAC7
ENSG00000222047	C10orf55	-2.3368538748659	5.6741075334215e-4	M1_vs_M0	HSALNG0078890	anti_sense,sense	Q75	NA	-	CAMK2G	GPBP1
ENSG00000240057	NEPRO-AS1	2.65295524897673	7.973301567845222e-14	M1_vs_M0	HSALNG0028082	integenic	Q90	hsa-miR-296-3p	Telomere length,Myopia,Body height	GTPBP8	CA11
ENSG00000205628	LINC01446	-2.77892845646072	5.039809531226e-4	M1_vs_M0	HSALNG0058095	integenic	Not conserved	NA	NA	SEC61G	SPA17
ENSG00000286062	ENSG00000286062	2.79664378112041	8.98952910507813e-10	M1_vs_M0	HSALNG0042332	integenic	Q75	hsa-miR-508-5p	Sepsis; Mortality,Systolic blood pressure,-	SGTB	TSPAN32
ENSG00000277534	ENSG00000277534	-1.63051477954698	0.00782796403970877	M1_vs_M0	HSALNG0120572	sense	Not conserved	NA	NA	KCTD1	DMRT3
ENSG00000261801	LOXL1-AS1	2.49707054930795	0.00371292680532322	M1_vs_M0	HSALNG0107133	anti_sense	Q50	hsa-miR-3194-5p,hsa-miR-500b-3p,hsa-miR-4667-3p,hsa-miR-6089	Feeling """"fed-up"""" measurement,Body height,Bmi-adjusted waist circumference,Bmi-adjusted waist circumference; Body height,Exfoliation syndrome,-	STOML1	TNPO3
ENSG00000238005	LNCATV	-1.47851073753738	4.4766706216192e-5	M1_vs_M0	HSALNG0011660	integenic	Q50	hsa-miR-6089,hsa-miR-6769b-3p	Serum gamma-glutamyl transferase measurement,Platelet count,Monocyte percentage of leukocytes; Monocyte count,Apolipoprotein a 1 measurement,Low density lipoprotein cholesterol measurement,Response to vaccine; Cytokine measurement,Cognitive function measurement,-	TOMM20	SNX24
ENSG00000197503	LINC00477	2.77209001950922	5.47701432151029e-21	M1_vs_M0	HSALNG0089868	integenic	Q50	NA	Cognitive decline measurement,Smoking status measurement,Neutrophil count,-	SOX5	NTN1
ENSG00000226409	ENSG00000226409	-5.08015131302348	0.00531460677634716	M1_vs_M0	HSALNG0053288	integenic	Not conserved	NA	NA	HDDC2	CTNNA2
ENSG00000205488	CALML3-AS1	-5.0799894924577504	0.00678385018351392	M1_vs_M0	HSALNG0075870	anti_sense	Q75	hsa-miR-216a-3p,hsa-miR-500b-3p,hsa-miR-3667-3p,hsa-miR-4691-5p,hsa-miR-4734,hsa-miR-6792-5p	Cortical surface area measurement,-	CALML5	CTNNA2
ENSG00000238062	SPATA3-AS1	-5.08022464477268	0.00479867724346478	M1_vs_M0	HSALNG0022908	anti_sense	Q50	hsa-miR-4688	-	GPR55	CTNNA2
ENSG00000267272	LINC01140	-2.24473097748062	9.5563311995991e-10	M1_vs_M0	HSALNG0004949	sense	Q90	NA	Smoking behavior,Cortical surface area measurement,-	NA	SPI1
ENSG00000273972	ENSG00000273972	4.86991855979996	5.75058505529052e-10	M1_vs_M0	HSALNG0105662	integenic	Not conserved	NA	-	SQOR	PLPP1
ENSG00000277283	ENSG00000277283	-1.34462324960267	0.00549582875027446	M1_vs_M0	HSALNG0094493	anti_sense	Not conserved	hsa-miR-1233-3p	NA	BICDL1	RHOA
ENSG00000248538	PPP1R3B-DT	-4.6624955778063	2.40524618014503e-8	M1_vs_M0	HSALNG0063318	integenic	Q50	hsa-miR-6803-5p	NA	ERI1	PRKCZ
ENSG00000266718	ENSG00000266718	-3.56233654493337	8.524917405768731e-15	M1_vs_M0	HSALNG0115789	anti_sense	Not conserved	NA	Nicotine dependence symptom count	CDK5R1	IP6K2
ENSG00000227704	ENSG00000227704	-2.3930147812899	3.2384023666694e-4	M1_vs_M0	HSALNG0055383	anti_sense	Not conserved	hsa-miR-1227-5p	-	ERMARD	SDK2
ENSG00000272512	ENSG00000272512	5.40066925628178	1.25012207463815e-14	M1_vs_M0	HSALNG0000065	integenic	Not conserved	NA	Apolipoprotein a 1 measurement,Parental longevity,-	HES4	FGF10
ENSG00000261296	ENSG00000261296	2.55623633698106	2.8636059531431e-4	M1_vs_M0	HSALNG0106417	integenic	Q50	NA	-	TLN2	CSNK2A2
ENSG00000284719	ENSG00000284719	-1.4653881442016	5.9401170322538305e-24	M1_vs_M0	HSALNG0002807	integenic	Q75	hsa-miR-619-5p,hsa-miR-659-5p,hsa-miR-6089,hsa-miR-1273h-5p	Hemorrhoid,-	PPIE	PTPN21
ENSG00000260329	TMEM263-DT	-2.84499342851925	2.7497425665571e-4	M1_vs_M0	HSALNG0093754	anti_sense	Q50	NA	Aging,Alkaline phosphatase measurement	MTERF2	ATP2B1
ENSG00000225953	SATB2-AS1	-2.17782439749991	1.77044096833899e-24	M1_vs_M0	HSALNG0021423	anti_sense	Q90	hsa-miR-3620-5p	Body height; Cortical thickness,Body height; Mathematical ability,-	C2orf69	TRIP13
ENSG00000287097	ENSG00000287097	7.5033632063305	4.45351968599759e-50	M1_vs_M0	HSALNG0052955	integenic	Q50	NA	Serum igg glycosylation measurement,Dna methylation,Carotid artery intima media thickness,-	MARCKS	PANX2
ENSG00000235724	PSMD14-DT	2.37667750886511	0.0382444779719547	M1_vs_M0	HSALNG0019993	integenic	Q90	NA	Intelligence; Unipolar depression	DPP4	FRY
ENSG00000288952	ENSG00000288952	3.90084631580283	4.81482331502207e-8	M1_vs_M0	HSALNG0024203	integenic	Q50	NA	NA	TIMP4	CA12
ENSG00000198496	NBR2	1.0966430247187	2.03193180815001e-8	M1_vs_M0	HSALNG0116616	anti_sense	Not conserved	hsa-miR-619-5p,hsa-miR-6089	Age at menopause,Neutrophil count,-	NBR1	TXK
ENSG00000197180	ATP6AP1-DT	1.24317544013396	6.06797442072732e-22	M1_vs_M0	HSALNG0140852	integenic	Q75	hsa-miR-619-5p,hsa-miR-4297,hsa-miR-4279	NA	DNASE1L1	EIF4G3
ENSG00000235770	LINC00607	6.39701576414233	4.6775777060854e-30	M1_vs_M0	HSALNG0022091	integenic	Not conserved	NA	-	MREG	VPS9D1
ENSG00000258457	AJUBA-DT	-1.46220489331522	0.0283377142420779	M1_vs_M0	HSALNG0099995	anti_sense	Q90	hsa-miR-7113-5p	Macula measurement,Gut microbiome measurement,Odontogenesis; Tooth eruption,Systolic blood pressure,Cognitive function measurement,-	PSMB11	RAB7A
ENSG00000223478	ZDHHC12-DT	-1.85643360029762	8.97289638135464e-7	M1_vs_M0	HSALNG0074656	anti_sense	Not conserved	hsa-miR-4492,hsa-miR-6799-5p	-	PKN3	CST7
ENSG00000268516	ZNF8-DT	-1.37880757284092	0.00783453921198181	M1_vs_M0	HSALNG0127940	anti_sense	Not conserved	hsa-miR-6769a-3p	Attention deficit hyperactivity disorder,-	A1BG	PPP2R5C
ENSG00000288772	ENSG00000288772	-1.44225213985767	0.0062612746158518	M1_vs_M0	HSALNG0003091	anti_sense	Q75	NA	White matter microstructure measurement,Platelet count; Platelet crit,Igf-1 measurement,-	CDC20	PKD2L2
ENSG00000230107	ENSG00000230107	-1.83758332965257	2.5641567541137e-4	M1_vs_M0	HSALNG0135708	integenic	Q90	hsa-miR-3158-5p,hsa-miR-4650-5p,hsa-miR-4691-5p,hsa-miR-6089,hsa-miR-6132	NA	SERHL2	MYH7B
ENSG00000234753	FOXP4-AS1	2.95261065870656	0.00169986580046674	M1_vs_M0	HSALNG0050034	integenic	Q90	hsa-miR-1227-5p,hsa-miR-6089,hsa-miR-8485	-	TFEB	RAPGEF3
ENSG00000177335	LINC02904	3.87389799408297	4.0075651531791e-42	M1_vs_M0	HSALNG0069224	integenic	Not conserved	hsa-miR-210-5p,hsa-miR-326,hsa-miR-331-3p,hsa-miR-939-3p,hsa-miR-4292,hsa-miR-1343-3p,hsa-miR-6735-5p	-	LY6E	KIF22
ENSG00000232453	LINC02777	-1.89432808240903	2.7563831828828e-4	M1_vs_M0	HSALNG0003962	integenic	Not conserved	NA	Bmi-adjusted hip circumference,-	JUN	DDX1
ENSG00000224939	LINC00184	2.5942693240614	0.0133050745057691	M1_vs_M0	HSALNG0011620	integenic	Q50	hsa-miR-885-3p,hsa-miR-3620-5p,hsa-miR-4505,hsa-miR-1587,hsa-miR-6726-5p	Balding measurement,Red blood cell distribution width,Body height,Heel bone mineral density,Health study participation,Alkaline phosphatase measurement,Lymphocyte count,Reticulocyte count; Reticulocyte measurement; Red blood cell distribution width,Total cholesterol measurement; Apolipoprotein b measurement; Low density lipoprotein cholesterol measurement,Eye colour measurement,Cardiac arrhythmia,Reticulocyte measurement; Red blood cell distribution width,Leukocyte count,Apolipoprotein b measurement,-	COA6	EPB41L2
ENSG00000263766	KPNB1-DT	1.5322082405798	0.00321994748148664	M1_vs_M0	HSALNG0117016	integenic	Not conserved	hsa-miR-4463,hsa-miR-4492,hsa-miR-6089	Mathematical ability	OSBPL7	KEAP1
ENSG00000288612	ENSG00000288612	-1.87689366272928	3.46653946237587e-7	M1_vs_M0	HSALNG0047550	sense	Q75	hsa-miR-1233-3p,hsa-miR-3943	NA	NQO2	PTPRH
ENSG00000286333	ENSG00000286333	-4.1935125801089	6.244877828172091e-10	M1_vs_M0	HSALNG0102303	anti_sense	Q50	hsa-miR-4254	C-reactive protein measurement; Alkaline phosphatase measurement,C-reactive protein measurement; Sex hormone-binding globulin measurement; Alkaline phosphatase measurement; Testosterone measurement; Aspartate aminotransferase measurement,C-reactive protein measurement,Lysine measurement,-	DPF3	MID2
ENSG00000277715	ENSG00000277715	2.82270919318014	0.0452812572666107	M1_vs_M0	HSALNG0093735	intronic_antisense	Q50	hsa-miR-609,hsa-miR-939-3p,hsa-miR-3960,hsa-miR-6791-3p,hsa-miR-6880-3p,hsa-miR-8072	Body height,-	TCP11L2	IL12RB2
ENSG00000254139	LINC03018	1.15018713310033	0.0219288126258932	M1_vs_M0	HSALNG0065529	integenic	Q50	NA	Disease progression measurement,Nose morphology measurement,Ischemic stroke,Gut microbiome measurement,-	FAM110B	ULK2
ENSG00000255121	CENATAC-DT	-2.07855244951898	4.05582218784439e-7	M1_vs_M0	HSALNG0087593	integenic	Not conserved	NA	-	RPS25	CAD
ENSG00000237187	NR2F1-AS1	-1.31638768499832	1.03411383932102e-7	M1_vs_M0	HSALNG0043533	anti_sense	Q90	NA	-	FAM172A	SCAMP1
ENSG00000235513	L3MBTL2-AS1	3.3309041348334	8.87778244282134e-103	M1_vs_M0	HSALNG0135617	anti_sense	Q75	hsa-miR-6731-5p	Anorexia nervosa; Autism spectrum disorder; Depressive symptom measurement; Obsessive-compulsive disorder; Attention deficit hyperactivity disorder; Unipolar depression; Bipolar disorder; Tourette syndrome; Neuroticism measurement,Neuroticism measurement,Breast carcinoma,Red blood cell distribution width,Mood instability measurement,Anxiety measurement; Neuroticism measurement,Depressive symptom measurement; Unipolar depression; Wellbeing measurement; Bipolar disorder; Neuroticism measurement,-	CHADL	TTC39A
ENSG00000261798	ENSG00000261798	-3.18690466514264	3.5256313448910195e-42	M1_vs_M0	HSALNG0002807	integenic	Q75	hsa-miR-619-5p,hsa-miR-659-5p,hsa-miR-6089,hsa-miR-1273h-5p	Hemorrhoid,-	PPIE	RAD54L
ENSG00000289070	ENSG00000289070	-1.97408695788759	2.81663999815328e-6	M1_vs_M0	HSALNG0118660	anti_sense	Q50	hsa-miR-619-5p	Blood protein measurement,-	CD300A	PSMC5
ENSG00000231312	MAP4K3-DT	2.31038323158357	1.44893143093926e-26	M1_vs_M0	HSALNG0014372	anti_sense,sense	Q50	hsa-miR-619-5p,hsa-miR-4447,hsa-miR-6089,hsa-miR-8485	Hematocrit; Hemoglobin measurement,Hematocrit; Erythrocyte count,Hematocrit,Hemoglobin measurement,Red blood cell density measurement,Response to candesartan,-	TMEM178A	OGFOD1
ENSG00000250748	MSRB3-AS1	-3.16542893237266	3.8049636979342e-4	M1_vs_M0	HSALNG0091992	integenic	Not conserved	hsa-miR-6089	Creatinine measurement	WIF1	TFAP2C
ENSG00000233922	LINC01694	-1.13355241354691	0.0153228697399492	M1_vs_M0	HSALNG0133661	integenic	Q75	hsa-miR-6763-5p	Covid-19,Myopia,Self reported educational attainment,-	PCBP3	ALG6
ENSG00000273314	ENSG00000273314	1.70900203026622	9.963174099135811e-15	M1_vs_M0	HSALNG0062087	anti_sense	Q50	hsa-miR-668-5p	NA	EZH2	EDEM2
ENSG00000283648	ENSG00000283648	6.35702598558263	1.17637831696123e-60	M1_vs_M0	HSALNG0062073	anti_sense	Q50	hsa-miR-6791-3p	Protein measurement,Parkinson's disease symptom measurement,Psoriasis; Inflammatory bowel disease; Ulcerative colitis; Ankylosing spondylitis; Crohn's disease; Sclerosing cholangitis,Gut microbiome measurement,Crohn's disease,Asparagine measurement,Uterine fibroid measurement,Chronic kidney disease; Diabetic nephropathy,Cardiovascular event measurement; Response to angiotensin-converting enzyme inhibitor; Response to angiotensin receptor blocker,-	EZH2	CPXM1
ENSG00000230928	ENSG00000230928	-5.52804891837351	4.9956613872517e-4	M1_vs_M0	HSALNG0080002	anti_sense	Not conserved	hsa-miR-6763-5p	Body height	R3HCC1L	SIRPG
ENSG00000288162	ENSG00000288162	-2.00064054495395	1.59748679181136e-32	M1_vs_M0	HSALNG0055417	integenic	Not conserved	hsa-miR-1233-5p	Balding measurement,Glaucoma; Open-angle glaucoma; Lymphocyte count,-	FAM120B	SLC8B1
ENSG00000163597	SNHG16	2.235894667343	3.158099879043909e-89	M1_vs_M0	HSALNG0118862	integenic	Not conserved	NA	Adolescent idiopathic scoliosis,Macular telangiectasia type 2,-	PRCD	P3H2
ENSG00000243926	TIPARP-AS1	-2.70976892701042	0.00107559296321408	M1_vs_M0	HSALNG0030062	anti_sense	Q75	hsa-miR-6727-5p	-	SSR3	PABPC4
ENSG00000261971	MMP25-AS1	2.12975928576603	5.51352344428993e-61	M1_vs_M0	HSALNG0109107	anti_sense	Q75	hsa-miR-455-3p,hsa-miR-619-5p,hsa-miR-3178,hsa-miR-4286,hsa-miR-4472,hsa-miR-4498,hsa-miR-3960,hsa-miR-4787-5p,hsa-miR-6132,hsa-miR-6767-5p,hsa-miR-6779-5p,hsa-miR-6803-5p,hsa-miR-6836-5p,hsa-miR-6860,hsa-miR-8072	-	BICDL2	OSBPL8
ENSG00000261889	ENSG00000261889	2.08499266264536	4.4633626473899e-5	M1_vs_M0	HSALNG0109131	integenic	Not conserved	hsa-miR-619-5p,hsa-miR-7704	Vital capacity,-	ZSCAN10	PITPNM3
ENSG00000287252	ENSG00000287252	-3.43828574009278	2.9980783955272e-5	M1_vs_M0	HSALNG0048904	integenic	Not conserved	hsa-miR-6089	NA	H2AC13	SUPT16H
ENSG00000258738	BAZ1A-AS1	1.425132904356	6.1873543317854e-4	M1_vs_M0	HSALNG0100538	anti_sense	Q90	NA	Heel bone mineral density,Monocyte count,Reticulocyte measurement,-	SRP54	ECHDC1
ENSG00000240990	HOXA11-AS	-1.82140722700103	1.95740671115076e-13	M1_vs_M0	HSALNG0056865	anti_sense	Q90	hsa-miR-920,hsa-miR-4286,hsa-miR-3960,hsa-miR-4769-5p,hsa-miR-5197-3p,hsa-miR-6741-3p,hsa-miR-10394-3p	Ulcerative colitis,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio; Waist-hip ratio,Bmi-adjusted waist-hip ratio,Heel bone mineral density,Serum alanine aminotransferase measurement; Sex hormone-binding globulin measurement; Low density lipoprotein triglyceride measurement; Bmi-adjusted waist circumference; Body fat percentage; High density lipoprotein cholesterol measurement; Bmi-adjusted waist-hip ratio; Aspartate aminotransferase measurement,Diuretic use measurement,-	EVX1	HDAC6
ENSG00000261338	ENSG00000261338	-1.35839465190139	5.8136079382261e-4	M1_vs_M0	NA	NA	NA	NA	NA	ARPC2	BRPF3
ENSG00000255559	ZNF252P-AS1	-1.86852265267295	0.0230841961336704	M1_vs_M0	HSALNG0069500	integenic	Not conserved	hsa-miR-6803-5p,hsa-miR-6858-5p,hsa-miR-6878-3p	-	C8orf33	MRPS18A
ENSG00000250519	ENSG00000250519	1.51808128261107	4.54039248779478e-9	M1_vs_M0	HSALNG0086510	integenic	Q50	NA	Serum alanine aminotransferase measurement,-	PANX1	PSMD8
ENSG00000267365	KCNJ2-AS1	-2.18067224099301	2.3907312801168397e-12	M1_vs_M0	HSALNG0118455	anti_sense	Q50	NA	Body weight,-	ABCA5	HCN2
ENSG00000290737	ENSG00000290737	-1.52050851165995	0.0185563310906235	M1_vs_M0	HSALNG0078861	integenic	Not conserved	NA	NA	AGAP5	SLC16A8
ENSG00000285756	ENSG00000285756	-2.16574775578159	4.23304234056917e-13	M1_vs_M0	HSALNG0136447	integenic	Not conserved	NA	NA	PRKX	NEFH
ENSG00000224259	LINC01133	-1.46858399492362	0.00740226000176459	M1_vs_M0	HSALNG0007801	integenic	Q50	NA	Visual perception measurement; Granulocyte count,-	KCNJ9	SGSM3
ENSG00000286179	ENSG00000286179	2.50956504397466	5.97973315835148e-18	M1_vs_M0	HSALNG0146969	integenic	Not conserved	NA	NA	SULF2	POLE2
ENSG00000229953	BCAN-AS2	-3.97895743695702	1.61392886324068e-35	M1_vs_M0	HSALNG0007612	anti_sense	Q75	hsa-miR-4722-5p,hsa-miR-6511a-3p	Blood protein measurement,-	NES	SNW1
ENSG00000233237	LINC00472	-3.04788293281501	1.29710204071921e-28	M1_vs_M0	HSALNG0051173	integenic	Q50	NA	NA	B3GAT2	CEP128
ENSG00000235478	LINC01664	-1.52051504454916	0.0185563310906235	M1_vs_M0	HSALNG0133870	anti_sense	Q75	hsa-miR-619-5p,hsa-miR-4279,hsa-miR-6132	Aging,Emotional symptom measurement,-	IL17RA	SRSF5
ENSG00000250509	ENSG00000250509	5.78738768333065	2.0356675938335e-19	M1_vs_M0	HSALNG0047167	integenic	Q75	hsa-miR-619-5p,hsa-miR-6086	Joint damage measurement,-	CNOT6	PCNX1
ENSG00000225032	ENSG00000225032	-1.76374301962587	2.31349468488691e-7	M1_vs_M0	HSALNG0074542	anti_sense	Q50	hsa-miR-6089	-	FPGS	PSMC1
ENSG00000258317	ENSG00000258317	1.61020619257869	0.0243231064311325	M1_vs_M0	HSALNG0091499	anti_sense	Q90	NA	Systemic scleroderma,-	SMARCC2	IFT52
ENSG00000250240	ENSG00000250240	1.36744573100503	9.52990354125001e-7	M1_vs_M0	HSALNG0043615	anti_sense	Q75	NA	-	SPATA9	DNAJC5
ENSG00000232006	ENSG00000232006	4.15154405161487	1.04744468993414e-5	M1_vs_M0	HSALNG0149924	integenic	Not conserved	hsa-miR-4691-5p	NA	NA	PRELID3B
ENSG00000272914	ENSG00000272914	1.44736520149421	0.0111261275549346	M1_vs_M0	HSALNG0077069	sense	Q90	NA	Body height,Neuroimaging measurement; Brain measurement,Neuroimaging measurement; Cortical thickness,-	ZNF438	SLC17A9
ENSG00000272068	BCAN-AS1	-2.89427461713901	4.90368652578918e-25	M1_vs_M0	HSALNG0007612	anti_sense	Q75	hsa-miR-4722-5p,hsa-miR-6511a-3p	Blood protein measurement,-	NES	JAG1
ENSG00000258458	OXA1L-DT	-1.94515313411045	0.0140664663580596	M1_vs_M0	HSALNG0099968	anti_sense	Q90	hsa-miR-4296	Susceptibility to infectious disease measurement,-	SLC7A7	TAFAZZIN
ENSG00000234028	EIF2AK3-DT	-1.46223679207777	0.0283377142420779	M1_vs_M0	HSALNG0016705	anti_sense	Q50	NA	-	RPIA	SUPT20H
ENSG00000231407	GORAB-AS1	7.61521092167835	6.755676257559431e-15	M1_vs_M0	HSALNG0008377	anti_sense	Q50	hsa-miR-5011-3p,hsa-miR-8485	Bmi-adjusted waist-hip ratio,Adolescent idiopathic scoliosis,Bmi-adjusted waist circumference,Soluble triggering receptor expressed on myeloid cells 2 measurement,-,Androgenetic alopecia	KIFAP3	ACOD1
ENSG00000277954	ENSG00000277954	-2.67335099025598	4.490381199080991e-9	M1_vs_M0	HSALNG0112888	anti_sense	Q75	NA	Bmi-adjusted waist circumference,Body height,-	MAF	MGRN1
ENSG00000274272	ENSG00000274272	-1.51636059578444	3.07689269034127e-5	M1_vs_M0	HSALNG0060024	sense	Not conserved	NA	-	LRCH4	MAZ
ENSG00000272502	ENSG00000272502	-1.86936193663505	3.02084317868604e-8	M1_vs_M0	HSALNG0068084	anti_sense	Not conserved	NA	NA	MTBP	AAGAB
ENSG00000287626	ENSG00000287626	6.5843139678491	5.80563379802329e-30	M1_vs_M0	HSALNG0048279	anti_sense	Not conserved	hsa-miR-6089,hsa-miR-6763-5p	Alkaline phosphatase measurement,Squamous cell carcinoma,Body height,-	JARID2	IGDCC4
ENSG00000291043	GLUD1P3	-1.94142137019303	1.80583560605959e-24	M1_vs_M0	HSALNG0078866	integenic	Not conserved	NA	-	SEC24C	CD276
ENSG00000261064	LINC02256	-2.39291080534222	3.2466982459601e-4	M1_vs_M0	HSALNG0104864	integenic	Not conserved	NA	NA	GOLGA8N	EIF3J
ENSG00000234199	LINC01191	1.59700334915558	4.17700232934679e-5	M1_vs_M0	HSALNG0018115	integenic	Not conserved	NA	NA	ACTR3	BLOC1S6
ENSG00000253199	LINC02153	6.50022906301187	1.24287542808899e-6	M1_vs_M0	HSALNG0063824	integenic	Q50	hsa-miR-6779-5p,hsa-miR-6889-3p	Sphingomyelin measurement,Cervical carcinoma,Response to tamsulosin,Body height; Body mass index,Body mass index,Attention function measurement,Cholesteryl ester 18:0 measurement; Sphingomyelin 16:1 measurement,Beta-amyloid 1-42 measurement,Sphingomyelin 18:1 measurement,Microglial activation measurement,Diabetes mellitus biomarker,Interleukin-6 measurement,Entorhinal cortical volume,Visceral adipose tissue measurement,Influenza a (h1n1),Protein measurement,Cognitive inhibition measurement,Self reported educational attainment; Intelligence; Cognitive function measurement; Mathematical ability,Irritable bowel syndrome,Mathematical ability,Diastolic blood pressure; Sodium measurement,Squamous cell lung carcinoma; Family history of lung cancer,Preterm premature rupture of the membranes; Spontaneous preterm birth,-	ATP6V1B2	SGK3
ENSG00000286153	ENSG00000286153	2.96315490708114	5.1903899156517e-22	M1_vs_M0	HSALNG0132875	anti_sense	Not conserved	NA	Erythrocyte count; Response to vaccine; Mean corpuscular hemoglobin; Cognitive decline measurement; Monocyte percentage of leukocytes,Balding measurement,Alopecia,Eosinophil count,Monocyte count,-	CLIC6	GSDMD
ENSG00000273002	ARHGEF2-AS2	1.35826680219585	9.868140771050321e-9	M1_vs_M0	HSALNG0007540	anti_sense	Q75	NA	Comparative body size at age 10, self-reported,-	RXFP4	SH2D4A
ENSG00000272142	LYRM4-AS1	-1.30548780678339	0.00319264369922964	M1_vs_M0	HSALNG0047777	integenic	Not conserved	NA	NA	PPP1R3G	MCM4
ENSG00000255775	ENSG00000255775	-3.35837020739172	0.0051102410531886	M1_vs_M0	HSALNG0088821	integenic	Not conserved	hsa-miR-210-5p,hsa-miR-619-5p,hsa-miR-4258,hsa-miR-3620-5p,hsa-miR-1587,hsa-miR-6089	Platelet component distribution width,Reticulocyte count; Reticulocyte measurement,Platelet count,Mean platelet volume; Platelet-to-lymphocyte ratio,Mean platelet volume,-	VWF	DHDH
ENSG00000248138	ENSG00000248138	-5.08057756703855	0.00630086700024713	M1_vs_M0	HSALNG0033105	integenic	Q75	NA	NA	CD38	MAP4K1
ENSG00000205885	C1RL-AS1	1.77940275397015	6.04243123204116e-6	M1_vs_M0	HSALNG0088972	anti_sense	Q50	hsa-miR-4418,hsa-miR-4733-3p,hsa-miR-6090,hsa-miR-6165,hsa-miR-8485	Neuritic plaque measurement,Platelet count,Platelet crit,-	CLSTN3	SARS2
ENSG00000245532	NEAT1	1.1143702245304	3.75283733036333e-40	M1_vs_M0	HSALNG0084892	integenic	Q50	hsa-miR-4308,hsa-miR-4710,hsa-miR-6724-5p,hsa-miR-6747-3p,hsa-miR-8485	Bmi-adjusted hip circumference,Hemoglobin a1 measurement,-	FRMD8	FCGRT
ENSG00000236013	LINC02941	-5.36576564707966	4.5930283888351303e-14	M1_vs_M0	HSALNG0053902	integenic	Not conserved	hsa-miR-574-5p	NA	HECA	PTOV1
ENSG00000254528	FXYD6-AS1	-4.29978091016704	8.487917473980909e-11	M1_vs_M0	HSALNG0087478	anti_sense	Q50	NA	-	IL10RA	LILRA1
ENSG00000226125	LINC01907	-3.27934949240553	7.90427626341808e-14	M1_vs_M0	HSALNG0022889	integenic	Not conserved	hsa-miR-6089	-	GPR55	SYDE1
ENSG00000270504	ENSG00000270504	-1.41922857406963	0.00528126234366755	M1_vs_M0	HSALNG0047648	anti_sense	Q50	hsa-miR-30b-3p,hsa-miR-6133	-	FAM50B	NKG7
ENSG00000260911	ENSG00000260911	1.69433919485982	0.0265144365808421	M1_vs_M0	HSALNG0110810	integenic	Not conserved	NA	NA	STX4	GRIN2D
ENSG00000261485	PAN3-AS1	-1.45324496208438	3.93722640734831e-13	M1_vs_M0	HSALNG0095998	anti_sense	Q90	NA	-	FLT3	HAS1
ENSG00000253414	LINC01605	-4.12147082516039	2.62224840127789e-41	M1_vs_M0	HSALNG0150382	integenic	Q90	hsa-miR-149-3p,hsa-miR-4486	Body height,Endometriosis,-	BRF2	ARMC6
ENSG00000289581	ENSG00000289581	5.98095391105049	7.91835321211511e-5	M1_vs_M0	NA	NA	NA	NA	NA	RGL1	ZNF14
ENSG00000275278	ENSG00000275278	-2.89523131630099	4.02516799745539e-8	M1_vs_M0	HSALNG0090086	anti_sense	Q50	hsa-miR-3960,hsa-miR-6744-3p,hsa-miR-4433b-3p	Fructose measurement; Glucose measurement; Galactose measurement,-	ERGIC2	PMPCB
ENSG00000288827	ENSG00000288827	2.02522239533588	3.5373599971707003e-10	M1_vs_M0	NA	NA	NA	NA	NA	DHX34	DNAJC2
ENSG00000277559	ENSG00000277559	-2.44996588799153	9.44131977600557e-18	M1_vs_M0	HSALNG0111560	anti_sense	Q90	hsa-miR-4456	Tonsillectomy risk measurement,Self reported educational attainment; Intelligence,-	FTO	TFPI2
ENSG00000260778	MIR3677HG	-1.50325058778246	0.0346326015627326	M1_vs_M0	HSALNG0108999	anti_sense	Not conserved	hsa-miR-1343-3p,hsa-miR-6089,hsa-miR-6791-5p	Bmi-adjusted hip circumference,-	DNASE1L2	DUS4L
ENSG00000291135	FCGR1BP	1.26866888093898	5.33706078918351e-5	M1_vs_M0	NA	NA	NA	NA	NA	SRGAP2C	H2AZ2
ENSG00000227953	LINC01341	-1.17193579208859	0.013260094996309	M1_vs_M0	HSALNG0012202	integenic	Q50	hsa-miR-939-5p,hsa-miR-4436a,hsa-miR-6089,hsa-miR-6753-5p,hsa-miR-6775-3p,hsa-miR-6812-3p,hsa-miR-7160-5p	-	SCCPDH	CPED1
ENSG00000234147	ENSG00000234147	-1.35898484893866	3.75283733036333e-40	M1_vs_M0	HSALNG0053918	integenic	Q75	hsa-miR-4281,hsa-miR-6776-5p,hsa-miR-8485	3-hydroxypropylmercapturic acid measurement,Susceptibility to bacterial meningitis measurement,Sleep quality,Facial emotion recognition measurement,Response to diisocyanate,Acute lymphoblastic leukemia,Systolic blood pressure change measurement; Response to hydrochlorothiazide,Fev/fec ratio,Reaction time measurement,-	NMBR	HSPB1
ENSG00000232197	ENSG00000232197	-2.59043872451613	8.07190713932059e-17	M1_vs_M0	HSALNG0055420	integenic	Not conserved	hsa-miR-6883-5p,hsa-miR-6890-3p	Prostate carcinoma,-	FAM120B	TMEM176B
ENSG00000291129	PPIEL	1.0320123659327	1.04289518407495e-15	M1_vs_M0	HSALNG0002774	anti_sense	Q90	hsa-miR-631,hsa-miR-3135b,hsa-miR-4722-5p,hsa-miR-6089,hsa-miR-8485	Forced expiratory volume; Red blood cell distribution width; Traffic air pollution measurement; Fev/fec ratio; Peak expiratory flow; Peripheral arterial disease,Peripheral arterial disease; Alkaline phosphatase measurement; Traffic air pollution measurement,Testosterone measurement,Diastolic blood pressure,Triglyceride measurement; Mean corpuscular volume,Mean corpuscular volume; Mean corpuscular hemoglobin,Mean corpuscular hemoglobin,High density lipoprotein cholesterol measurement; Waist-hip ratio,Triglyceride measurement; C-reactive protein measurement; Waist-hip ratio,Chronic obstructive pulmonary disease; Resting heart rate,-	PABPC4	PRKAG2
ENSG00000249173	LINC01093	4.99303548937536	0.0220338516378563	M1_vs_M0	HSALNG0039055	integenic	Q50	hsa-miR-619-5p,hsa-miR-4505,hsa-miR-6808-5p,hsa-miR-6769b-5p	NA	ACSL1	RLN1
ENSG00000270112	ST8SIA5-DT	-4.26562826940844	3.48313281030493e-40	M1_vs_M0	HSALNG0121346	anti_sense	Q75	hsa-miR-4667-3p,hsa-miR-6089,hsa-miR-6803-5p	Adolescent idiopathic scoliosis,-	KATNAL2	PLGRKT
ENSG00000187185	ENSG00000187185	-8.74083620298087	1.09213427970302e-32	M1_vs_M0	HSALNG0111803	anti_sense	Q75	hsa-miR-619-5p,hsa-miR-6069	-	KATNB1	PLGRKT
ENSG00000270127	ENSG00000270127	1.26562121989424	9.69459519838048e-6	M1_vs_M0	HSALNG0108582	integenic	Not conserved	NA	NA	CERS3	ABCA2
ENSG00000269420	PLA2G4C-AS1	1.86318002964536	0.0497308089121037	M1_vs_M0	HSALNG0126825	anti_sense	Q50	hsa-miR-6803-5p	-	ELSPBP1	RAB11FIP2
ENSG00000272953	ENSG00000272953	-2.77891249225627	5.8146355183482e-4	M1_vs_M0	HSALNG0055874	anti_sense	Q50	hsa-miR-326,hsa-miR-762,hsa-miR-3195,hsa-miR-4505,hsa-miR-4632-3p,hsa-miR-5787,hsa-miR-6803-5p	Pcsk9 protein measurement,-	SLC29A4	STN1
ENSG00000259081	ENSG00000259081	-3.05556254593036	2.97074688789878e-11	M1_vs_M0	HSALNG0102584	anti_sense	Not conserved	NA	NA	ANGEL1	MAP3K8
ENSG00000290404	ENSG00000290404	-4.43032705067205	5.99879373609154e-12	M1_vs_M0	NA	NA	NA	NA	NA	GOSR1	CBX1
ENSG00000232082	RPS6KA2-IT1	2.45312159370229	1.33808245034435e-7	M1_vs_M0	HSALNG0055101	sense	Not conserved	hsa-miR-4505,hsa-miR-6895-5p	NA	RPS6KA2	TMEM33
ENSG00000284196	ENSG00000284196	-4.4611733498083	3.09469964850736e-12	M1_vs_M0	HSALNG0098167	integenic	Q75	hsa-miR-552-5p,hsa-miR-3620-5p,hsa-miR-4505,hsa-miR-1587	Sleep duration,Cortical surface area measurement,Atopic eczema,Thrombocytopenia,Interleukin-6 measurement,Body height,Mosquito bite reaction size measurement; Mosquito bite reaction itch intensity measurement,Body mass index; Fasting blood insulin measurement,Cleft lip; Cleft palate,-	SPRY2	MANBA
ENSG00000289135	ENSG00000289135	-2.00756780423268	2.8390933579912502e-9	M1_vs_M0	HSALNG0017086	anti_sense	Q50	hsa-miR-4488,hsa-miR-9899	Parental genotype effect measurement; Birth weight,-	ANKRD23	CCDC34
ENSG00000291099	ENSG00000291099	-4.89378791049149	0.0100412595425432	M1_vs_M0	HSALNG0055915	integenic	Not conserved	NA	NA	OCM	EIF4G2
ENSG00000261659	ENSG00000261659	-2.03372485505632	9.0586235463914e-4	M1_vs_M0	NA	NA	NA	NA	NA	STUB1	SLC1A2
ENSG00000277228	ENSG00000277228	-2.7890197041387	2.2341006539894302e-9	M1_vs_M0	HSALNG0096883	integenic	Q50	hsa-miR-4492	-	LRCH1	RPS13
ENSG00000236885	ENSG00000236885	5.6713680159182	0.00254804602565252	M1_vs_M0	HSALNG0146626	integenic	Not conserved	hsa-miR-653-3p	NA	RBM43	EXPH5
ENSG00000255491	ENSG00000255491	-2.45069492765979	2.4857414629209e-89	M1_vs_M0	HSALNG0068289	integenic	Q50	hsa-miR-363-5p,hsa-miR-4505,hsa-miR-6089,hsa-miR-6754-5p	Platelet component distribution width,Triacylglycerol 58:6 measurement,Left ventricular ejection fraction measurement; Dilated cardiomyopathy; Left ventricular structural measurement; Left ventricular systolic function measurement; Hematocrit; Heart function measurement,Reticulocyte measurement,Hematocrit; Hemoglobin measurement; Pr interval,Pr interval; Left ventricular structural measurement; Atrial fibrillation,Left ventricular systolic function measurement,Platelet crit; Heart relative wall thickness; Left ventricular ejection fraction measurement; Fractional shortening; Left ventricular diastolic function measurement; Left ventricular systolic function measurement; Electrocardiography; Ejection fraction measurement,-	MTSS1	FOXM1
ENSG00000253930	TNFRSF10A-AS1	1.62472042577521	0.0412309546589652	M1_vs_M0	HSALNG0150163	anti_sense	Not conserved	NA	NA	CHMP7	ACAD10
ENSG00000235092	ID2-AS1	-1.30660120506365	1.86703677261954e-8	M1_vs_M0	HSALNG0012846	anti_sense	Q90	hsa-miR-4787-5p,hsa-miR-6784-5p,hsa-miR-6793-3p,hsa-miR-6858-5p,hsa-miR-6877-3p,hsa-miR-7108-3p	-	KIDINS220	ACAD10
ENSG00000291158	LINC00869	1.02631872110357	3.3467735572341303e-9	M1_vs_M0	HSALNG0141914	integenic	Not conserved	NA	NA	PPIAL4C	RAB5B
ENSG00000285722	ENSG00000285722	-3.98619811405873	2.11585086545579e-21	M1_vs_M0	HSALNG0136188	integenic	Q50	hsa-miR-4667-5p	-	ZBED4	KRR1
ENSG00000284391	ENSG00000284391	-5.34625418373349	1.57627073490706e-22	M1_vs_M0	HSALNG0138430	anti_sense	Q90	NA	NA	TEX11	CDCA3
ENSG00000239415	ENSG00000239415	-2.09668669956665	0.0430677387152768	M1_vs_M0	HSALNG0133724	sense	Q50	hsa-miR-6089	-	MCM3AP	GNPTAB
ENSG00000255139	ENSG00000255139	2.44129534142269	8.7966270571314e-4	M1_vs_M0	HSALNG0084419	anti_sense	Q90	hsa-miR-4447,hsa-miR-3960,hsa-miR-6085	Protein measurement,-,Igf-1 measurement	OR4D9	NT5DC3
ENSG00000266947	ENSG00000266947	1.21720776108689	3.51672902309459e-7	M1_vs_M0	HSALNG0115929	integenic	Not conserved	hsa-miR-619-5p	-	SLC35G3	FAM184A
ENSG00000258754	LINC01579	-2.77902307950257	5.0596045039422e-4	M1_vs_M0	HSALNG0144618	integenic	Q75	NA	-	RGMA	GABRR2
ENSG00000288966	ENSG00000288966	-3.4179376876928	2.8724670978976e-9	M1_vs_M0	HSALNG0066049	integenic	Q75	hsa-miR-149-3p,hsa-miR-3943,hsa-miR-4710,hsa-miR-4743-5p	Alkaline phosphatase measurement,-	XKR9	SOBP
ENSG00000267262	ENSG00000267262	-1.46222267096407	0.0283377142420779	M1_vs_M0	HSALNG0123520	anti_sense	Q75	hsa-miR-619-5p	-	ACSBG2	MRPL2
ENSG00000176659	LINC02910	-5.2152082673305	2.16426585276707e-52	M1_vs_M0	HSALNG0131382	integenic	Not conserved	NA	NA	CDH26	LAMA4
ENSG00000256955	ENSG00000256955	-2.29925471178957	0.0199953988067657	M1_vs_M0	HSALNG0095244	integenic	Not conserved	hsa-miR-619-5p,hsa-miR-4534,hsa-miR-6784-5p,hsa-miR-8073	NA	MMP17	MEP1A
ENSG00000233223	ENSG00000233223	2.30718722785942	2.84299755357918e-26	M1_vs_M0	HSALNG0114322	anti_sense	Q50	hsa-miR-363-5p,hsa-miR-1224-3p,hsa-miR-6089,hsa-miR-7160-3p	Testosterone measurement; Sex hormone-binding globulin measurement; Serum igm measurement,Testosterone measurement,Serum metabolite measurement,Cortical thickness,Metabolic syndrome,Heel bone mineral density,Fev/fec ratio; Response to bronchodilator,-,Testosterone measurement; Sex hormone-binding globulin measurement,Protein measurement; Sex hormone-binding globulin measurement; Serum iga measurement,Red blood cell distribution width,Platelet component distribution width	SOX15	HARS2
ENSG00000276649	ENSG00000276649	1.14903496942236	0.00314395805530163	M1_vs_M0	HSALNG0128155	anti_sense	Q75	hsa-miR-361-3p,hsa-miR-762,hsa-miR-4710,hsa-miR-5008-5p,hsa-miR-6845-3p	Uridine diphosphate galactose measurement; Uridine diphosphate glucose measurement,-	PDYN	PCDHB3
ENSG00000272115	ENSG00000272115	-2.39098474491166	0.0420040718766873	M1_vs_M0	HSALNG0069415	anti_sense	Not conserved	hsa-miR-8072	NA	ADCK5	CCNG1
ENSG00000265519	ENSG00000265519	1.89024638523608	7.58170553894871e-7	M1_vs_M0	HSALNG0114816	integenic	Not conserved	hsa-miR-1224-3p	-	TRIM16	TRAPPC13
ENSG00000262223	LINC03048	3.52958038914323	6.7630881776017e-6	M1_vs_M0	HSALNG0119251	integenic	Q50	hsa-miR-132-5p,hsa-miR-619-5p,hsa-miR-3620-5p,hsa-miR-4492,hsa-miR-4505,hsa-miR-1587,hsa-miR-6769b-5p,hsa-miR-4433b-3p	Dental caries; Bmi-adjusted hip circumference; Dentures,Self reported educational attainment,Body height,Systolic blood pressure,Beta blocking agent use measurement,-	SLC38A10	COL7A1
ENSG00000225886	ENSG00000225886	4.41209863655937	2.1903263724216894e-55	M1_vs_M0	HSALNG0002013	integenic	Not conserved	NA	NA	FAM76A	CBLB
ENSG00000273174	ENSG00000273174	1.71388691120599	5.14351745772017e-18	M1_vs_M0	HSALNG0028857	anti_sense	Q50	NA	-	GP9	KLHL18
ENSG00000226312	CFLAR-AS1	2.39586145580412	1.56786663264637e-8	M1_vs_M0	HSALNG0021529	anti_sense	Q50	hsa-miR-30b-3p	Total blood protein measurement,-	HYCC2	COMMD2
ENSG00000272839	ENSG00000272839	-2.08787128563382	0.00508857181126885	M1_vs_M0	HSALNG0062763	anti_sense	Not conserved	hsa-miR-4463	NA	DNAJB6	RRP9
ENSG00000288845	ENSG00000288845	3.1049242398185	0.014067202049583701	M1_vs_M0	HSALNG0054719	anti_sense	Q50	hsa-miR-485-5p,hsa-miR-4467,hsa-miR-4516,hsa-miR-4530,hsa-miR-3960,hsa-miR-4707-3p,hsa-miR-6791-5p,hsa-miR-6858-3p,hsa-miR-7108-3p,hsa-miR-7112-5p	Leukocyte count,Lymphocyte count,Myeloid white cell count; Celiac disease,Lipoprotein a measurement,Nicotine dependence symptom count,Autoimmune disease; Systemic lupus erythematosus; Celiac disease,Hypothyroidism,Leukocyte count; Neutrophil count,Neutrophil count; Leukocyte count; Neutrophil percentage of leukocytes; Eosinophil count; Granulocyte count,Eczema,Crohn's disease; Inflammatory bowel disease; Celiac disease,Rheumatoid arthritis; Crohn's disease,Gut microbiome measurement,Psoriasis; Ulcerative colitis; Ankylosing spondylitis; Crohn's disease; Rheumatoid arthritis; Sclerosing cholangitis,Celiac disease,Rheumatoid arthritis,Rheumatoid arthritis; Celiac disease,-,Systemic lupus erythematosus,Cognitive inhibition measurement,Eosinophil percentage of leukocytes	FNDC1	EIF4G1
ENSG00000227719	ENSG00000227719	-1.84746042987114	0.00223298832232938	M1_vs_M0	HSALNG0056082	anti_sense	Q75	hsa-miR-6809-3p	NA	GLCCI1	RTKN
ENSG00000254287	ENSG00000254287	9.15638160326247	3.34547903131091e-42	M1_vs_M0	HSALNG0150387	anti_sense	Q50	NA	-	ADAM2	OTOF
ENSG00000287335	ENSG00000287335	8.0536282812132	1.2674846096727899e-18	M1_vs_M0	HSALNG0130592	integenic	Not conserved	hsa-miR-619-5p,hsa-miR-6089	Seasonality measurement,-	NCOA3	TLX2
ENSG00000266389	PIK3R5-DT	1.6446619216768	2.54050462990669e-5	M1_vs_M0	HSALNG0114479	integenic	Q75	hsa-miR-4492,hsa-miR-6810-3p,hsa-miR-6845-5p	NA	NTN1	DNAH6
ENSG00000233098	CCDC144NL-AS1	1.24275772391581	1.32891352331197e-62	M1_vs_M0	HSALNG0115238	integenic	Not conserved	hsa-miR-4286	NA	DHRS7B	UXS1
ENSG00000229431	MED8-AS1	1.27182013557325	6.19254062721257e-6	M1_vs_M0	HSALNG0003091	anti_sense	Q75	NA	White matter microstructure measurement,Platelet count; Platelet crit,Igf-1 measurement,-	SZT2	QPCT
ENSG00000271936	ENSG00000271936	-1.34459076056788	0.00548079319812785	M1_vs_M0	HSALNG0013623	anti_sense	Q50	NA	Appendicular lean mass,Body height,Age at menarche,Bmi-adjusted waist circumference,Bmi-adjusted hip circumference,Susceptibility to pneumonia measurement,Body mass index,Reticulocyte count,Psoriasis; Inflammatory bowel disease; Ulcerative colitis; Ankylosing spondylitis; Crohn's disease; Sclerosing cholangitis,C-reactive protein measurement,-	CENPO	SLC25A12
ENSG00000291233	ENSG00000291233	3.95339185312292	7.15731518548562e-5	M1_vs_M0	NA	NA	NA	NA	NA	NBPF9	RMDN2
ENSG00000251209	LINC00923	-1.89460733253659	1.77753215416882e-8	M1_vs_M0	HSALNG0108451	integenic	Q50	hsa-miR-3620-5p,hsa-miR-4505,hsa-miR-1587,hsa-miR-6803-5p	Executive function measurement,Dna methylation,Small cell lung carcinoma,Thyroid carcinoma,Bone mineral content measurement,Body mass index,Smoking status measurement,Diastolic blood pressure,Systolic blood pressure,Bmi-adjusted waist-hip ratio,Childhood trauma measurement; Smoking behaviour measurement,Response to ketamine; Dissociation measurement,Ischemic stroke; Coronary artery disease,-	PGPEP1L	SDC1
ENSG00000289260	ENSG00000289260	3.10062424875625	5.0813514820608e-4	M1_vs_M0	HSALNG0044043	integenic	Not conserved	NA	-	FER	SDC1
ENSG00000204929	LINC02934	2.16058885160208	0.0273514317172629	M1_vs_M0	HSALNG0015567	integenic	Not conserved	NA	-	ACTR2	COX7A2L
ENSG00000227527	ENSG00000227527	-1.35541925904867	0.0137263113683339	M1_vs_M0	HSALNG0002990	sense	Q50	hsa-miR-3960	NA	FOXJ3	DNAJC16
ENSG00000266913	LINC01841	5.68776094303874	7.9972314354802e-4	M1_vs_M0	HSALNG0124294	integenic	Not conserved	hsa-miR-766-3p,hsa-miR-4323	NA	DDX39A	MARK1
ENSG00000285517	ENSG00000285517	-1.39613667370277	3.19745185621585e-8	M1_vs_M0	HSALNG0090154	integenic	Not conserved	hsa-miR-6780a-5p	NA	TSPAN11	KIAA2013
ENSG00000259248	USP3-AS1	1.32443114819903	0.0208429406159493	M1_vs_M0	HSALNG0106502	anti_sense	Q90	hsa-miR-612,hsa-miR-1226-5p,hsa-miR-3176,hsa-miR-4472,hsa-miR-6769b-5p	Self reported educational attainment; Mathematical ability,Bmi-adjusted waist circumference,Bmi-adjusted waist-hip ratio,Forced expiratory volume; Fev/fec ratio; Peak expiratory flow,Electrocardiography,Thyroxine measurement,Qrs duration,Aortic root size,Reticulocyte count; Reticulocyte measurement,Inflammatory biomarker measurement; Ykl40 measurement,Heel bone mineral density,-	HERC1	RO60
ENSG00000275763	ZNF516-DT	-1.81195670045597	8.35699097885542e-5	M1_vs_M0	HSALNG0145503	integenic	Q75	NA	-	ZNF236	OLFML3
ENSG00000231721	LINC-PINT	3.03322377408597	1.26543020045894e-125	M1_vs_M0	HSALNG0150064	integenic	Q50	NA	NA	KLF14	ECE1
ENSG00000255874	PRECSIT	1.52298284632055	3.12824761294658e-5	M1_vs_M0	HSALNG0141617	integenic	Not conserved	NA	Sitting height ratio	ANKRD10	DR1
ENSG00000235204	ENSG00000235204	-1.22057602798909	0.00221877992912531	M1_vs_M0	HSALNG0074324	anti_sense	Q50	NA	-	PSMB7	PTBP2
ENSG00000236345	SCAT8	-1.57619761477868	1.11925546781321e-17	M1_vs_M0	HSALNG0050986	anti_sense	Q75	hsa-miR-6763-5p	-	PHF3	DARS2
ENSG00000262097	LINC02185	-4.24520529383504	3.451430182199599e-98	M1_vs_M0	HSALNG0109713	integenic	Q50	hsa-miR-645,hsa-miR-4330,hsa-miR-4453	-	PARN	STMN1
ENSG00000285725	ENSG00000285725	2.95728165373613	0.00244547643850295	M1_vs_M0	HSALNG0059775	integenic	Q90	hsa-miR-619-5p,hsa-miR-4505,hsa-miR-6089,hsa-miR-7113-3p	-	OCM2	PPP1R8
ENSG00000290735	ENSG00000290735	3.0217439793964	1.09903371664264e-6	M1_vs_M0	HSALNG0006949	integenic	Not conserved	NA	NA	H3-7	DDX59
ENSG00000231535	LINC00278	1.42050722379279	3.38367652120491e-16	M1_vs_M0	HSALNG0140973	integenic	Not conserved	NA	NA	ZFY	CREB1
ENSG00000272505	ENSG00000272505	-1.09338750341563	2.87945771425583e-5	M1_vs_M0	HSALNG0063375	anti_sense	Not conserved	NA	Bmi-adjusted waist circumference; White matter microstructure measurement,Bmi-adjusted waist-hip ratio,Neuroticism measurement,Bmi-adjusted waist circumference,-	PRSS55	SLC16A7
ENSG00000245017	LINC02453	-4.89272055950807	0.0206027733329219	M1_vs_M0	HSALNG0093379	integenic	Q90	NA	Colorectal adenoma,-	IKBIP	STBD1
ENSG00000289123	ENSG00000289123	-4.15627312661094	1.2183708649295102e-9	M1_vs_M0	HSALNG0072704	integenic	Q50	hsa-miR-619-5p,hsa-miR-644a,hsa-miR-4258,hsa-miR-4466,hsa-miR-4685-3p,hsa-miR-6803-5p,hsa-miR-6837-3p,hsa-miR-7704,hsa-miR-8069	Balding measurement,Platelet crit,Platelet count,Ulcerative colitis; Inflammatory bowel disease,Eczema,Bmi-adjusted waist-hip ratio,Waist-hip ratio,Neutrophil percentage of granulocytes,Eosinophil percentage of leukocytes,Eosinophil count,Parental genotype effect measurement; Gestational blood glucose measurement; Glycosuria,Leukocyte count,-	SYK	MFSD1
ENSG00000291143	ENSG00000291143	1.83866854811268	0.00420609735343114	M1_vs_M0	NA	NA	NA	NA	NA	OR2AG2	UBE2B
ENSG00000289161	ENSG00000289161	2.83929387925658	1.1501272407131196e-162	M1_vs_M0	HSALNG0069294	anti_sense	Not conserved	hsa-miR-619-5p	-	MROH6	SET
ENSG00000204387	SNHG32	1.18230779174359	8.86038339968917e-62	M1_vs_M0	HSALNG0049337	integenic	Not conserved	hsa-miR-4463,hsa-miR-4722-5p,hsa-miR-5680,hsa-miR-6800-3p	Hiv-1 infection,Serum igg glycosylation measurement,Platelet count,Coronary artery disease,Bmi-adjusted hip circumference,Response to thioamide; Drug-induced agranulocytosis,-	HSPA1B	RBM18
ENSG00000289407	ENSG00000289407	-3.93350581678483	1.0492211980653e-4	M1_vs_M0	HSALNG0003260	anti_sense	Q90	hsa-miR-619-5p,hsa-miR-6089	-	CCDC17	YLPM1
ENSG00000232485	RPL37A-DT	-2.4587896939589	9.9335930495494e-4	M1_vs_M0	HSALNG0022128	anti_sense	Not conserved	hsa-miR-619-5p,hsa-miR-4286	-	MARCHF4	TTLL5
ENSG00000290793	ENSG00000290793	2.52853409814202	7.93398347897288e-10	M1_vs_M0	NA	NA	NA	NA	NA	AMZ2	FLVCR2
ENSG00000233532	LINC00460	5.69721956103143	4.3245329648077e-4	M1_vs_M0	HSALNG0099182	integenic	Q75	NA	-	DAOA	PPP4R4
ENSG00000231528	FAM225A	2.87152112763492	2.5103205544678895e-126	M1_vs_M0	HSALNG0073810	integenic	Not conserved	NA	NA	SLC31A2	KLHL29
ENSG00000291077	ENSG00000291077	3.25681581426179	1.70973434030456e-41	M1_vs_M0	NA	NA	NA	NA	NA	ARHGEF19	YIPF4
ENSG00000289589	ENSG00000289589	3.52411752244309	3.36246609444783e-8	M1_vs_M0	HSALNG0008846	integenic	Not conserved	hsa-miR-619-5p,hsa-miR-7108-5p	Eosinophil count; Eosinophil percentage of leukocytes,Eosinophil count,Neuroimaging measurement; Cortical thickness; Brain measurement,-	STX6	OGFRL1
ENSG00000270605	ENSG00000270605	-1.5241276033848	0.00276987060697196	M1_vs_M0	HSALNG0002045	anti_sense	Q50	hsa-miR-19b-2-5p,hsa-miR-619-5p,hsa-miR-3620-5p,hsa-miR-4505,hsa-miR-4508,hsa-miR-1587,hsa-miR-5693,hsa-miR-5787,hsa-miR-6089	Aspartate aminotransferase measurement,-	DNAJC8	IDE
ENSG00000272405	ENSG00000272405	-3.63182334653108	7.450296207296099e-201	M1_vs_M0	HSALNG0007612	anti_sense	Q75	hsa-miR-4722-5p,hsa-miR-6511a-3p	Blood protein measurement,-	NES	ACAT2
ENSG00000260430	ENSG00000260430	1.9584246636853	4.5870757629816595e-11	M1_vs_M0	HSALNG0109982	sense	Not conserved	hsa-miR-6809-3p,hsa-miR-8072	Corneal astigmatism,Diastolic blood pressure,-	COQ7	SERP1
ENSG00000236985	ENSG00000236985	3.8835602484825	1.9266309336277e-4	M1_vs_M0	HSALNG0128858	integenic	Not conserved	hsa-miR-619-5p	NA	KIF16B	ABCC11
ENSG00000256262	USP30-AS1	6.41147641209422	1.57823054384336e-28	M1_vs_M0	HSALNG0093872	anti_sense	Not conserved	hsa-miR-4467,hsa-miR-3960	Platelet-to-lymphocyte ratio; Platelet count; Platelet crit,-	SVOP	CD80
ENSG00000227531	ENSG00000227531	9.96971415553542	5.68156360318368e-54	M1_vs_M0	HSALNG0073676	integenic	Q50	hsa-miR-23a-5p,hsa-miR-619-5p,hsa-miR-6089,hsa-miR-7107-5p	Bmi-adjusted waist-hip ratio,Monocyte count,Bmi-adjusted hip circumference,Electrocardiography,Leukocyte count,Body height at birth; Birth weight,Waist-hip ratio; Bmi-adjusted waist-hip ratio; Monocyte count,Granulocyte percentage of myeloid white cells; Waist-hip ratio; Bmi-adjusted hip circumference; Myeloid white cell count; Bmi-adjusted waist-hip ratio; Monocyte count; Monocyte percentage of leukocytes,Late-onset alzheimers disease,Myeloid white cell count,Leukocyte count; Lymphocyte percentage of leukocytes,Monocyte percentage of leukocytes,Granulocyte percentage of myeloid white cells; Monocyte percentage of leukocytes,Body height,Neutrophil percentage of leukocytes; Bmi-adjusted waist-hip ratio; Monocyte count,Granulocyte percentage of myeloid white cells; Monocyte percentage of leukocytes; Monocyte count,Neutrophil percentage of leukocytes; Birth weight; Basophil count,Eosinophil count,Parental genotype effect measurement; Birth weight,Response to antineoplastic agent; Venous thromboembolism,-	OR2K2	CD80
ENSG00000267607	ICAM4-AS1	4.02171708101394	3.82305517896433e-5	M1_vs_M0	HSALNG0123921	anti_sense	Q50	hsa-miR-361-3p,hsa-miR-4472,hsa-miR-4632-3p,hsa-miR-6803-5p,hsa-miR-7111-3p	Icam-1 measurement,Covid-19; Blood protein measurement,Icam-1 measurement; Adhesion molecule measurement,-,Protein measurement,Blood protein measurement; Sex hormone-binding globulin measurement	ZGLP1	POLR3GL
ENSG00000231728	TMSB15B-AS1	-2.95247093141183	0.0302424861578753	M1_vs_M0	HSALNG0139338	integenic	Not conserved	NA	NA	RAB9B	LY9
ENSG00000274213	ENSG00000274213	2.17542193760953	7.0545029858102515e-9	M1_vs_M0	HSALNG0117605	integenic	Not conserved	hsa-miR-500b-3p	-	DGKE	RPAP2
ENSG00000257761	ENSG00000257761	3.22722469561173	0.00886340262503781	M1_vs_M0	HSALNG0092343	anti_sense	Q50	hsa-miR-6731-5p	-	ZFC3H1	POLM
ENSG00000177410	ZFAS1	1.41122224743052	5.12014330645859e-63	M1_vs_M0	HSALNG0130661	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-4271,hsa-miR-7112-5p	Body height,Intelligence,Cognitive function measurement,-	DDX27	SRGN
ENSG00000291236	ENSG00000291236	4.66017683151495	2.25322457007486e-20	M1_vs_M0	NA	NA	NA	NA	NA	TNS1	CHST3
ENSG00000187013	LINC02875	-3.67374068329997	7.0890112833535e-4	M1_vs_M0	HSALNG0145122	integenic	Not conserved	hsa-miR-331-3p,hsa-miR-920,hsa-miR-4749-3p	Hypertension; Systolic blood pressure,-	TBX2	EXOSC9
ENSG00000255269	LINC02710	3.09791377285239	0.0235760420880444	M1_vs_M0	HSALNG0083975	integenic	Q50	hsa-miR-619-5p,hsa-miR-6089	Reaction time measurement,Venous thromboembolism,Fev/fec ratio; Response to bronchodilator	PHF21A	MATN4
ENSG00000264660	ENSG00000264660	3.19533613472436	3.7118297087464e-6	M1_vs_M0	HSALNG0115236	integenic	Not conserved	NA	NA	DHRS7B	RAB22A
ENSG00000212719	LINC02693	1.70427293723329	1.57762707095676e-10	M1_vs_M0	HSALNG0115274	integenic	Not conserved	hsa-miR-612,hsa-miR-4268,hsa-miR-3670,hsa-miR-4486,hsa-miR-4492,hsa-miR-4514,hsa-miR-6870-5p,hsa-miR-6879-5p	Protein measurement,-	NATD1	STAU1
ENSG00000261512	ENSG00000261512	1.13406177797538	0.00260927582876536	M1_vs_M0	NA	NA	NA	NA	NA	SHCBP1	FASTKD3
ENSG00000228742	LINC02577	3.94165661207272	3.29464240397347e-28	M1_vs_M0	HSALNG0060386	integenic	Not conserved	hsa-miR-4281,hsa-miR-4710	Eosinophil count,Agents acting on the renin-angiotensin system use measurement,Systolic blood pressure; Common carotid intimal medial thickness; Alcohol drinking,Diuretic use measurement,Systolic blood pressure; Mean arterial pressure,Eosinophil percentage of leukocytes,Cognitive inhibition measurement,-	PIK3CG	PEPD
ENSG00000197815	ENSG00000197815	-2.38990968940447	0.0103814933039329	M1_vs_M0	HSALNG0114992	anti_sense	Not conserved	hsa-miR-4492,hsa-miR-6089	Susceptibility to strep throat measurement	RAI1	MPHOSPH10
ENSG00000291029	FKBP9P1	-2.39189818651701	0.00910194529671009	M1_vs_M0	HSALNG0058201	integenic	Not conserved	NA	-	SEPTIN14	MOCS1
ENSG00000280213	UCKL1-AS1	1.04471574577911	0.00599638297952954	M1_vs_M0	HSALNG0146891	anti_sense	Q75	NA	Urate measurement,-	DNAJC5	GNMT
ENSG00000285905	BMP8B-AS1	-2.89517968490418	3.99061685031306e-8	M1_vs_M0	HSALNG0002806	anti_sense	Q75	hsa-miR-4753-5p	-	PPIE	COL21A1
ENSG00000286585	ENSG00000286585	-2.9524686879593	0.0302301243806874	M1_vs_M0	HSALNG0030033	anti_sense	Not conserved	hsa-miR-6089	-	GMPS	GOT2
ENSG00000185433	LINC00158	10.3003750832957	1.53086991593095e-90	M1_vs_M0	HSALNG0132374	integenic	Not conserved	NA	NA	MRPL39	IRF1
ENSG00000257551	HLX-AS1	1.84443253020933	8.44244301383378e-8	M1_vs_M0	HSALNG0010765	anti_sense	Q90	hsa-miR-23a-5p,hsa-miR-6735-3p	Heart failure,Body height,Heel bone mineral density,Apolipoprotein b measurement,Urate measurement,Serum albumin measurement,Monocyte count,Neutrophil percentage of leukocytes,Leukocyte count,Granulocyte percentage of myeloid white cells; Monocyte percentage of leukocytes,Eosinophil count; Basophil count,Lymphocyte count,Neutrophil count,Fetal hemoglobin measurement,C-reactive protein measurement; Vital capacity,C-reactive protein measurement; Total cholesterol measurement,-	RAB3GAP2	UPF3B
ENSG00000246430	LINC00968	1.06757636742311	0.0131145122184529	M1_vs_M0	HSALNG0065481	integenic	Q75	hsa-miR-6791-5p	NA	PENK	MSTO1
ENSG00000286872	ENSG00000286872	2.85309282645769	1.03371873926637e-5	M1_vs_M0	HSALNG0107736	integenic	Not conserved	hsa-miR-4447,hsa-miR-4505	NA	HDGFL3	TTF1
ENSG00000269439	PGLS-DT	1.44672921739965	2.5084933276940703e-9	M1_vs_M0	HSALNG0124531	anti_sense	Q90	hsa-miR-619-5p,hsa-miR-1182,hsa-miR-4723-3p,hsa-miR-6727-3p,hsa-miR-7160-3p	Gut microbiome measurement,-	NXNL1	OPRL1
ENSG00000253633	LINC03047	-4.89245093011288	0.0276825941629114	M1_vs_M0	HSALNG0067441	integenic	Q50	NA	Mean platelet volume,Iga glomerulonephritis,Platelet component distribution width,-	ODF1	INSIG2
ENSG00000290790	ENSG00000290790	1.76650143641657	5.25459050579045e-6	M1_vs_M0	HSALNG0006964	integenic	Not conserved	hsa-miR-6743-5p	NA	H2BC18	OPA3
ENSG00000289234	ZNF496-DT	1.50000268039053	1.60277587904321e-30	M1_vs_M0	HSALNG0012257	integenic	Not conserved	hsa-miR-7156-3p	NA	NLRP3	TMX4
ENSG00000247982	LINC00926	2.60636844316737	1.6647720650179998e-109	M1_vs_M0	HSALNG0106171	sense	Q50	hsa-miR-4492,hsa-miR-4508,hsa-miR-6803-5p	-	TCF12	PLAGL2
ENSG00000259321	ENSG00000259321	2.43418683277685	3.96947514509075e-8	M1_vs_M0	HSALNG0100096	anti_sense,sense	Q90	hsa-miR-619-5p	Serum igg glycosylation measurement,-	PSME1	GLIS2
ENSG00000234456	MAGI2-AS3	2.0942276607108	8.75531151191921e-15	M1_vs_M0	HSALNG0059170	anti_sense	Q75	hsa-miR-339-5p,hsa-miR-4447,hsa-miR-3960,hsa-miR-5001-3p,hsa-miR-6749-3p,hsa-miR-6786-5p,hsa-miR-8485	-	GNAI1	ELK1
ENSG00000253230	MIR124-1HG	-1.82104451639349	3.45262560011854e-49	M1_vs_M0	HSALNG0063354	integenic	Q75	hsa-miR-486-3p,hsa-miR-650,hsa-miR-1224-3p,hsa-miR-762,hsa-miR-3178,hsa-miR-3677-3p,hsa-miR-4467,hsa-miR-4505,hsa-miR-3960,hsa-miR-6779-5p,hsa-miR-6858-3p,hsa-miR-7150	Obesity; Body mass index,Bipolar disorder,Bmi-adjusted waist circumference,-	PRSS51	DLGAP5
ENSG00000287245	ENSG00000287245	-2.39577378608547	6.79319497519935e-8	M1_vs_M0	HSALNG0087038	anti_sense	Not conserved	NA	NA	ZC3H12C	ZC4H2
ENSG00000290927	ENSG00000290927	2.64299014950648	4.08224771731513e-50	M1_vs_M0	HSALNG0110892	integenic	Not conserved	hsa-miR-210-5p,hsa-miR-320a-5p,hsa-miR-4289,hsa-miR-6132,hsa-miR-6722-3p,hsa-miR-6776-5p	-	KRBOX5	HELB
ENSG00000259250	ENSG00000259250	-1.86289895871586	2.41287864714615e-8	M1_vs_M0	HSALNG0106240	anti_sense	Q50	NA	-	LIPC	IDUA
ENSG00000248187	ENSG00000248187	-2.5631379480134	8.470688136711191e-15	M1_vs_M0	HSALNG0037074	integenic	Q50	hsa-miR-6855-5p,hsa-miR-6769b-5p	NA	PGRMC2	PLA2G5
ENSG00000291058	ENSG00000291058	-3.42377567879023	1.11622011265063e-36	M1_vs_M0	HSALNG0104695	integenic	Not conserved	NA	-	APBA2	PKMYT1
ENSG00000228436	RRAGC-DT	1.77399025127782	0.0016632122490856	M1_vs_M0	HSALNG0002723	overlap_antisense,anti_sense	Q90	hsa-miR-363-5p,hsa-miR-619-5p	Protein measurement,Blood protein measurement,Kunitz-type protease inhibitor 1 measurement,Triglyceride measurement,Age at menopause,Unipolar depression,Sweet beverage consumption measurement,-	AKIRIN1	METTL25
ENSG00000286248	ENSG00000286248	5.84057861350564	1.1086119911378e-35	M1_vs_M0	HSALNG0094569	anti_sense	Not conserved	hsa-miR-1268b	Interleukin-8 measurement; C-reactive protein measurement; Chronic obstructive pulmonary disease,C-reactive protein measurement,C-reactive protein measurement; Serum gamma-glutamyl transferase measurement,-	CAMKK2	PNKD
ENSG00000238045	MVP-DT	1.50100508402339	2.26267902875675e-5	M1_vs_M0	HSALNG0144898	anti_sense	Q90	hsa-miR-4745-3p	NA	CDIPT	MTERF1
ENSG00000272841	MAP3K4-AS1	3.07204827274164	3.05573888540954e-36	M1_vs_M0	NA	NA	NA	NA	NA	AGPAT4	ASPHD2
ENSG00000245556	SCAMP1-AS1	1.32381312082359	2.95807876215468e-13	M1_vs_M0	HSALNG0042878	integenic	Q50	hsa-miR-619-5p	NA	AP3B1	MPST
ENSG00000286548	ENSG00000286548	6.87349844324059	1.5639101718743698e-132	M1_vs_M0	HSALNG0005059	anti_sense	Q50	NA	Prostate carcinoma,Blood protein measurement,Total blood protein measurement,Mathematical ability,Adolescent idiopathic scoliosis,Bilirubin measurement,-	GBP5	APOBEC3A
ENSG00000272767	JMJD1C-AS1	-2.36064987583568	3.6843413663064e-11	M1_vs_M0	HSALNG0078365	anti_sense	Q50	hsa-miR-211-3p,hsa-miR-874-3p	Sex hormone-binding globulin measurement,-	REEP3	IFT22
ENSG00000262691	ENSG00000262691	-2.09731007308262	0.0426333207719777	M1_vs_M0	NA	NA	NA	NA	NA	SLC9A5	MKLN1
ENSG00000291113	ENSG00000291113	-2.23781780143275	6.26183037704688e-13	M1_vs_M0	HSALNG0046977	integenic	Not conserved	hsa-miR-202-3p,hsa-miR-619-5p,hsa-miR-4727-5p,hsa-miR-6089	Cleft lip; Cleft palate,-	N4BP3	MKLN1
ENSG00000231638	LUARIS	5.79310870381784	2.7518577047218e-4	M1_vs_M0	HSALNG0057557	anti_sense	Q90	NA	Beta-amyloid 1-42 measurement; Cerebrospinal fluid biomarker measurement,-	COA1	DNAJB9
ENSG00000266402	SNHG25	-2.17277022607584	1.93249566391663e-6	M1_vs_M0	HSALNG0118080	anti_sense	Q75	hsa-miR-3620-5p,hsa-miR-4505,hsa-miR-1587,hsa-miR-6716-5p	-	PRR29	LRRC17
ENSG00000290862	NMRAL2P	4.82492556400384	0.0158097783820578	M1_vs_M0	NA	NA	NA	NA	NA	SENP2	HOXD10
ENSG00000288685	ENSG00000288685	4.8282063080145	0.0244310350234191	M1_vs_M0	HSALNG0036417	integenic	Q50	NA	NA	FAM241A	HOXD10
ENSG00000237787	LINC02877	4.82581592610684	0.0175676703275688	M1_vs_M0	HSALNG0029938	integenic	Not conserved	NA	NA	RAP2B	HOXD10
ENSG00000244124	ATP1B3-AS1	5.80265042700119	3.983326774742e-4	M1_vs_M0	HSALNG0029431	anti_sense	Q50	NA	Pulse pressure measurement; Mean corpuscular hemoglobin,Red blood cell distribution width,Hair color,Hair colour measurement,Thyroid preparation use measurement,-	TFDP2	HOXD10
ENSG00000230322	ENSG00000230322	4.82396845767251	0.0142183373844179	M1_vs_M0	HSALNG0142712	intronic_antisense	Not conserved	NA	NA	USP6NL	HOXD10
ENSG00000288803	ENSG00000288803	5.8043562818281504	6.9321691645848e-4	M1_vs_M0	HSALNG0005997	integenic	Q90	hsa-miR-619-5p	-	CD53	HOXD10
ENSG00000260876	LINC01229	-1.232242780356	2.1829656689231097e-11	M1_vs_M0	HSALNG0112914	integenic	Q90	NA	NA	WWOX	WDFY4
ENSG00000270084	GAS5-AS1	-1.78717822435908	0.0368890133738835	M1_vs_M0	HSALNG0008546	integenic	Not conserved	hsa-miR-6089	Intelligence,Body height	DARS2	DUT
ENSG00000236708	SDK1-AS1	2.59406930338566	0.0140010535263326	M1_vs_M0	HSALNG0055787	anti_sense	Q90	hsa-miR-3960,hsa-miR-4787-5p	NA	CARD11	KIF1C
ENSG00000267432	DNAH17-AS1	2.15238109806398	1.67626082988816e-11	M1_vs_M0	HSALNG0119037	anti_sense	Q90	hsa-miR-515-3p,hsa-miR-3197,hsa-miR-1268b,hsa-miR-6089,hsa-miR-6165,hsa-miR-6879-3p,hsa-miR-7843-5p	-	PGS1	ASH2L
ENSG00000268362	ENSG00000268362	-1.10435778560163	3.02222255152059e-5	M1_vs_M0	HSALNG0125076	sense	Not conserved	hsa-miR-363-5p,hsa-miR-619-5p,hsa-miR-4492,hsa-miR-4505,hsa-miR-6089,hsa-miR-6090	Response to paclitaxel,Adolescent idiopathic scoliosis	ZNF254	SGO1
ENSG00000269934	ENSG00000269934	-1.11410903452524	6.05883390948086e-5	M1_vs_M0	HSALNG0011224	anti_sense	Not conserved	NA	-	TRIM11	STARD8
ENSG00000251002	TRD-AS1	-2.29783462068054	1.9117683981315e-4	M1_vs_M0	HSALNG0099951	integenic	Not conserved	hsa-miR-4505	NA	DAD1	ATP8B3
ENSG00000245008	ENSG00000245008	-2.4780425015494	0.00521843958116041	M1_vs_M0	HSALNG0088107	anti_sense	Q50	hsa-miR-7150	Lymphocyte percentage of leukocytes; Lymphocyte count,Rheumatoid arthritis; Neoplasm of mature b-cells,Total blood protein measurement,Serum non-albumin protein measurement,Systemic lupus erythematosus; Chronic lymphocytic leukemia,Albumin:globulin ratio measurement; Lymphocyte count; Serum non-albumin protein measurement,Rheumatoid arthritis,Digit length ratio,Monocyte count,Monocyte percentage of leukocytes,Bmi-adjusted waist circumference,-	ETS1	TRPM4
ENSG00000231613	ENSG00000231613	-3.93287703705924	1.057882194416e-4	M1_vs_M0	HSALNG0005090	sense	Q50	hsa-miR-4505,hsa-miR-4741,hsa-miR-5787	Protein measurement,Mean platelet volume	NA	ZC3H4
ENSG00000237938	ENSG00000237938	1.5255053149561	1.9652299102083e-4	M1_vs_M0	HSALNG0001105	anti_sense	Q75	hsa-miR-5047	Systolic blood pressure,-	UQCRHL	ANGPTL6
ENSG00000259760	ENSG00000259760	3.70780076194412	2.10770022279528e-63	M1_vs_M0	HSALNG0108537	anti_sense	Q75	NA	-	TTC23	SHFL
ENSG00000286646	MAP3K5-AS2	-3.54992501927608	0	M1_vs_M0	HSALNG0053719	anti_sense	Q50	hsa-miR-619-5p	NA	PEX7	UBE4B
ENSG00000277142	LINC00235	-1.57606956379154	5.9189869955751e-4	M1_vs_M0	HSALNG0108743	anti_sense	Not conserved	hsa-miR-1182	NA	METTL26	EPS8L1
ENSG00000289932	ENSG00000289932	-7.77156097920804	4.50347872964845e-17	M1_vs_M0	HSALNG0113246	integenic	Not conserved	NA	Monocyte count,Monocyte percentage of leukocytes,Triglyceride measurement; Response to hydrochlorothiazide,-	IRF8	NUP210
ENSG00000237753	SLC20A1-DT	-1.43133073587755	7.13173791066112e-10	M1_vs_M0	HSALNG0017985	anti_sense	Q75	hsa-miR-619-5p,hsa-miR-3652,hsa-miR-4443,hsa-miR-4508,hsa-miR-378j	-	CKAP2L	FCRLA
ENSG00000229873	OGFR-AS1	2.02863066627459	1.26821852755322e-5	M1_vs_M0	HSALNG0131564	anti_sense	Q90	hsa-miR-1271-5p,hsa-miR-6800-3p	-	TCFL5	SNAP25
ENSG00000233884	ENSG00000233884	-3.57572771084933	0.00137761535756896	M1_vs_M0	HSALNG0072499	integenic	Not conserved	hsa-miR-6085,hsa-miR-7855-5p	-	CDK20	IGHMBP2
ENSG00000132832	ENSG00000132832	5.15933080356471	0.00947622494352483	M1_vs_M0	HSALNG0146964	integenic	Not conserved	NA	NA	ADA	ENSG00000132832
ENSG00000259319	JDP2-AS1	1.23156237409955	3.7674960136195e-4	M1_vs_M0	HSALNG0102519	anti_sense	Q75	hsa-miR-663b	-	ERG28	FBXO44
ENSG00000259583	ALDH1A3-AS1	-3.16315210559832	2.16173265536916e-7	M1_vs_M0	HSALNG0108607	anti_sense	Q90	NA	-	CHSY1	CPLANE2
ENSG00000287538	ENSG00000287538	2.50590764787697	2.92451404317558e-7	M1_vs_M0	HSALNG0084155	integenic	Not conserved	hsa-miR-6779-5p	NA	OR4C45	MORC4
ENSG00000276170	ENSG00000276170	-5.00103438930973	8.7906493331898e-11	M1_vs_M0	HSALNG0116158	intronic_antisense	Q50	hsa-miR-939-3p,hsa-miR-4312,hsa-miR-6812-3p	Red blood cell distribution width	SRCIN1	MKRN1
ENSG00000117242	PINK1-AS	-1.28121811516626	4.03959710641914e-6	M1_vs_M0	HSALNG0001460	intronic_antisense	Not conserved	NA	-	DDOST	ERG28
ENSG00000185168	LINC00482	-1.71813008077958	8.04383079632551e-22	M1_vs_M0	HSALNG0145393	integenic	Not conserved	hsa-miR-6852-5p	-	SLC38A10	MBD2
ENSG00000249502	MED28-DT	3.14806489758287	1.85417211673049e-50	M1_vs_M0	HSALNG0033145	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-4771	-	FAM184B	CCNB1
ENSG00000196756	SNHG17	1.27005217564309	2.1214445795158e-40	M1_vs_M0	HSALNG0129980	integenic	Q50	hsa-miR-25-5p,hsa-miR-619-5p,hsa-miR-3191-5p,hsa-miR-4323,hsa-miR-3620-5p,hsa-miR-4505,hsa-miR-1587,hsa-miR-3960,hsa-miR-4690-3p,hsa-miR-6792-3p,hsa-miR-8485	Excessive daytime sleepiness measurement,Response to fenofibrate; Triglyceride change measurement; Response to simvastatin,-	KIAA1755	GSTM1
ENSG00000237220	ENSG00000237220	5.80914527508537	6.5900104035114e-4	M1_vs_M0	HSALNG0019571	anti_sense	Q50	hsa-miR-6089	Platelet count,Arterial stiffness measurement,-	TNFAIP6	NGF
ENSG00000291114	SIGLEC17P	-2.57721602858257	3.30952812132462e-16	M1_vs_M0	NA	NA	NA	NA	NA	SIGLEC7	AP4B1
ENSG00000250929	LINC01181	5.39146349906462	2.78235257189534e-25	M1_vs_M0	HSALNG0067501	integenic	Q50	NA	Small vessel stroke,Idiopathic osteonecrosis of the femoral head,Attention deficit hyperactivity disorder,Growth-regulated alpha protein measurement,Pelvic organ prolapse,-	BAALC	CFHR4
ENSG00000251393	ENSG00000251393	2.37977339096845	2.21216499736912e-26	M1_vs_M0	HSALNG0102349	anti_sense	Q75	hsa-miR-619-5p	Self reported educational attainment,Platelet component distribution width,Platelet crit,-	RIOX1	ECHDC3
ENSG00000248927	ENSG00000248927	1.71144185124942	5.4497598840436895e-11	M1_vs_M0	HSALNG0044434	sense	Q90	NA	Self reported educational attainment,Mathematical ability,Fev/fec ratio,-	PRR16	PIWIL4
ENSG00000223949	ROR1-AS1	7.29506507612939	3.0239743656765797e-12	M1_vs_M0	HSALNG0004144	anti_sense	Q90	NA	Intelligence,Blood protein measurement,-	ITGB3BP	MTNR1B
ENSG00000253317	ENSG00000253317	1.74766754279032	2.8063188484679e-4	M1_vs_M0	HSALNG0066124	integenic	Not conserved	NA	-	KCNB2	BTF3L4
ENSG00000272720	ENSG00000272720	-2.26199031758242	5.595770833668199e-11	M1_vs_M0	HSALNG0135382	anti_sense	Q75	hsa-miR-363-5p,hsa-miR-1238-5p,hsa-miR-3196,hsa-miR-3620-5p,hsa-miR-4446-3p,hsa-miR-4463,hsa-miR-4492,hsa-miR-4505,hsa-miR-1587,hsa-miR-3960,hsa-miR-4722-5p,hsa-miR-4758-5p	White matter microstructure measurement,Age-related hearing impairment,Tinnitus,Glioma; Central nervous system cancer; Glioblastoma multiforme,-	PICK1	POGLUT2
ENSG00000288771	ENSG00000288771	-4.6961054364815	1.5405271361604898e-20	M1_vs_M0	HSALNG0071712	anti_sense	Q50	NA	Fasting blood glucose measurement	PRKACG	POGLUT2
ENSG00000242258	LINC00996	4.71011780734115	1.17636110893468e-131	M1_vs_M0	HSALNG0062275	sense	Not conserved	NA	Electroencephalogram measurement	GIMAP8	GOLM1
ENSG00000234263	MAP3K5-AS1	3.09998262722195	1.20125402944838e-5	M1_vs_M0	HSALNG0053716	anti_sense	Q75	NA	Unipolar depression	PEX7	ADAM19
ENSG00000263069	RNF213-AS1	3.36467769848611	3.25334314761185e-32	M1_vs_M0	HSALNG0119191	anti_sense	Q50	NA	-	NPTX1	TBX3
ENSG00000288947	ENSG00000288947	1.95620723797632	7.31295417127832e-7	M1_vs_M0	NA	NA	NA	NA	NA	TBX20	CCDC146
ENSG00000259354	ENSG00000259354	9.08504073506191	1.72472722006138e-38	M1_vs_M0	HSALNG0105653	intronic_antisense	Not conserved	NA	NA	C15orf48	CPM
ENSG00000203999	LINC01270	3.72710571461646	5.64192010939538e-7	M1_vs_M0	HSALNG0130755	integenic	Not conserved	NA	NA	CEBPB	CYP27A1
ENSG00000265688	MILIP	-1.02865842720191	0.00132744892833688	M1_vs_M0	HSALNG0119342	integenic	Not conserved	hsa-miR-5585-3p	-	NPB	MFSD9
ENSG00000257167	TMPO-AS1	-2.55619231368821	7.12068867104169e-17	M1_vs_M0	HSALNG0093383	anti_sense	Q90	hsa-miR-762,hsa-miR-877-5p,hsa-miR-3960	-	IKBIP	ANKRD36
ENSG00000290085	ENSG00000290085	-1.36767809687411	0.00168401843482406	M1_vs_M0	HSALNG0016448	integenic	Q75	hsa-miR-619-5p,hsa-miR-1268b,hsa-miR-3960,hsa-miR-1199-3p,hsa-miR-6085	NA	TRABD2A	USP44
ENSG00000291300	PRSS30P	-1.75272621453561	0.0105917986144925	M1_vs_M0	NA	NA	NA	NA	NA	PRSS22	TNS3
ENSG00000285492	ENSG00000285492	3.74386094468386	1.68504376539688e-26	M1_vs_M0	HSALNG0054723	sense	Q90	hsa-miR-7160-3p	Myeloid white cell count; Celiac disease,Lipoprotein a measurement,Nicotine dependence symptom count,Autoimmune disease; Systemic lupus erythematosus; Celiac disease,Hypothyroidism,Leukocyte count,Leukocyte count; Neutrophil count,Neutrophil count; Leukocyte count; Neutrophil percentage of leukocytes; Eosinophil count; Granulocyte count,Eczema,Crohn's disease; Inflammatory bowel disease; Celiac disease,Rheumatoid arthritis; Crohn's disease,Gut microbiome measurement,Psoriasis; Ulcerative colitis; Ankylosing spondylitis; Crohn's disease; Rheumatoid arthritis; Sclerosing cholangitis,Celiac disease,Rheumatoid arthritis,Myeloid white cell count; Neutrophil count; Basophil count,Psoriasis vulgaris,Rheumatoid arthritis; Celiac disease,Eosinophil percentage of leukocytes,-	TAGAP	TTC5
ENSG00000274818	ENSG00000274818	2.19241991284108	2.88281898141345e-6	M1_vs_M0	HSALNG0102246	integenic	Q75	NA	NA	MAP3K9	ADAMTS7
ENSG00000236901	MIR600HG	-1.88403629248418	4.6158419236595e-33	M1_vs_M0	HSALNG0074272	sense	Not conserved	NA	-	STRBP	EPRS1
ENSG00000248473	LINC01962	-4.40219146846364	1.11542730630658e-6	M1_vs_M0	HSALNG0047230	integenic	Q75	hsa-miR-1268b,hsa-miR-4497,hsa-miR-6089,hsa-miR-8072	-	TRIM7	STAM
ENSG00000284738	ENSG00000284738	-2.90204737704039	8.29808176418587e-6	M1_vs_M0	HSALNG0007353	anti_sense	Q75	NA	NA	CREB3L4	DNAJC1
ENSG00000267247	ENSG00000267247	-3.93193531408387	3.4367214333098e-11	M1_vs_M0	HSALNG0120096	anti_sense	Q50	hsa-miR-874-3p,hsa-miR-1343-3p,hsa-miR-6728-3p,hsa-miR-6852-3p,hsa-miR-7155-5p	-	AFG3L2	NCBP1
ENSG00000255366	ENSG00000255366	-1.45116614314618	5.513157295643e-4	M1_vs_M0	HSALNG0065054	integenic	Not conserved	NA	-	SPIDR	NCBP1
ENSG00000269446	ENSG00000269446	2.77768081938258	1.60132901356375e-8	M1_vs_M0	HSALNG0062712	integenic	Not conserved	NA	NA	UBE3C	DNAJB5
ENSG00000247095	MIR210HG	-2.3936882797812	2.90950224963007e-31	M1_vs_M0	HSALNG0081992	anti_sense	Q50	hsa-miR-766-3p,hsa-miR-4707-5p,hsa-miR-5587-3p,hsa-miR-6735-5p,hsa-miR-6735-3p,hsa-miR-6858-5p,hsa-miR-7843-5p	Systemic lupus erythematosus,High density lipoprotein cholesterol measurement,-	LMNTD2	DCTN3
ENSG00000287733	ENSG00000287733	5.7851679105103	1.8480807486421e-208	M1_vs_M0	HSALNG0061536	integenic	Not conserved	hsa-miR-4761-3p	Monocyte count	TMEM140	GMPR
ENSG00000249096	LINC02362	1.429173189436	7.52322595473434e-6	M1_vs_M0	HSALNG0039015	integenic	Not conserved	hsa-miR-6089,hsa-miR-6127,hsa-miR-6129	NA	IRF2	TFAP2A
ENSG00000289307	ENSG00000289307	1.54646617271397	0.0367242083124225	M1_vs_M0	HSALNG0111608	integenic	Q50	hsa-miR-619-5p,hsa-miR-4266,hsa-miR-6746-5p,hsa-miR-6754-5p,hsa-miR-10392-3p	Adolescent idiopathic scoliosis,Diet measurement; Body mass index,-	IRX3	TJAP1
ENSG00000286471	ENSG00000286471	1.33213180768757	9.8280307645737e-4	M1_vs_M0	HSALNG0065372	integenic	Q50	hsa-miR-619-5p,hsa-miR-1229-5p,hsa-miR-6801-3p	-	SOX17	PGBD1
ENSG00000249771	ENSG00000249771	4.08733781254563	2.12134029183941e-5	M1_vs_M0	HSALNG0034072	integenic	Q90	hsa-miR-619-5p,hsa-miR-4258	-	PHOX2B	TPMT
ENSG00000267287	ENSG00000267287	-2.98050198040691	4.06164844952021e-21	M1_vs_M0	HSALNG0122765	integenic	Not conserved	hsa-miR-3197,hsa-miR-4664-5p	Heel bone mineral density,Lean mass-adjusted fat body mass; Femoral neck bone mineral density,Maximum cigarettes per day measurement,-	NFATC1	MAPKBP1
ENSG00000203709	MIR29B2CHG	2.98627955336527	3.4006923745458497e-69	M1_vs_M0	HSALNG0010132	integenic	Q50	NA	Febrile seizure (within the age range of 3 months to 6 years); Mmr-related febrile seizures,Reaction time measurement,Pulse pressure measurement,Red blood cell distribution width	CD34	TMEM62
ENSG00000232354	VIPR1-AS1	-8.27051245591797	6.59808326791637e-24	M1_vs_M0	HSALNG0025430	anti_sense	Q50	hsa-miR-3194-5p,hsa-miR-3198	Cerebrospinal fluid clusterin measurement,Bmi-adjusted hip circumference,-	SEC22C	SLC44A5
ENSG00000287299	ENSG00000287299	1.49453750724349	0.00295376423312199	M1_vs_M0	HSALNG0021467	anti_sense	Q75	hsa-miR-7703	Reaction time measurement,Urinary albumin to creatinine ratio,Alcoholic pancreatitis; Alcoholic liver cirrhosis,-	KCTD18	ADCY3
ENSG00000228649	SNHG26	1.22410764428855	1.45176263625422e-8	M1_vs_M0	HSALNG0056623	integenic	Q75	hsa-miR-483-3p,hsa-miR-4320	Alkaline phosphatase measurement,-	IL6	THUMPD2
ENSG00000284677	ENSG00000284677	2.3173644849989	0.00249409902568082	M1_vs_M0	HSALNG0002871	integenic	Not conserved	NA	-	COL9A2	THUMPD2
ENSG00000227741	ENSG00000227741	2.50878265611303	1.27135277697654e-13	M1_vs_M0	HSALNG0007819	anti_sense	Q90	hsa-miR-1227-5p,hsa-miR-4483,hsa-miR-3960,hsa-miR-6846-5p,hsa-miR-7109-5p	-	DCAF8	ANXA7
ENSG00000186235	LINC02610	-1.01625333497381	0.00115301521165903	M1_vs_M0	HSALNG0023418	integenic	Not conserved	hsa-miR-3620-5p,hsa-miR-4492,hsa-miR-4505,hsa-miR-1587,hsa-miR-4685-3p,hsa-miR-6753-5p,hsa-miR-6784-5p,hsa-miR-1273h-5p,hsa-miR-7846-3p,hsa-miR-8072	Chronotype measurement	HES6	SLC40A1
ENSG00000226067	LINC00623	1.64717994016678	1.07805632878332e-51	M1_vs_M0	HSALNG0006641	integenic	Not conserved	NA	NA	PPIAL4A	PRDM5
ENSG00000247240	UBL7-DT	-1.47939565977042	1.69932424857832e-5	M1_vs_M0	HSALNG0107191	integenic	Q50	hsa-miR-619-5p,hsa-miR-885-3p,hsa-miR-1227-5p,hsa-miR-6763-5p,hsa-miR-8072	Mean corpuscular volume,Caffeine metabolite measurement,Mosquito bite reaction size measurement; Mosquito bite reaction itch intensity measurement,-	ARID3B	LEF1
ENSG00000239911	PRKAG2-AS1	1.48939600040584	0.0122543102452234	M1_vs_M0	HSALNG0062390	anti_sense	Q90	hsa-miR-1227-5p,hsa-miR-3620-5p,hsa-miR-1587,hsa-miR-6791-5p	-	GALNTL5	LLPH
ENSG00000264345	LINC01894	3.54357425673328	0.00139820567603389	M1_vs_M0	HSALNG0120527	integenic	Q90	NA	-	ZNF521	GLIPR1
ENSG00000251141	MRPS30-DT	4.05587301249284	4.09229257480548e-9	M1_vs_M0	HSALNG0041549	anti_sense	Q50	hsa-miR-6878-3p	Balding measurement,Lip morphology measurement,Dental caries; Dentures,Breast carcinoma,Gut microbiome measurement,Breast carcinoma; Cancer,Creatinine measurement,Protein measurement,Glomerular filtration rate,Response to cetuximab; Skin disease,Depressive symptom measurement; Response to antidepressant,Upper face morphology measurement,-	FGF10	DENR
ENSG00000260997	ENSG00000260997	8.05676767476578	7.061169886168708e-19	M1_vs_M0	NA	NA	NA	NA	NA	MYO1G	WARS1
ENSG00000288714	ENSG00000288714	-3.99689105787901	1.75116551581239e-8	M1_vs_M0	HSALNG0149266	integenic	Not conserved	NA	-	HECA	PARN
ENSG00000233621	ZC3H12A-DT	2.31478132528664	9.54685843449097e-109	M1_vs_M0	HSALNG0002623	integenic	Not conserved	NA	NA	MEAF6	IGSF6
ENSG00000267279	ENSG00000267279	-5.24369925908527	0.00987399092981023	M1_vs_M0	HSALNG0121939	anti_sense	Q75	hsa-miR-4307,hsa-miR-6071,hsa-miR-6124	Serum alanine aminotransferase measurement; Aspartate aminotransferase measurement,Energy intake,Glomerular filtration rate,Sex hormone-binding globulin measurement,Reticulocyte count,Reticulocyte measurement,Creatinine measurement,Creatinine measurement; Glomerular filtration rate,-	RNF152	GCSH
ENSG00000290926	LINC03006	-1.50274710485621	0.0344324249252128	M1_vs_M0	HSALNG0058555	integenic	Not conserved	NA	NA	GUSB	NOL3
ENSG00000290879	ENSG00000290879	-3.60540727241697	6.83452771861477e-11	M1_vs_M0	NA	NA	NA	NA	NA	APBA2	TBCD
ENSG00000282572	FAM157D	-3.47065032139099	0.0026873442155624	M1_vs_M0	HSALNG0055481	integenic	Not conserved	hsa-miR-30b-3p,hsa-miR-6089	-	PDGFA	IGLON5
ENSG00000287998	ENSG00000287998	-5.24859982227486	0.0169211142369582	M1_vs_M0	HSALNG0150225	integenic	Not conserved	hsa-miR-8485	-	BHLHE22	PADI1
ENSG00000259476	ENSG00000259476	-4.89613011983068	0.0320989583253816	M1_vs_M0	HSALNG0106235	sense	Q50	NA	NA	LIPC	PADI1
ENSG00000291078	ENSG00000291078	1.59342678745831	1.15762781694736e-20	M1_vs_M0	HSALNG0024083	integenic	Not conserved	hsa-miR-6873-3p	NA	EMC3	GPN2
ENSG00000233542	ENSG00000233542	-5.08157743138828	0.011772282564356	M1_vs_M0	HSALNG0000215	integenic	Not conserved	hsa-miR-30c-2-3p,hsa-miR-30c-1-3p,hsa-miR-619-5p	-	CFAP74	BARHL2
ENSG00000254006	ENSG00000254006	-3.88778295576044	6.59047176128716e-29	M1_vs_M0	HSALNG0065805	integenic	Q90	NA	NA	CYP7B1	ILDR2
ENSG00000289217	ENSG00000289217	3.8593385012174	8.90404146273119e-8	M1_vs_M0	HSALNG0095701	integenic	Not conserved	hsa-miR-574-5p	Response to alcohol,Fasting blood glucose measurement,-	SGCG	FCGR2A
ENSG00000253557	ENSG00000253557	-4.92321326565381	2.77721208320392e-50	M1_vs_M0	HSALNG0063737	integenic	Q50	hsa-miR-7155-5p	Bone quantitative ultrasound measurement,Platelet count,Mean platelet volume,Gout,Smooth surface dental caries,Urate measurement,Intelligence,Insulin measurement,Telomere length,-	PSD3	METTL25B
ENSG00000136315	RNASE2CP	-3.21940607229241	1.25815180842112e-12	M1_vs_M0	HSALNG0099840	integenic	Not conserved	NA	NA	RNASE3	SNX27
ENSG00000122043	LINC00544	-6.30362755910581	3.53549207969206e-6	M1_vs_M0	HSALNG0096079	integenic	Not conserved	hsa-miR-4478	-	MTUS2	PI4KB
ENSG00000271882	ENSG00000271882	1.33078775360526	2.3900077621563e-5	M1_vs_M0	HSALNG0067354	anti_sense	Q75	hsa-miR-6722-3p	-	GRHL2	ACP1
ENSG00000260912	ENSG00000260912	-3.45162204579826	4.1412394483635785e-28	M1_vs_M0	NA	NA	NA	NA	NA	ACER2	PDIA6
ENSG00000260804	LINC01963	-1.66925610334664	2.6810708229956802e-15	M1_vs_M0	HSALNG0022112	integenic	Q50	NA	NA	XRCC5	PDIA6
ENSG00000290062	ENSG00000290062	-2.63460800355871	0.03794171173133	M1_vs_M0	HSALNG0149078	anti_sense	Q50	hsa-miR-5587-3p	NA	TMEM170B	ETAA1
ENSG00000267712	LINC01539	6.9756665484781	6.79691804747575e-10	M1_vs_M0	HSALNG0121712	integenic	Q75	hsa-miR-4492,hsa-miR-4505,hsa-miR-1587,hsa-miR-7108-3p	Risk-taking behaviour,Risky sexual behaviour measurement,Smoking status measurement,Smoking initiation,Smoking behavior; Smoking status measurement,Diabetic retinopathy,Self reported educational attainment; Mathematical ability,Diverticular disease,Unipolar depression,Hiv-1 infection,Attention deficit hyperactivity disorder; Antisocial behaviour measurement; Substance abuse,Systolic blood pressure; Smoking behaviour measurement,-	TCF4	NAT8
ENSG00000272931	LRRC8D-DT	-2.37651074669933	2.35863393328986e-11	M1_vs_M0	HSALNG0005094	anti_sense	Q75	hsa-miR-6746-3p,hsa-miR-6800-3p	-	GBP5	SLC20A1
ENSG00000254027	LNMICC	-1.02136269056599	0.00608058617827701	M1_vs_M0	HSALNG0066560	anti_sense	Not conserved	hsa-miR-3195,hsa-miR-4508	-	PMP2	AFF3
ENSG00000289915	ENSG00000289915	5.59533323325241	7.512262281409351e-17	M1_vs_M0	HSALNG0126752	integenic	Q75	hsa-miR-378a-5p,hsa-miR-619-5p,hsa-miR-6726-3p,hsa-miR-6763-3p,hsa-miR-6873-3p	Body mass index,Leukocyte count,-	BBC3	DYNC1LI1
ENSG00000244040	IL12A-AS1	-1.69406043589547	0.0320415920153872	M1_vs_M0	HSALNG0030211	integenic	Not conserved	NA	NA	NA	PTPRG
ENSG00000206337	HCP5	2.71423048179177	7.762580381137719e-89	M1_vs_M0	HSALNG0049264	sense	Not conserved	hsa-miR-4257,hsa-miR-4492,hsa-miR-6769b-5p	Trichloroethylene-induced hypersensitivity,Hiv-1 infection,Female reproductive system disease,Blood protein measurement,Heel bone mineral density,Systemic lupus erythematosus,Mhc class i polypeptide-related sequence a measurement,Uveitis,Reticulocyte measurement,Hiv-1 infection; Mhc class i polypeptide-related sequence a measurement; Susceptibility to common cold measurement; Mean platelet volume,Cervical carcinoma,Body height; Bmi-adjusted hip circumference; Basophil percentage of leukocytes,Platelet component distribution width; Eosinophil percentage of leukocytes,Temporal arteritis; Blood protein measurement,Platelet count; Atopic asthma,Platelet-to-lymphocyte ratio; Bmi-adjusted hip circumference,Bmi-adjusted waist-hip ratio,Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Chronic hepatitis c virus infection,Psoriatic arthritis,Cervical intraepithelial neoplasia grade 2/3; Mhc class i polypeptide-related sequence a measurement; Bmi-adjusted hip circumference; Cervical carcinoma,Mosquito bite reaction size measurement; Aspirin use measurement; Calcium channel blocker use measurement,Neutrophil percentage of granulocytes; Eosinophil percentage of leukocytes; Eosinophil percentage of granulocytes,Bmi-adjusted hip circumference,Body weight,Neutrophil percentage of leukocytes,Response to antineoplastic agent,Beta-2 microglobulin measurement,Non-melanoma skin carcinoma,Bmi-adjusted hip circumference; Neutrophil count; Lymphocyte count,Neutrophil count,Bmi-adjusted waist-hip ratio; Red blood cell distribution width,Iritis,17-hydroxyprogesterone measurement,Blood protein measurement; Trefoil factor 3 measurement,Mhc class i polypeptide-related sequence a measurement; Hemoglobin measurement,Platelet-derived growth factor bb measurement,Autism spectrum disorder,Mean platelet volume,Platelet count,Age at diagnosis,Eosinophil count,Platelet aggregation; Prostate carcinoma,Uterine fibroid; Bmi-adjusted waist-hip ratio,Red blood cell distribution width,Keratinocyte carcinoma; Squamous cell carcinoma,Apolipoprotein b measurement,Intelligence,Lung carcinoma,Mhc class i polypeptide-related sequence a measurement; Blood protein measurement,Body height; Stromal cell-derived factor 1 alpha measurement,Granulocyte percentage of myeloid white cells,Susceptibility to mononucleosis measurement,Platelet component distribution width,Hiv-1 infection; Aids; Psoriasis; Drug-induced liver injury,Renal system measurement,Myositis,Polymyositis; Physical activity measurement; Bmi-adjusted waist-hip ratio; Myositis,Eosinophil count; Platelet count,Cytokine measurement; Herpes zoster,Thyroid peroxidase antibody measurement,Squamous cell lung carcinoma; Mmr-related febrile seizures; Bmi-adjusted waist circumference; Lung carcinoma; Eosinophil count,Appendicular lean mass,Glucose measurement,Platelet-to-lymphocyte ratio,Aging,Bmi-adjusted hip circumference; Mhc class i polypeptide-related sequence b measurement; Bmi-adjusted waist-hip ratio,Upper aerodigestive tract neoplasm; Bmi-adjusted hip circumference; Anilide use measurement; Lung carcinoma; Body weight,Parental longevity,Visual perception measurement,Carpal tunnel syndrome,Herpes zoster,Thyrotoxic periodic paralysis,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio,Susceptibility to cold sores measurement; Eosinophil percentage of leukocytes,Tonsillectomy risk measurement,Eosinophil percentage of leukocytes,Susceptibility to childhood ear infection measurement,Body height,Lymphocyte count; Basophil count; Myositis; Leukocyte count; Monocyte count,Serum alanine aminotransferase measurement,Bmi-adjusted waist-hip ratio; Mhc class i polypeptide-related sequence b measurement,Angina pectoris,Clinical treatment,Bmi-adjusted waist circumference; Autism spectrum disorder; Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Susceptibility to chickenpox measurement,Susceptibility to shingles measurement,Parental genotype effect measurement; Birth weight,Body mass index; Visceral adipose tissue measurement,Response to drug; Drug-induced agranulocytosis,Mosquito bite reaction size measurement; Mosquito bite reaction itch intensity measurement,Toxic epidermal necrolysis; Stevens-johnson syndrome,Eczema; Allergic rhinitis,Response to thioamide; Drug-induced agranulocytosis,Prion disease; Psychotic symptoms,Susceptibility to pneumonia measurement,Human papilloma virus infection; Oropharynx cancer,Bmi-adjusted waist circumference; Hypertension; Bmi-adjusted waist-hip ratio	MICB	NFKBIZ
ENSG00000289390	ENSG00000289390	2.25243694649966	0.0165565780386879	M1_vs_M0	HSALNG0047002	integenic	Not conserved	hsa-miR-5010-5p,hsa-miR-6798-5p	NA	PHYKPL	SPATA5
ENSG00000273243	ENSG00000273243	3.54286909519186	0.00149238282255631	M1_vs_M0	HSALNG0135916	integenic	Q50	hsa-miR-4492,hsa-miR-6763-5p	Mean corpuscular hemoglobin concentration,-	KIAA0930	ATG12
ENSG00000237125	HAND2-AS1	-5.24745998476089	0.0120240737350229	M1_vs_M0	HSALNG0038609	anti_sense	Q90	hsa-miR-513a-5p,hsa-miR-619-5p,hsa-miR-4297,hsa-miR-4316,hsa-miR-4281,hsa-miR-4285,hsa-miR-1268b,hsa-miR-4505,hsa-miR-6089,hsa-miR-6726-5p,hsa-miR-6732-5p,hsa-miR-6732-3p,hsa-miR-6735-5p,hsa-miR-6747-3p,hsa-miR-6805-5p,hsa-miR-6813-5p,hsa-miR-6845-3p,hsa-miR-8485	Pr interval,Lower face morphology measurement,Cardiac arrhythmia,Electrocardiography,Moderate albuminuria,Response to drug,Cocaine dependence,Diabetic nephropathy,Pulse pressure measurement,Vital capacity,Hormone measurement,Cardiac arrhythmia; Atrial fibrillation,Atrial fibrillation,Inguinal hernia,Multiple myeloma,Heel bone mineral density,Erosive tooth wear measurement,Bone mineral content measurement,Response to bisphosphonate; Atypical femoral fracture,Ovarian serous carcinoma; Response to carboplatin; Response to paclitaxel; Progression free survival,Parental genotype effect measurement; Birth weight,-	SAP30	C1QTNF2
ENSG00000267886	ENSG00000267886	-5.24739401628285	0.0110714363964472	M1_vs_M0	HSALNG0125019	sense	Not conserved	hsa-miR-4281,hsa-miR-4673	NA	ZNF730	C1QTNF2
ENSG00000223725	ENSG00000223725	3.10914612736513	9.3326616293038e-4	M1_vs_M0	HSALNG0021871	integenic	Not conserved	NA	NA	METTL21A	PSD2
ENSG00000228302	ENSG00000228302	-1.24796988043931	0.00261422365019559	M1_vs_M0	HSALNG0142716	anti_sense	Not conserved	hsa-miR-1268b	Forced expiratory volume	NUDT5	KLHL3
ENSG00000281162	LINC01127	3.36640616325309	6.557057922043221e-15	M1_vs_M0	HSALNG0017393	integenic	Q50	hsa-miR-939-3p,hsa-miR-6728-3p,hsa-miR-6737-3p	Eosinophil count,Protein measurement,St2 protein measurement,Neutrophil count,-	IL1R2	ANO7
ENSG00000237036	ZEB1-AS1	-2.51919948133668	1.2778213411724e-10	M1_vs_M0	HSALNG0077083	anti_sense	Q90	hsa-miR-30b-3p,hsa-miR-3178,hsa-miR-3960,hsa-miR-4685-3p,hsa-miR-4707-5p,hsa-miR-5587-3p,hsa-miR-6089,hsa-miR-6769b-3p,hsa-miR-7113-3p,hsa-miR-9901	Lumbar disc degeneration,Mathematical ability,Sex hormone-binding globulin measurement,Glucose homeostasis measurement; Disposition index measurement,Tinnitus; Response to cisplatin,Peripheral arterial disease; Traffic air pollution measurement,-	ZNF438	CCZ1B
ENSG00000289089	ENSG00000289089	2.27100968731568	1.16893228655172e-7	M1_vs_M0	NA	NA	NA	NA	NA	TBX20	TMEM47
ENSG00000230773	ENSG00000230773	1.67892835093214	6.7292736925852e-4	M1_vs_M0	HSALNG0014797	integenic	Not conserved	NA	NA	FBXO11	ZNF185
ENSG00000236364	ENSG00000236364	-3.23801970989708	2.062411658392e-4	M1_vs_M0	HSALNG0008158	anti_sense	Q50	NA	-	TMCO1	CCDC25
ENSG00000261795	ENSG00000261795	-2.63468751830554	6.74608720013105e-25	M1_vs_M0	HSALNG0055499	integenic	Not conserved	NA	NA	PDGFA	NR6A1
ENSG00000258294	ENSG00000258294	-1.89765626541504	0.00138108808527075	M1_vs_M0	HSALNG0092412	integenic	Q90	NA	Adipose tissue measurement,-	ZFC3H1	WDR31
ENSG00000272341	ENSG00000272341	-1.46859955046604	0.0073999774362638	M1_vs_M0	HSALNG0048332	anti_sense	Q75	hsa-miR-6799-5p	-	STMND1	PTGES2
ENSG00000277782	ENSG00000277782	-1.20036613366916	0.00782685536138694	M1_vs_M0	HSALNG0107630	anti_sense	Q90	hsa-miR-5787	-	MESD	GLUD1
ENSG00000227502	MROCKI	3.17054560172352	7.966569951219658e-83	M1_vs_M0	HSALNG0052921	integenic	Q50	hsa-miR-619-5p,hsa-miR-4505	NA	HDAC2	ANKRD1
ENSG00000261644	CYLD-AS1	3.49062942316767	1.5693085821578298e-33	M1_vs_M0	HSALNG0111361	anti_sense	Q50	hsa-miR-6089,hsa-miR-8485	Psoriasis; Inflammatory bowel disease; Ulcerative colitis; Ankylosing spondylitis; Crohn's disease; Sclerosing cholangitis,Psoriasis; Ulcerative colitis; Ankylosing spondylitis; Crohn's disease; Sclerosing cholangitis,-	SNX20	DGKZ
ENSG00000248587	GDNF-AS1	3.70853065995706	0.00153718978693608	M1_vs_M0	HSALNG0041260	integenic	Q75	NA	NA	WDR70	CCDC81
ENSG00000237352	LINC01358	2.15763135717352	4.94564802464762e-9	M1_vs_M0	HSALNG0003970	integenic	Q50	NA	Serum albumin measurement,Response to lithium ion; Bipolar disorder,Hematocrit; Pulse pressure measurement,-	FGGY	TENM4
ENSG00000205086	LINC02898	-5.1792649494863	5.978745926599589e-122	M1_vs_M0	NA	NA	NA	NA	NA	COX7A2L	DUSP15
ENSG00000227917	ENSG00000227917	1.11606222401436	1.53256585442904e-6	M1_vs_M0	HSALNG0069521	integenic	Not conserved	hsa-miR-4722-5p	-	FOXD4	LTO1
ENSG00000227486	ENSG00000227486	1.47016157252499	6.5682871223613e-4	M1_vs_M0	HSALNG0138143	integenic	Q90	hsa-miR-4279,hsa-miR-4488,hsa-miR-6132,hsa-miR-6816-5p,hsa-miR-7111-3p	Prostate specific antigen measurement,Androgenetic alopecia,3-hydroxy-1-methylpropylmercapturic acid measurement,Neuroticism measurement; Balding measurement,Creatinine measurement	KLF8	ADGRL3
ENSG00000233117	LINC00702	-1.37217104709379	2.55080773871323e-28	M1_vs_M0	HSALNG0075773	integenic	Q50	hsa-miR-4279,hsa-miR-4710	Anti-thyroglobulin antibody measurement,Biological sex,Body height,-	KLF6	UBC
ENSG00000268027	ENSG00000268027	-7.74420952989689	1.143031647509e-16	M1_vs_M0	HSALNG0126205	sense	Not conserved	hsa-miR-619-5p,hsa-miR-6803-5p	NA	CEACAM21	TMEM86A
ENSG00000260868	LINC01960	1.93516761528673	2.06275761440086e-5	M1_vs_M0	HSALNG0146267	integenic	Q75	NA	NA	SP9	TMEM86A
ENSG00000231113	LINC02976	-1.79619798127753	3.7284015940765195e-12	M1_vs_M0	HSALNG0050136	integenic	Not conserved	hsa-miR-619-5p,hsa-miR-4505,hsa-miR-6089	Diabetic nephropathy; Mean corpuscular hemoglobin,Apolipoprotein a 1 measurement,-	CNPY3	ZNF385D
ENSG00000253420	ENSG00000253420	-4.42778338246395	0.0488824149512677	M1_vs_M0	HSALNG0067589	anti_sense	Q50	NA	-	LRP12	TLCD4
ENSG00000289055	ENSG00000289055	-4.42768595207485	0.0439868562271681	M1_vs_M0	HSALNG0012055	integenic	Q75	hsa-miR-4707-3p,hsa-miR-6803-5p,hsa-miR-8485	Mortality; Response to allogeneic hematopoietic stem cell transplant,-	AKT3	TLCD4
ENSG00000203876	ADD3-AS1	-4.42770500612235	0.044856701892121	M1_vs_M0	HSALNG0080557	anti_sense	Q50	NA	Mathematical ability,Mean corpuscular hemoglobin concentration,Biliary atresia,Cortical surface area measurement,Eosinophil count,Eosinophil count; Eosinophil percentage of leukocytes,Monocyte count,-	XPNPEP1	TLCD4
ENSG00000286393	ENSG00000286393	-4.42777230653053	0.0482763910740634	M1_vs_M0	HSALNG0136208	integenic	Q75	hsa-miR-140-3p,hsa-miR-1273h-5p	Low density lipoprotein cholesterol measurement,Monocyte percentage of leukocytes,Protein measurement,Nt-probnp measurement,-	BRD1	TLCD4
ENSG00000289000	ENSG00000289000	-4.42779746733698	0.0496593443835152	M1_vs_M0	HSALNG0074871	integenic	Not conserved	NA	Uric acid measurement; Urate measurement,Urate measurement	FAM78A	TLCD4
ENSG00000226950	DANCR	-2.16728686837398	1.02656483196023e-26	M1_vs_M0	HSALNG0148096	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-7108-3p	Response to citalopram; Mood disorder; Response to escitalopram; Unipolar depression,-	RASL11B	ATP5F1A
ENSG00000289007	ENSG00000289007	2.03304593903359	3.848662424351559e-18	M1_vs_M0	HSALNG0136377	integenic	Not conserved	hsa-miR-370-3p,hsa-miR-1228-5p,hsa-miR-6769b-5p	NA	DHRSX	KCNK13
ENSG00000259238	ENSG00000259238	2.33888412656584	0.010477451303721	M1_vs_M0	HSALNG0106306	anti_sense	Q75	hsa-miR-619-5p,hsa-miR-6784-5p	-	GCNT3	FAM151B
ENSG00000185332	TMEM105	-1.78122553071148	0.00200127710073427	M1_vs_M0	HSALNG0145394	integenic	Q50	hsa-miR-619-5p,hsa-miR-761,hsa-miR-1249-5p,hsa-miR-4447,hsa-miR-4472,hsa-miR-6803-5p	Sugar consumption measurement,-	SLC38A10	FAM151B
ENSG00000242242	NECTIN3-AS1	-4.51182356165709	2.03868662889054e-7	M1_vs_M0	HSALNG0027990	integenic	Not conserved	NA	NA	ZBED2	MBNL1
ENSG00000228109	MELTF-AS1	-1.52050850551964	0.0185563310906235	M1_vs_M0	HSALNG0031988	anti_sense	Q50	hsa-miR-331-3p,hsa-miR-1228-5p,hsa-miR-4472,hsa-miR-4492,hsa-miR-4701-3p,hsa-miR-4734,hsa-miR-7108-3p	-	NCBP2AS2	CAST
ENSG00000236021	COP1-DT	1.03630251961757	0.0188808153749145	M1_vs_M0	HSALNG0008629	integenic	Q75	hsa-miR-619-5p,hsa-miR-6763-5p	Wellbeing measurement; Neuroticism measurement; Depressive symptom measurement,Body height,Cognitive function measurement,Bmi-adjusted hip circumference,Wellbeing measurement,Bmi-adjusted waist-hip ratio; Physical activity measurement,Unipolar depression; Endometriosis,-	PAPPA2	ADGRF4
ENSG00000260101	AFTPH-DT	-1.30218336631626	2.1563430786598e-4	M1_vs_M0	HSALNG0015480	anti_sense	Q90	NA	Epithelial cell adhesion molecule measurement,Gut microbiome measurement,-	SERTAD2	LYSET
ENSG00000259590	LINC02244	3.94957475687227	5.439181734379141e-47	M1_vs_M0	HSALNG0108537	anti_sense	Q75	NA	-	TTC23	TEX29
ENSG00000257258	ENSG00000257258	-2.91503287790031	2.8091712871226198e-31	M1_vs_M0	HSALNG0090086	anti_sense	Q50	hsa-miR-3960,hsa-miR-6744-3p,hsa-miR-4433b-3p	Fructose measurement; Glucose measurement; Galactose measurement,-	ERGIC2	LURAP1L
ENSG00000290933	ENSG00000290933	-2.32362198823726	0.00312873091337142	M1_vs_M0	NA	NA	NA	NA	NA	LAIR2	JAZF1
ENSG00000255680	ENSG00000255680	-2.62898949242753	0.0214743584559688	M1_vs_M0	HSALNG0082458	anti_sense	Q90	NA	-	ILK	FBXO36
ENSG00000228058	LINC01736	-7.40311537276645	1.92312857522773e-13	M1_vs_M0	HSALNG0011359	integenic	Not conserved	NA	NA	GALNT2	GDPD1
ENSG00000180066	LINC02870	-4.09932314015412	1.96563554586618e-26	M1_vs_M0	HSALNG0081790	integenic	Q50	hsa-miR-1227-5p,hsa-miR-4485-5p,hsa-miR-4514,hsa-miR-4763-3p,hsa-miR-5001-3p,hsa-miR-6813-5p	-	PWWP2B	GDPD1
ENSG00000241990	PRR34-AS1	-1.43590184296567	0.00305653590216115	M1_vs_M0	HSALNG0135994	integenic	Q50	hsa-miR-920,hsa-miR-939-5p,hsa-miR-3620-5p,hsa-miR-4472,hsa-miR-4505,hsa-miR-1587,hsa-miR-3972,hsa-miR-4707-5p,hsa-miR-5587-3p,hsa-miR-5589-5p,hsa-miR-6775-3p	Birth weight,Wellbeing measurement; Dupuytren contracture,Alcohol use disorder measurement; Alcohol consumption measurement,Body weight,Body height; Body weight,Smoking status measurement,Attention deficit hyperactivity disorder; Bipolar disorder; Major depressive disorder; Autism spectrum disorder,-	PPARA	NUS1
ENSG00000269220	LINC00528	-1.5957212689708	4.94004777850417e-5	M1_vs_M0	HSALNG0133922	anti_sense	Not conserved	hsa-miR-619-5p,hsa-miR-1247-5p,hsa-miR-4257,hsa-miR-6089,hsa-miR-6877-3p	Response to diisocyanate,Adiponectin measurement	BCL2L13	ANKRD29
ENSG00000288983	ENSG00000288983	-1.2298525591413	0.0164862016653804	M1_vs_M0	HSALNG0110765	integenic	Not conserved	hsa-miR-619-5p	-	PRR14	DIPK1A
ENSG00000231711	LINC00899	-2.49902342145339	6.58284211074708e-27	M1_vs_M0	HSALNG0135993	integenic	Q50	hsa-miR-320a-5p,hsa-miR-762,hsa-miR-3178,hsa-miR-6763-3p	Birth weight,Smoking status measurement	WNT7B	CHODL
ENSG00000235823	OLMALINC	-1.39552776218818	6.842200835287481e-9	M1_vs_M0	HSALNG0080102	sense	Q50	hsa-miR-378a-5p,hsa-miR-619-5p,hsa-miR-6089	Alkaline phosphatase measurement,-	SCD	TSEN2
ENSG00000287346	ENSG00000287346	-2.95211311164172	0.0309726526098586	M1_vs_M0	HSALNG0104044	integenic	Q50	hsa-miR-619-5p,hsa-miR-4512,hsa-miR-6089	-	TDRD9	CCDC174
ENSG00000246582	TNFRSF10A-DT	2.08850767583904	8.50872974622013e-16	M1_vs_M0	HSALNG0063968	anti_sense	Not conserved	hsa-miR-4687-5p	Wet macular degeneration; Atrophic macular degeneration; Central serous retinopathy; Tnf-related apoptosis-inducing ligand measurement; Age-related macular degeneration,Protein measurement	CHMP7	APCDD1
ENSG00000287743	ENSG00000287743	1.48939684866943	0.0122543102452234	M1_vs_M0	HSALNG0002890	anti_sense	Q75	NA	-	NFYC	PROM2
ENSG00000234464	ENSG00000234464	-7.71630969342345	3.89775518263684e-16	M1_vs_M0	HSALNG0142045	integenic	Not conserved	hsa-miR-363-5p,hsa-miR-1268b,hsa-miR-6089	NA	RYR2	MARVELD1
ENSG00000196951	SCOC-AS1	-1.48087014026479	5.20854278890463e-7	M1_vs_M0	HSALNG0037486	anti_sense	Not conserved	hsa-miR-370-3p	NA	CLGN	ZCCHC10
ENSG00000229140	CCDC26	-2.00310246951706	0.0287736154756134	M1_vs_M0	HSALNG0068551	integenic	Q50	hsa-miR-575,hsa-miR-619-5p,hsa-miR-885-3p,hsa-miR-4287,hsa-miR-4328,hsa-miR-3677-3p,hsa-miR-6809-3p,hsa-miR-6873-3p,hsa-miR-6892-3p,hsa-miR-8485	Dna methylation,Eczema,Balding measurement,Heel bone mineral density,Lip morphology measurement,Facial morphology measurement,Unipolar depression,Creatinine measurement,Cleft lip; Oral cleft; Cleft palate,Myeloid white cell count,Cleft lip; Progranulin measurement,Cortical surface area measurement; Cortical thickness,Alkaline phosphatase measurement,Cleft lip; Neuroimaging measurement; Heel bone mineral density; Blood phosphate measurement; Cleft palate; Brain measurement,Cleft lip; Oral cleft,Lung adenocarcinoma,Leukocyte count,Neutrophil count,Cleft lip,Eosinophil count,Vital capacity,Self reported educational attainment,Forced expiratory volume,Mathematical ability,Fev/fec ratio,Acute lymphoblastic leukemia,Body height,Monocyte count,Monocyte percentage of leukocytes,B-cell acute lymphoblastic leukemia,Gut microbiome measurement,Creatinine measurement; Glomerular filtration rate,Nicotine dependence,Glioma,Central nervous system cancer,Hypospadias,Urate measurement,Lateral occipital cortex volume measurement,Uterine fibroid,Platelet count; Platelet crit,Indole-3-propionate measurement,Bullous pemphigoid,Cortical surface area measurement,Mitochondrial dna measurement,Inflammatory bowel disease; Mean corpuscular hemoglobin concentration; Mean corpuscular hemoglobin; Monocyte count; Mean corpuscular volume,Leukocyte count; Monocyte count,Mean corpuscular volume; Mean corpuscular hemoglobin; Erythrocyte count,Eosinophil count; Monocyte count; Basophil count; Eosinophil percentage of leukocytes,Eosinophil count; Eosinophil percentage of granulocytes; Eosinophil percentage of leukocytes,Neutrophil-to-lymphocyte ratio,Cortical thickness,Leukocyte count; Neutrophil count; Myeloid white cell count,Neutrophil percentage of leukocytes; Mean corpuscular hemoglobin,Mosaic loss of chromosome y measurement,Resistin measurement; Myeloperoxidase measurement,Lymphocyte percentage of leukocytes; Neutrophil count,Eosinophil percentage of leukocytes; Eosinophil percentage of granulocytes,Leukocyte count; Neutrophil count; Monocyte count,Neutrophil percentage of granulocytes; Neutrophil percentage of leukocytes,Granulocyte percentage of myeloid white cells; Monocyte percentage of leukocytes,Inflammatory bowel disease; Ulcerative colitis; Monocyte count; Monocyte:lymphocyte ratio; Mean corpuscular volume; Red blood cell density measurement; Erythrocyte count,Adolescent idiopathic scoliosis,Monocyte count; Mean corpuscular hemoglobin concentration; Erythrocyte count,Neutrophil count; Basophil count; Leukocyte count; Eosinophil count; Granulocyte count,Mean corpuscular volume; Mean corpuscular hemoglobin; Monocyte count,Erythrocyte count,Leukocyte count; Lymphocyte percentage of leukocytes; Neutrophil count; Myeloid white cell count,Red blood cell density measurement,Mean reticulocyte volume,Neutrophil percentage of leukocytes,Basophil percentage of granulocytes; Educational attainment; Basophil count; Basophil percentage of leukocytes,Granulocyte percentage of myeloid white cells,Eye color,Monocyte percentage of leukocytes; Monocyte count,Neuroimaging measurement; Glioblastoma multiforme; Glioma; White matter microstructure measurement; Brain volume measurement; Age at onset; Central nervous system cancer,Platelet count,Basophil count,Retinopathy,Granulocyte percentage of myeloid white cells; Monocyte percentage of leukocytes; Monocyte count,Leukocyte count; Lymphocyte percentage of leukocytes; Myeloid white cell count,Basophil count; Eosinophil percentage of leukocytes,Platelet crit,Eosinophil count; Eosinophil percentage of leukocytes,Response to methotrexate; Juvenile idiopathic arthritis,Cleft lip; Cleft palate,Unipolar depression; Endometriosis,Brain volume measurement; Neuroimaging measurement; Brain measurement,-	GSDMC	C16orf87
ENSG00000284602	ENSG00000284602	1.43689522076917	0.00156642548902734	M1_vs_M0	HSALNG0001782	integenic	Q50	hsa-miR-3620-5p,hsa-miR-1587	Mean corpuscular hemoglobin concentration; Mean corpuscular volume; Platelet count; Platelet crit,-	RHD	SETD9
ENSG00000272476	ENSG00000272476	-1.28762908101795	3.964833836368e-4	M1_vs_M0	HSALNG0052540	anti_sense	Q90	hsa-miR-504-3p,hsa-miR-4467,hsa-miR-3960	-	NR2E1	DEPTOR
ENSG00000260231	KDM7A-DT	2.21244417802228	1.44876469490425e-12	M1_vs_M0	HSALNG0061777	anti_sense	Q90	NA	NA	TBXAS1	LSM11
ENSG00000258673	LINC01397	6.07352141032787	1.86022413222387e-5	M1_vs_M0	HSALNG0005950	integenic	Not conserved	NA	NA	UBL4B	ART3
ENSG00000229619	MBNL1-AS1	-3.07422613321313	1.08252644065206e-52	M1_vs_M0	HSALNG0029874	anti_sense	Q50	hsa-miR-4492,hsa-miR-5587-3p	Body height,Balding measurement,Colorectal cancer,Pulse pressure measurement,Hematocrit; Hemoglobin measurement,Lymphocyte percentage of leukocytes; Neutrophil count,Neutrophil count,Myeloid white cell count,-	IGSF10	TDRD9
ENSG00000234883	MIR155HG	3.38704905951353	1.7139245066064196e-140	M1_vs_M0	HSALNG0132382	anti_sense,sense	Q75	hsa-miR-6089,hsa-miR-8485	Neuropsychological test,Intelligence,Response to carboplatin,Nicotine dependence symptom count,Gout,Open-angle glaucoma,Triglyceride measurement,Erythrocyte count,Chronic lymphocytic leukemia,Cerebrospinal fluid biomarker measurement; Alpha synuclein measurement,Duchenne muscular dystrophy; Disease progression measurement,-,Amyloid plaque accumulation rate	JAM2	FGF18
ENSG00000265494	ENSG00000265494	7.39873765931877	4.50169684117962e-13	M1_vs_M0	NA	NA	NA	NA	NA	COX10	FBXO32
ENSG00000272425	ENSG00000272425	-1.35448493199077	0.0012815248583883	M1_vs_M0	HSALNG0066560	anti_sense	Not conserved	hsa-miR-3195,hsa-miR-4508	-	PMP2	RNF111
ENSG00000234191	LINC01283	2.57766580366604	1.20453905846187e-56	M1_vs_M0	HSALNG0137357	integenic	Q75	NA	NA	BCOR	TMEM268
ENSG00000260196	ENSG00000260196	-1.20655605274715	0.00936860893528519	M1_vs_M0	HSALNG0082946	integenic	Not conserved	NA	Pulse pressure measurement; Body mass index; Systolic blood pressure; Bmi-adjusted waist-hip ratio; Social communication impairment,Systolic blood pressure; Alcohol drinking	NCR3LG1	PSMG3
ENSG00000273341	ENSG00000273341	3.32231883427628	7.36595819017082e-18	M1_vs_M0	HSALNG0059115	anti_sense	Q50	hsa-miR-4466,hsa-miR-7703	Body mass index,Gut microbiome measurement,Hba1c measurement,Hemoglobin a1 measurement,-	CCDC146	PRXL2B
ENSG00000285813	ENSG00000285813	1.75428794960645	0.00408370385821361	M1_vs_M0	HSALNG0086900	anti_sense	Not conserved	NA	NA	GRIA4	PANK4
ENSG00000278709	NKILA	6.30850251944586	1.32406526381796e-5	M1_vs_M0	HSALNG0131196	anti_sense	Q50	hsa-miR-6763-3p	-	PCK1	GRHL3
ENSG00000288817	ENSG00000288817	-3.6743015259352	7.1904578500267e-4	M1_vs_M0	HSALNG0136685	integenic	Q75	NA	NA	FAM9C	UBXN11
ENSG00000237980	LINC02773	4.94344477162198	1.59355696756129e-10	M1_vs_M0	HSALNG0010379	integenic	Q50	hsa-miR-4313,hsa-miR-4466	-	BATF3	HPD
ENSG00000215866	LINC01356	-2.39098356960994	0.0420001396875241	M1_vs_M0	HSALNG0006139	integenic	Not conserved	hsa-miR-619-5p,hsa-miR-4433a-3p,hsa-miR-4433b-3p	Response to sulfasalazine; Drug-induced agranulocytosis	SLC16A1	COLEC12
ENSG00000286975	ENSG00000286975	2.58849517005902	0.0214817093006602	M1_vs_M0	HSALNG0119632	integenic	Q50	NA	3-hydroxypropylmercapturic acid measurement,-	METTL4	GPRASP2
ENSG00000281404	LINC01176	2.05102322664869	3.48666639869298e-20	M1_vs_M0	HSALNG0149630	sense	Not conserved	NA	NA	NA	MITD1
ENSG00000249001	ENSG00000249001	-4.75910154819304	1.30323776429613e-78	M1_vs_M0	HSALNG0035715	anti_sense	Q50	hsa-miR-4281,hsa-miR-4486	Urate measurement,Sparc-like protein 1 measurement,Idiopathic dilated cardiomyopathy,Body weight,Gout; Urate measurement,Bmi-adjusted hip circumference,Mental or behavioural disorder,Heel bone mineral density,Body height,-,Omega-6:omega-3 polyunsaturated fatty acid ratio; Omega-3 polyunsaturated fatty acid measurement; Docosahexaenoic acid measurement	SPARCL1	AHCYL2
ENSG00000260260	SNHG19	-1.49285157831474	5.25459050579045e-6	M1_vs_M0	HSALNG0108990	anti_sense	Q50	NA	-	PKD1	CD1E
ENSG00000237877	LINC01473	1.64987002596321	3.56059123726322e-5	M1_vs_M0	HSALNG0020959	integenic	Q50	NA	NA	ZSWIM2	NPM2
ENSG00000248360	LINC00504	1.15904232696096	9.96885632933861e-25	M1_vs_M0	HSALNG0033029	integenic	Q75	hsa-miR-5047	Diacylglycerol 36:2 measurement,Protein measurement,Skin pigmentation,Nausea,Systolic blood pressure,-	FBXL5	TOMM40L
ENSG00000289317	ENSG00000289317	3.80161250717276	2.5835274076739e-4	M1_vs_M0	HSALNG0042985	integenic	Not conserved	hsa-miR-328-5p	NA	ANKRD34B	CLIC6
ENSG00000284669	ENSG00000284669	1.86801482556703	7.49641882478229e-9	M1_vs_M0	HSALNG0025266	anti_sense	Q90	hsa-miR-3620-5p,hsa-miR-4492,hsa-miR-1587,hsa-miR-6850-3p	Sex hormone-binding globulin measurement,Memory performance; Paragraph delayed recall measurement,-	TTC21A	BTG2
ENSG00000235560	ZNF747-DT	-1.91425708833227	0.0420412949342652	M1_vs_M0	HSALNG0110746	anti_sense	Not conserved	hsa-miR-30b-3p,hsa-miR-378g	Serum gamma-glutamyl transferase measurement,Ccl5 measurement,-	ITGAL	CCDC107
ENSG00000174370	KCNJ5-AS1	-2.50133477936904	8.85824023968477e-75	M1_vs_M0	NA	NA	NA	NA	NA	TP53AIP1	ZNF222
ENSG00000255553	LINC02733	7.46408877607831	1.30210278484127e-13	M1_vs_M0	HSALNG0084581	integenic	Not conserved	NA	Alkaline phosphatase measurement,Phosphatidylcholine measurement,-	FTH1	PRMT2
ENSG00000228022	HCG20	4.15112035441378	1.08546303664106e-5	M1_vs_M0	HSALNG0049198	integenic	Not conserved	NA	NA	TUBB	C19orf47
ENSG00000224738	ENSG00000224738	-2.92090514057647	0.00220859771693172	M1_vs_M0	HSALNG0117749	intronic_antisense	Q75	NA	NA	PRR11	SHKBP1
ENSG00000266473	HELZ-AS1	-2.95096022464246	0.0413901036037958	M1_vs_M0	HSALNG0118281	anti_sense	Q75	hsa-miR-3663-5p,hsa-miR-4447,hsa-miR-1343-3p,hsa-miR-6089,hsa-miR-6803-5p,hsa-miR-7704,hsa-miR-8485	Lymphocyte count,Protein measurement,Sex hormone-binding globulin measurement,-	PITPNC1	PKN3
ENSG00000260630	SNAI3-AS1	-1.02463200403298	1.3962470464134e-7	M1_vs_M0	HSALNG0113528	anti_sense	Q50	hsa-miR-665,hsa-miR-3195,hsa-miR-6089	Airway imaging measurement,Hair colour measurement,Reticulocyte count; Reticulocyte measurement,-	CTU2	TAOK1
ENSG00000275765	ENSG00000275765	-1.67825938212673	0.00156602735751721	M1_vs_M0	HSALNG0045934	anti_sense,sense	Q50	hsa-miR-6783-3p,hsa-miR-6789-3p	Red blood cell distribution width,-	ATOX1	CHRNB2
ENSG00000270055	ENSG00000270055	-3.66282803917245	1.9428228415275095e-11	M1_vs_M0	HSALNG0104765	integenic	Not conserved	NA	NA	GOLGA8Q	PAQR6
ENSG00000233871	DLG5-AS1	-2.49892959987824	1.0387610831752e-4	M1_vs_M0	HSALNG0079068	anti_sense	Q50	NA	Serum gamma-glutamyl transferase measurement,-	RPS24	PPP1R35
ENSG00000283384	ENSG00000283384	5.01339794602315	4.4385975010990294e-11	M1_vs_M0	HSALNG0099263	integenic	Not conserved	hsa-miR-331-3p,hsa-miR-505-5p,hsa-miR-619-5p,hsa-miR-1207-3p,hsa-miR-4483,hsa-miR-4650-5p,hsa-miR-6763-5p	Granulocyte percentage of myeloid white cells; Leukocyte count; Blood protein measurement; Serum non-albumin protein measurement; Monocyte percentage of leukocytes,Serum non-albumin protein measurement,Monocyte count,Leukocyte count; Neutrophil count; Monocyte count,Venous thromboembolism,Blood protein measurement; Serum non-albumin protein measurement,Tonsillectomy risk measurement,Alcohol dependence measurement,Fev/fec ratio; Response to bronchodilator,-	TNFSF13B	NACC1
ENSG00000287278	ENSG00000287278	6.92986657423889	1.60444446249634e-9	M1_vs_M0	HSALNG0077187	integenic	Q50	hsa-miR-6848-5p	Triglyceride measurement; High density lipoprotein cholesterol measurement,Apolipoprotein a 1 measurement; High density lipoprotein cholesterol measurement,Bmi-adjusted waist-hip ratio,Waist-hip ratio,Intelligence; Mathematical ability,Crohn's disease; Disease progression measurement,-	CCDC7	LY6E
ENSG00000289602	ENSG00000289602	-6.14545122638078	4.43552091224452e-5	M1_vs_M0	HSALNG0011006	integenic	Q75	hsa-miR-619-5p	NA	SRP9	DVL3
ENSG00000260188	ENSG00000260188	-1.11442221283439	5.28798024443145e-8	M1_vs_M0	HSALNG0052706	anti_sense	Q50	hsa-miR-2113,hsa-miR-874-3p,hsa-miR-1268b,hsa-miR-4456,hsa-miR-4778-3p,hsa-miR-6089	Hba1c measurement,Heel bone mineral density,Arachidonic acid measurement,Alpha peak frequency measurement; Electroencephalogram measurement; Alpha wave measurement,-	CDC40	FDXR
ENSG00000255921	ENSG00000255921	6.00831594269301	6.22210431416398e-57	M1_vs_M0	HSALNG0089886	anti_sense	Not conserved	hsa-miR-6763-5p,hsa-miR-7847-3p	-	IRAG2	CYGB
ENSG00000253141	ENSG00000253141	-2.3126682038061	1.73116578042638e-33	M1_vs_M0	HSALNG0046692	integenic	Q50	hsa-miR-198,hsa-miR-665,hsa-miR-4435,hsa-miR-4446-3p,hsa-miR-4505,hsa-miR-5787,hsa-miR-6728-3p	Antipsychotic drug related weight gain,Stroke,Cognitive function measurement,Prostate carcinoma; Cytokine measurement,Peripheral arterial disease; Traffic air pollution measurement,Mosquito bite reaction size measurement; Mosquito bite reaction itch intensity measurement,Oral cleft,Cleft lip; Cleft palate,Body height,Bmi-adjusted hip circumference,Adiponectin measurement,-	BNIP1	ADCY9
ENSG00000232956	SNHG15	2.08243739492973	6.56634958839368e-142	M1_vs_M0	HSALNG0057702	anti_sense,sense	Q50	hsa-miR-4726-3p,hsa-miR-7107-5p	Body height,Diastolic blood pressure,-	MYO1G	UBXN1
ENSG00000253746	ENSG00000253746	-7.00253213961763	3.39068756836664e-10	M1_vs_M0	HSALNG0064563	integenic	Q50	hsa-miR-4447,hsa-miR-4508,hsa-miR-4539,hsa-miR-3960,hsa-miR-6501-3p,hsa-miR-6780a-3p,hsa-miR-8072	Mathematical ability,Adolescent idiopathic scoliosis,Interleukin-6 measurement,Body height,Endometriosis,Sex hormone-binding globulin measurement,Triglyceride measurement,Empathy measurement,Leukocyte count; Lymphocyte count,Body mass index,-	BRF2	SLC45A1
ENSG00000234286	ENSG00000234286	-2.31162792764545	3.93295712998798e-5	M1_vs_M0	HSALNG0149890	anti_sense	Q50	NA	NA	TRA2A	RBP7
ENSG00000260135	MMP2-AS1	8.9387067913528	1.32514978947085e-29	M1_vs_M0	HSALNG0111641	anti_sense	Q90	NA	Abnormality of refraction,Age-related hearing impairment,-	CES1	LRRC38
ENSG00000273487	ENSG00000273487	-2.18220292129649	5.3859248181755e-6	M1_vs_M0	HSALNG0005192	sense	Q50	NA	Serum alanine aminotransferase measurement,Aspartate aminotransferase measurement,-	BTBD8	LAPTM5
ENSG00000239653	PSMD6-AS2	1.53413660295454	0.00512934575108667	M1_vs_M0	HSALNG0026555	anti_sense	Q50	hsa-miR-619-5p	Drugs used in diabetes use measurement,Glomerular filtration rate,Neuroimaging measurement; Cortical thickness,-	ATXN7	ZNF326
ENSG00000280007	ENSG00000280007	-2.29170850628686	2.57530225371572e-21	M1_vs_M0	HSALNG0133953	anti_sense	Not conserved	hsa-miR-619-5p	Atrial fibrillation,T-tau measurement,Carotid plaque build,-,Mean platelet volume	MICAL3	TRIM58
ENSG00000237422	ENSG00000237422	-3.1376646613597	1.15199456804899e-5	M1_vs_M0	HSALNG0072689	integenic	Q50	hsa-miR-331-3p,hsa-miR-619-5p,hsa-miR-4292,hsa-miR-5001-3p,hsa-miR-6763-3p	Antisaccade response measurement,Adenosine diphosphate measurement,Balding measurement,Platelet crit,Platelet count,Ulcerative colitis; Inflammatory bowel disease,Eczema,Bmi-adjusted waist-hip ratio,Waist-hip ratio,Neutrophil percentage of granulocytes,Eosinophil percentage of leukocytes,Eosinophil count,Bilirubin measurement; Aspartate aminotransferase measurement,Parental genotype effect measurement; Gestational blood glucose measurement; Glycosuria,Hematocrit; Hemoglobin measurement; Erythrocyte count,Leukocyte count,-	AUH	IGSF8
ENSG00000215458	AATBC	-2.99498682923714	3.90270214985404e-20	M1_vs_M0	HSALNG0133454	anti_sense	Not conserved	hsa-miR-6089	-	CSTB	OLFML2B
ENSG00000257557	PPP1R12A-AS1	1.13635633517655	9.9815896862365e-4	M1_vs_M0	HSALNG0092662	anti_sense	Q50	hsa-miR-619-5p	Platelet count,Reticulocyte count; Reticulocyte measurement,-	OTOGL	BPNT1
ENSG00000263731	ENSG00000263731	-1.29433587476664	0.0430677387152768	M1_vs_M0	HSALNG0119325	integenic	Not conserved	NA	NA	ALYREF	BROX
ENSG00000203527	SCUBE1-AS1	-4.6812630711050804	0.0444432441956164	M1_vs_M0	HSALNG0135784	anti_sense	Not conserved	NA	NA	TSPO	HAAO
ENSG00000266088	ENSG00000266088	-3.7692303846409	5.02687554722582e-7	M1_vs_M0	HSALNG0116373	integenic	Q50	hsa-miR-4463,hsa-miR-6803-5p,hsa-miR-7108-3p,hsa-miR-8485	-	IGFBP4	DISC1
ENSG00000249592	PCGF3-AS1	-1.03453212507424	2.37801474327221e-6	M1_vs_M0	HSALNG0032188	anti_sense	Q75	NA	-	CPLX1	COL6A3
ENSG00000245293	CYP2U1-AS1	-4.84165194099028	1.41045465741356e-9	M1_vs_M0	HSALNG0036264	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-874-5p,hsa-miR-548l,hsa-miR-4328,hsa-miR-10392-3p	Monoclonal gammopathy,Protein measurement,Glycine measurement,-	LEF1	CIP2A
ENSG00000188185	LINC00265	2.34999755035464	9.77877347533626e-17	M1_vs_M0	HSALNG0057380	sense	Not conserved	hsa-miR-3925-3p,hsa-miR-6089	-	RALA	ANKZF1
ENSG00000288018	ENSG00000288018	-1.22474924361007	1.0353034540364e-4	M1_vs_M0	HSALNG0086321	integenic	Not conserved	NA	-	TYR	FBLN2
ENSG00000278970	HEIH	1.61849039648103	4.48336082731938e-27	M1_vs_M0	HSALNG0047200	integenic	Not conserved	hsa-miR-4707-5p,hsa-miR-6726-5p,hsa-miR-6731-5p,hsa-miR-6736-5p	Asthma exacerbation measurement	MGAT1	ICA1L
ENSG00000253286	ENSG00000253286	5.66227743566589	1.00899801242574e-17	M1_vs_M0	HSALNG0068229	anti_sense	Q50	hsa-miR-6829-5p	Electrocardiography; Pr interval; Atrial fibrillation,Qrs duration,Systolic blood pressure,Electrocardiography,-	FAM91A1	PTX3
ENSG00000205853	RFPL3S	2.02341635778403	2.7176539793121e-4	M1_vs_M0	HSALNG0135027	anti_sense	Not conserved	hsa-miR-30b-3p,hsa-miR-593-3p,hsa-miR-6089	-	RTCB	RCHY1
ENSG00000249249	TICAM2-AS1	2.31787173749692	0.00246608807865298	M1_vs_M0	HSALNG0044270	anti_sense	Q90	NA	-	AP3S1	RYK
ENSG00000262898	ENSG00000262898	-2.39026127306237	0.0458795281188023	M1_vs_M0	HSALNG0145192	integenic	Not conserved	NA	NA	METRNL	NDST3
ENSG00000273729	ENSG00000273729	1.10391512271027	0.0262900136715374	M1_vs_M0	HSALNG0102621	anti_sense	Q50	hsa-miR-615-5p,hsa-miR-4290,hsa-miR-1268b,hsa-miR-4467,hsa-miR-3960,hsa-miR-4685-3p,hsa-miR-6795-3p,hsa-miR-6838-5p	Response to anticonvulsant,Smoking status measurement; Smoking behaviour measurement,Triglyceride measurement,Feeling nervous measurement,Sleep quality; Mathematical ability,C-reactive protein measurement,Serum alanine aminotransferase measurement; Aspartate aminotransferase measurement,Fev/fec ratio; Systolic blood pressure,Serum alanine aminotransferase measurement,Body weight,Serum albumin measurement,Body mass index,Smoking status measurement,Attention deficit hyperactivity disorder; Antisocial behaviour measurement; Substance abuse,-,Body mass index; Aspartate aminotransferase measurement	CIPC	ANAPC10
ENSG00000291176	ENSG00000291176	-2.17271613882888	1.92145649536343e-6	M1_vs_M0	HSALNG0017006	integenic	Q75	NA	NA	CIAO1	TMEM184C
ENSG00000272449	ENSG00000272449	2.9415683099207	5.19719426165697e-21	M1_vs_M0	HSALNG0000274	integenic	Not conserved	hsa-miR-8485	NA	TNFRSF14	PRMT9
ENSG00000250777	ENSG00000250777	-3.23894364144575	2.0176202599235e-4	M1_vs_M0	HSALNG0037343	integenic	Q75	hsa-miR-6825-5p	Parental longevity,Energy intake,Systemic lupus erythematosus,Sleep duration; Triglyceride measurement,Triglyceride measurement; High density lipoprotein cholesterol measurement,-	PCDH18	C5orf63
ENSG00000247934	ENSG00000247934	1.27423595121022	3.5446760159338e-4	M1_vs_M0	HSALNG0090059	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-3529-5p,hsa-miR-6089	Serum igg glycosylation measurement,Seasonal allergic rhinitis,Bmi-adjusted waist circumference,Balding measurement,Open-angle glaucoma,Gut microbiome measurement,Attention deficit hyperactivity disorder; Behavior,Bmi-adjusted waist circumference; Bmi-adjusted hip circumference,Blood protein measurement,Brain volume measurement,Cortical surface area measurement; Facial morphology measurement,Forced expiratory volume; Vital capacity,Reticulocyte measurement,Bmi-adjusted hip circumference,Volumetric bone mineral density,Chronic obstructive pulmonary disease,Body height,Neuroimaging measurement; Cortical thickness,Forced expiratory volume; Response to bronchodilator,Brain volume measurement; Neuroimaging measurement; Brain measurement,-	PTHLH	UBLCP1
ENSG00000259732	ENSG00000259732	-1.50291610511577	0.0343202213716093	M1_vs_M0	HSALNG0106282	anti_sense,sense	Not conserved	NA	-	CCNB2	UTP15
ENSG00000255355	PATL1-DT	5.36797692825677	0.0196100699656652	M1_vs_M0	HSALNG0084422	integenic	Not conserved	hsa-miR-619-5p	NA	STX3	ADGRF2
ENSG00000258733	LINC02328	2.68189794538285	1.4169516455834998e-31	M1_vs_M0	HSALNG0102968	integenic	Not conserved	NA	NA	FLRT2	BMT2
ENSG00000285533	RELA-DT	-1.93239745815476	5.7483113431152405e-9	M1_vs_M0	HSALNG0084930	anti_sense	Q50	hsa-miR-30b-3p,hsa-miR-619-5p,hsa-miR-762,hsa-miR-665,hsa-miR-4508,hsa-miR-6086	Urate measurement,Heel bone mineral density,Platelet count,-	SIPA1	INTS1
ENSG00000261824	LINC00662	3.58743796546706	2.780188666130399e-224	M1_vs_M0	HSALNG0125113	integenic	Not conserved	hsa-miR-619-5p,hsa-miR-920	Testicular germ cell tumor,-	UQCRFS1	BAALC
ENSG00000267040	ATP8B1-AS1	1.12294126093049	0.0070392467578961	M1_vs_M0	HSALNG0121780	anti_sense	Q50	hsa-miR-30b-3p,hsa-miR-619-5p,hsa-miR-4273,hsa-miR-4768-5p,hsa-miR-6089	Serum alanine aminotransferase measurement; Hemoglobin measurement; Gallstones; Serum gamma-glutamyl transferase measurement; Hematocrit; Red blood cell density measurement; Aspartate aminotransferase measurement,Low density lipoprotein cholesterol measurement; Cholelithiasis,Hemoglobin measurement,Erythrocyte count,Aspartate aminotransferase to alanine aminotransferase ratio; Serum gamma-glutamyl transferase measurement; Serum alanine aminotransferase measurement,Red blood cell density measurement,Hemoglobin measurement; Erythrocyte count,Serum alanine aminotransferase measurement; Hemoglobin measurement; Serum gamma-glutamyl transferase measurement; Hematocrit; Erythrocyte count,-	ONECUT2	CTHRC1
ENSG00000265728	ENSG00000265728	-2.80338177859374	1.37093603279261e-16	M1_vs_M0	HSALNG0120011	integenic	Not conserved	NA	3-hydroxypropylmercapturic acid measurement,-	NAPG	INTS8
ENSG00000231808	LINC01388	1.5396818784012	2.87545079821716e-32	M1_vs_M0	HSALNG0069521	integenic	Not conserved	hsa-miR-4722-5p	-	FOXD4	PDP1
ENSG00000289263	ENSG00000289263	-5.52884550790603	0.00234820843833573	M1_vs_M0	HSALNG0069085	integenic	Not conserved	hsa-miR-6848-3p	Systolic blood pressure,-	PTP4A3	FXN
ENSG00000254054	ENSG00000254054	-5.55532906874035	4.11281174938281e-50	M1_vs_M0	HSALNG0063689	anti_sense	Q50	hsa-miR-331-3p,hsa-miR-3194-3p,hsa-miR-4257,hsa-miR-2467-3p	NA	PCM1	CYBB
ENSG00000291080	ZNF252P	-1.08378477435469	2.6589724165459507e-15	M1_vs_M0	NA	NA	NA	NA	NA	ZNF16	KIAA1958
ENSG00000231160	KLF3-AS1	-1.44228909064301	0.00625444089149708	M1_vs_M0	HSALNG0148326	integenic	Q50	NA	Eosinophil percentage of leukocytes,Mean platelet volume; Eosinophil count,Comparative body size at age 10, self-reported; Neuroimaging measurement; Brain volume measurement; Brain measurement; Cortical thickness,Erythrocyte count,Eosinophil count; Eosinophil percentage of leukocytes,Neutrophil percentage of granulocytes	TLR10	CLDN3
ENSG00000250497	ENSG00000250497	4.32576908744395	1.57695062420337e-6	M1_vs_M0	HSALNG0033009	integenic	Q50	hsa-miR-181d-3p,hsa-miR-3158-3p,hsa-miR-3960,hsa-miR-5047	Facial morphology measurement,Erythrocyte count,-	BOD1L1	ZNF503
ENSG00000290835	ENSG00000290835	1.30400554159792	1.39487796414328e-8	M1_vs_M0	HSALNG0056000	integenic	Not conserved	hsa-miR-619-5p	Neutrophil count,Leukocyte count; Myeloid white cell count,Ejection fraction measurement,Hematocrit; Hemoglobin measurement,Apoe carrier status,-	RSPH10B2	SPACA9
ENSG00000281103	TRG-AS1	-3.03602881544969	9.2023449647966e-56	M1_vs_M0	HSALNG0057335	integenic	Not conserved	NA	NA	STARD3NL	METTL17
ENSG00000261879	ZNF594-DT	-2.62171567508027	0.0235238915689052	M1_vs_M0	HSALNG0114109	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-4492,hsa-miR-6089	Head and neck squamous cell carcinoma,Family history of alzheimers disease,-	USP6	AGBL2
ENSG00000233093	LINC00892	-4.88317760215449	7.02524413414518e-10	M1_vs_M0	HSALNG0140334	integenic	Q50	hsa-miR-671-5p	NA	CD40LG	IFI27L1
ENSG00000277978	ENSG00000277978	-1.50295577344791	2.1867250807919e-4	M1_vs_M0	HSALNG0112104	anti_sense	Q50	hsa-miR-4433a-3p,hsa-miR-4492,hsa-miR-4433b-3p	-	TK2	CACNB2
ENSG00000235027	PRADX	1.45800557688622	4.13733479770466e-6	M1_vs_M0	NA	NA	NA	NA	NA	KRTAP5-6	HIF1AN
ENSG00000267546	ENSG00000267546	2.3178558565911	0.00247376060085449	M1_vs_M0	HSALNG0118852	anti_sense,sense	Q90	hsa-miR-331-3p,hsa-miR-619-5p,hsa-miR-5587-3p,hsa-miR-6803-5p	Diabetic nephropathy; Moderate albuminuria,-	CYGB	TPP1
ENSG00000271848	SYNPO2L-AS1	-5.76587105687303	8.1715770108786e-4	M1_vs_M0	HSALNG0078853	anti_sense	Q90	hsa-miR-4436a	Atrial fibrillation,Pr interval,Heart failure,Atrial fibrillation; Systolic blood pressure,Electrocardiography,Serum gamma-glutamyl transferase measurement,Systolic blood pressure,-	SEC24C	LMO1
ENSG00000246763	RGMB-AS1	-2.70692412702249	1.30584166733927e-8	M1_vs_M0	HSALNG0043698	anti_sense	Q90	hsa-miR-9899	-	CHD1	CENPN
ENSG00000289582	ENSG00000289582	8.84969828773264	1.77260042654065e-34	M1_vs_M0	NA	NA	NA	NA	NA	GBP2	CLEC4E
ENSG00000245928	SDAD1-AS1	7.22153771059724	1.13361227064115e-11	M1_vs_M0	HSALNG0035291	anti_sense	Not conserved	NA	Lung carcinoma,Blood protein measurement,-	ART3	CLEC4E
ENSG00000274104	ENSG00000274104	2.71217598217545	5.47276734710615e-5	M1_vs_M0	HSALNG0125517	anti_sense	Not conserved	hsa-miR-1343-3p,hsa-miR-6748-3p,hsa-miR-6873-3p	NA	ZNF599	TMEM135
ENSG00000255337	TMEM123-DT	2.43533266921059	4.56559515642809e-8	M1_vs_M0	HSALNG0086787	anti_sense	Not conserved	hsa-miR-7113-3p	-	BIRC2	PLEKHA7
ENSG00000285888	ENSG00000285888	3.6200678124246	7.38857707955227e-46	M1_vs_M0	HSALNG0149144	anti_sense	Not conserved	hsa-miR-4492	Basophil percentage of leukocytes	RAB44	TMEM170A
ENSG00000246662	CIBAR1-DT	6.1577947490633	2.66491004967476e-5	M1_vs_M0	HSALNG0066967	integenic	Q50	NA	-	RBM12B	TAC3
ENSG00000290441	ENSG00000290441	3.02174665146826	1.09903371664264e-6	M1_vs_M0	HSALNG0148215	integenic	Not conserved	hsa-miR-4505,hsa-miR-1587	NA	TLR2	TEF
ENSG00000232520	GCSIR	-6.22698275858898	3.76964746587298e-5	M1_vs_M0	HSALNG0022903	integenic	Q50	hsa-miR-4508,hsa-miR-5011-3p,hsa-miR-7160-3p	-	ITM2C	KATNAL2
ENSG00000290965	OR7E47P	-4.42768629679186	0.0440002241897716	M1_vs_M0	NA	NA	NA	NA	NA	SMIM41	CD3D
ENSG00000246100	LINC00900	1.03948673398401	4.27454560885444e-12	M1_vs_M0	HSALNG0087365	integenic	Q75	hsa-miR-665,hsa-miR-4281,hsa-miR-1268b,hsa-miR-3960	NA	CADM1	MYO5B
ENSG00000287825	ENSG00000287825	-2.8303355168811	2.62952226822158e-38	M1_vs_M0	HSALNG0050133	anti_sense	Q75	hsa-miR-619-5p	-	PEX6	PPP2R3B
ENSG00000288600	ENSG00000288600	-3.2334967135676	0.0116735719721272	M1_vs_M0	HSALNG0096628	integenic	Q50	NA	Heel bone mineral density	RGCC	TUBA1C
ENSG00000260197	ENSG00000260197	-1.55314419510183	0.042887187761295	M1_vs_M0	HSALNG0141379	integenic	Not conserved	NA	NA	KDM5D	PSCA
ENSG00000227398	KIF9-AS1	-1.52050847562939	0.0185563310906235	M1_vs_M0	HSALNG0025756	integenic	Not conserved	hsa-miR-4259,hsa-miR-6089,hsa-miR-8485	NA	KLHL18	NUDT8
ENSG00000291003	ENSG00000291003	-1.41995078009639	1.11945709109107e-27	M1_vs_M0	HSALNG0104483	integenic	Not conserved	NA	NA	GOLGA6L22	CYP7A1
ENSG00000291188	ENSG00000291188	5.17421571680618	0.00355706771620648	M1_vs_M0	HSALNG0110573	integenic	Not conserved	NA	NA	LAT	MLST8
ENSG00000260498	ENSG00000260498	2.85309827387325	1.03371873926637e-5	M1_vs_M0	HSALNG0113423	integenic	Not conserved	hsa-miR-4448,hsa-miR-4456,hsa-miR-6732-5p	NA	KLHDC4	VWCE
ENSG00000246375	PPM1K-DT	7.58688573030682	1.417028884164e-14	M1_vs_M0	HSALNG0035747	anti_sense	Q50	hsa-miR-6089	Urate measurement,Serum metabolite measurement,Metabolite measurement; Blood metabolite measurement; Coronary artery calcification; Amino acid measurement,Bipolar disorder,Serum metabolite measurement; Amino acid measurement,Gout; Urate measurement,Blood metabolite measurement; Breast carcinoma,Gout,Protein measurement; Blood metabolite measurement; Amino acid measurement,-	HERC6	FAM107A
ENSG00000259188	ENSG00000259188	-4.42742130774734	0.0481509194988121	M1_vs_M0	HSALNG0105854	anti_sense	Q75	NA	-	DTWD1	CAVIN2
ENSG00000259038	ENSG00000259038	-4.42749534887431	0.0442762994726822	M1_vs_M0	HSALNG0102098	anti_sense	Q50	hsa-miR-1227-5p,hsa-miR-4308,hsa-miR-6869-3p	Cognitive function measurement,Monoclonal gammopathy,Prostate carcinoma,Body height,Coronary artery calcification,Bmi-adjusted waist-hip ratio; Gut microbiome measurement,Waist-hip ratio; Bmi-adjusted waist-hip ratio; Balding measurement,High density lipoprotein cholesterol measurement,Diabetic nephropathy,-	ZFP36L1	CAVIN2
ENSG00000224281	SLC25A5-AS1	-1.13648824578583	0.0185563310906235	M1_vs_M0	HSALNG0139763	anti_sense	Q75	hsa-miR-6085,hsa-miR-6781-5p,hsa-miR-6803-5p,hsa-miR-7155-5p	Body height,Blood urea nitrogen measurement	STEEP1	SLC20A2
ENSG00000223552	CCR5AS	4.20575334113889	1.04639089469218e-47	M1_vs_M0	HSALNG0025681	anti_sense	Not conserved	hsa-miR-455-3p,hsa-miR-619-5p	Granulocyte percentage of myeloid white cells; Monocyte percentage of leukocytes; Monocyte count,Ccl4 measurement,Leukocyte count,Granulocyte percentage of myeloid white cells,Ccl2 measurement,Aids,Blood urea nitrogen measurement,Monocyte count,Psoriasis; Ulcerative colitis; Ankylosing spondylitis; Crohn's disease; Sclerosing cholangitis,-	LTF	SEMA4C
ENSG00000227066	ENSG00000227066	-1.05916677714544	2.68970012595381e-5	M1_vs_M0	HSALNG0001417	integenic	Not conserved	NA	NA	PLA2G2F	ENHO
ENSG00000231999	LRRC8C-DT	-1.02119382747016	2.2542095208966e-4	M1_vs_M0	HSALNG0005078	integenic	Q75	NA	NA	GBP5	DHRSX
ENSG00000233975	LINC02574	2.0495789257495	7.1219116620678e-5	M1_vs_M0	HSALNG0002009	integenic	Q50	hsa-miR-619-5p	Body weight,Systolic blood pressure; Pulse pressure measurement; Mean arterial pressure,Body mass index,-	IFI6	CSNK1G1
ENSG00000272711	HK2-DT	2.50881932404407	1.25726930378836e-13	M1_vs_M0	HSALNG0016101	anti_sense	Q75	hsa-miR-619-5p,hsa-miR-3196,hsa-miR-6132,hsa-miR-6758-5p,hsa-miR-7108-3p	-	M1AP	ADRB2
ENSG00000261253	ENSG00000261253	-4.68685778970467	1.50461725264987e-14	M1_vs_M0	HSALNG0113602	anti_sense	Not conserved	hsa-miR-505-5p,hsa-miR-1587,hsa-miR-3972,hsa-miR-6812-5p	Carotid plaque build	ZNF778	PGM2
ENSG00000290838	NCF1B	7.75199423882964	4.56150254972181e-16	M1_vs_M0	HSALNG0058823	integenic	Not conserved	hsa-miR-619-5p	NA	FKBP6	CXCL8
ENSG00000237742	HEY2-AS1	-5.0815228054164	0.0111616886665105	M1_vs_M0	HSALNG0053298	integenic	Not conserved	NA	NA	HDDC2	FRMPD4
ENSG00000278607	ENSG00000278607	-3.76532518145781	4.0552357689758e-4	M1_vs_M0	HSALNG0122474	anti_sense	Not conserved	NA	Total blood protein measurement; Insomnia,-	PTGR3	TMEM192
ENSG00000184566	ENSG00000184566	-2.39129994018594	0.00893706147882724	M1_vs_M0	HSALNG0083549	anti_sense	Not conserved	NA	NA	CAPRIN1	RNF150
ENSG00000251363	LINC02315	-1.75208307438877	3.6308547138499e-4	M1_vs_M0	HSALNG0100823	integenic	Not conserved	hsa-miR-619-5p	NA	LRFN5	CMTM8
ENSG00000259869	ENSG00000259869	-3.71904341325545	9.81567074747089e-7	M1_vs_M0	HSALNG0077502	integenic	Not conserved	NA	-	ZNF33B	TCAF2
ENSG00000233030	ENSG00000233030	3.12498444923952	1.92023142509026e-41	M1_vs_M0	HSALNG0142341	anti_sense,intronic_sense	Not conserved	NA	Monocyte count,-	H2BC18	RIOX1
ENSG00000228274	ENSG00000228274	-1.96041176172463	2.9554151498024e-4	M1_vs_M0	HSALNG0135429	anti_sense	Q50	hsa-miR-4695-5p,hsa-miR-6089,hsa-miR-6754-5p	Mean corpuscular volume,C-reactive protein measurement,Hemoglobin measurement,Hematocrit,-	JOSD1	ARMC10
ENSG00000223960	CHROMR	2.1321436025721	1.0051639630416997e-85	M1_vs_M0	HSALNG0020702	anti_sense	Q50	hsa-miR-6089	Blood protein measurement,Psoriasis; Atopic eczema,-,Oligoclonal band measurement	OSBPL6	INSR
ENSG00000232679	LINC01705	2.88800880927735	1.2626144125274e-4	M1_vs_M0	HSALNG0010821	integenic	Q50	hsa-miR-619-5p,hsa-miR-6728-3p,hsa-miR-6729-3p,hsa-miR-8485	Eosinophil percentage of leukocytes,Homa-ir,Self reported educational attainment,Colorectal cancer,Adolescent idiopathic scoliosis,C-reactive protein measurement,Serum alanine aminotransferase measurement; Sex hormone-binding globulin measurement; Low density lipoprotein triglyceride measurement; Body fat percentage; High density lipoprotein cholesterol measurement; Aspartate aminotransferase measurement,Colon carcinoma,Waist-hip ratio; Bmi-adjusted waist-hip ratio,Progressive supranuclear palsy,Tonsillectomy risk measurement,Thyroid stimulating hormone measurement,Self reported educational attainment; Intelligence,Fev/fec ratio; Response to bronchodilator,Colorectal cancer; Colorectal adenoma,Colorectal cancer; Progressive supranuclear palsy,Cluster headache,-	DUSP10	APLN
ENSG00000253477	ENSG00000253477	3.51968459095293	1.3992070325261e-12	M1_vs_M0	HSALNG0067527	anti_sense,sense	Q90	hsa-miR-1233-5p,hsa-miR-6089,hsa-miR-6726-3p,hsa-miR-6748-3p,hsa-miR-7150,hsa-miR-8485	-	NA	P2RY6
ENSG00000286540	ENSG00000286540	4.82078020192697	0.0265687977776595	M1_vs_M0	HSALNG0053142	integenic	Not conserved	hsa-miR-619-5p	Temporal horn of lateral ventricle volume measurement,Chronic obstructive pulmonary disease; Resting heart rate	GJA1	IFNB1
ENSG00000261416	CORO1A-AS1	-1.57630002775771	5.8885548601704e-4	M1_vs_M0	HSALNG0110699	anti_sense	Q75	hsa-miR-92a-2-5p,hsa-miR-3178,hsa-miR-4308,hsa-miR-3689a-3p,hsa-miR-3689b-3p,hsa-miR-4447,hsa-miR-3689c,hsa-miR-4505,hsa-miR-4690-5p,hsa-miR-4734,hsa-miR-5787,hsa-miR-6085,hsa-miR-6737-5p,hsa-miR-7152-5p	-	BOLA2B	NME6
ENSG00000274414	ENSG00000274414	-1.7922272996747	3.45174531028392e-5	M1_vs_M0	HSALNG0129378	integenic	Q50	NA	Response to diisocyanate,Cystatin c measurement,-	ABHD12	TPSAB1
ENSG00000226756	ENSG00000226756	-2.51258232039045	0.0311285623408928	M1_vs_M0	HSALNG0015489	intronic_antisense	Q90	hsa-miR-4292	Mean corpuscular hemoglobin concentration,Mean corpuscular volume; Mean corpuscular hemoglobin concentration,Mean corpuscular volume; Mean corpuscular hemoglobin,Mean reticulocyte volume; Mean corpuscular volume,-	AFTPH	C5orf34
ENSG00000226137	BAIAP2-DT	-1.60551720068593	8.811273964462189e-87	M1_vs_M0	HSALNG0119226	integenic	Not conserved	hsa-miR-3943	-	AATK	PRSS27
ENSG00000253891	ENSG00000253891	7.1440780905225	4.3030230609111695e-11	M1_vs_M0	HSALNG0064035	anti_sense	Q90	hsa-miR-619-5p,hsa-miR-1249-5p,hsa-miR-4447,hsa-miR-4463,hsa-miR-4505,hsa-miR-7106-5p	Bmi-adjusted waist circumference; Body height; Bmi-adjusted hip circumference,Bmi-adjusted waist circumference,Body height,Ankylosing spondylitis,Cleft palate,Necrotizing enterocolitis,Hair colour measurement,Susceptibility to scarlet fever measurement,White matter integrity,Corneal endothelial cell measurement,Idiopathic dilated cardiomyopathy,Mathematical ability,Age at onset,Nicotine withdrawal symptom count,Pallidum volume,Myopia,Brain volume measurement,Seasonality measurement,Interleukin-6 measurement,Forced expiratory volume; Fev/fec ratio; Response to bronchodilator,Fev/fec ratio; Response to bronchodilator,Myocarditis; Response to clozapine,Cingulate cortex measurement; Amyloid-beta measurement,Brain volume measurement; Neuroimaging measurement,-	STC1	EFCAB3
ENSG00000271216	LINC01050	6.82381461253043	1.14606865055067e-76	M1_vs_M0	HSALNG0096679	anti_sense	Q75	hsa-miR-6735-3p	Cognitive decline measurement,-	EPSTI1	EFCAB3
ENSG00000231079	KIF5C-AS1	-1.91557108159393	0.045023278833174	M1_vs_M0	HSALNG0019510	anti_sense	Q50	hsa-miR-4448,hsa-miR-4455	-	MMADHC	RSPH9
ENSG00000280832	GSEC	-2.25907699542611	1.98898689468241e-12	M1_vs_M0	HSALNG0088026	anti_sense	Q50	NA	Neutrophil count,Low density lipoprotein cholesterol measurement,-	KIRREL3	ZMAT3
ENSG00000204044	SLC12A5-AS1	1.72604555802644	0.0454280970507741	M1_vs_M0	HSALNG0130456	anti_sense	Q75	hsa-miR-4258	Blood protein measurement,Triglyceride measurement; High density lipoprotein cholesterol measurement; Apolipoprotein b measurement,-	NCOA5	ZNF596
ENSG00000232098	ZNF584-DT	-2.08613121859211	3.45889155784765e-13	M1_vs_M0	HSALNG0127962	anti_sense	Not conserved	NA	Mean platelet volume,-	ZNF837	VANGL1
ENSG00000231106	LINC01436	1.29197324911318	2.42379814074114e-17	M1_vs_M0	HSALNG0132900	anti_sense	Q90	hsa-miR-1224-3p,hsa-miR-4478	-	CBR1	C11orf80
ENSG00000271344	ENSG00000271344	1.35501972227347	0.0234557637689618	M1_vs_M0	HSALNG0061234	integenic	Not conserved	NA	NA	GARIN1A	ZNF791
ENSG00000261618	LINC02605	8.91015841647719	2.02904490186172e-34	M1_vs_M0	HSALNG0150243	integenic	Not conserved	NA	Platelet-to-lymphocyte ratio; Lymphocyte count	ZC2HC1A	C1QTNF1
ENSG00000205930	C21orf62-AS1	-1.82815191430232	0.00125322885661652	M1_vs_M0	HSALNG0132731	integenic	Q90	NA	Tea consumption measurement,-	OLIG2	SLCO4C1
ENSG00000287787	ENSG00000287787	-3.28841066776721	1.6878456530444e-6	M1_vs_M0	HSALNG0113198	sense	Not conserved	NA	Balding measurement,Alopecia,Systolic blood pressure,Body weight,Triglyceride measurement; Response to diuretic	GSE1	CEP19
ENSG00000260274	ENSG00000260274	-1.55626752339683	2.8970222388112e-4	M1_vs_M0	HSALNG0107284	anti_sense	Q75	hsa-miR-1301-3p,hsa-miR-1207-3p,hsa-miR-6813-5p,hsa-miR-7156-3p	-	NEIL1	FAM3C2P
ENSG00000225127	LINC00237	1.06643820997874	0.00123913856760258	M1_vs_M0	HSALNG0129088	integenic	Q50	hsa-miR-920,hsa-miR-4660,hsa-miR-4701-3p,hsa-miR-6763-3p,hsa-miR-6873-3p	Body mass index,-	NKX2-4	MSRB3
ENSG00000259291	ZNF710-AS1	-1.53296324539785	2.36864469778635e-10	M1_vs_M0	HSALNG0108098	anti_sense	Q90	NA	Body height,Comparative body size at age 10, self-reported,-	IDH2	EXO1
ENSG00000176349	ENSG00000176349	2.78181146533562	6.61581103020323e-14	M1_vs_M0	NA	NA	NA	NA	NA	ELFN1	TRHR
ENSG00000249669	CARMN	-2.30060902582037	0.0271997162081934	M1_vs_M0	HSALNG0045753	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-5787,hsa-miR-6751-3p,hsa-miR-6769a-3p	Antipsychotic drug related weight gain,Heel bone mineral density,3-hydroxypropylmercapturic acid measurement,Diet measurement; Bilirubin measurement,-	PCYOX1L	NPAS4
ENSG00000232043	ENSG00000232043	2.37688710860636	0.0405986355848805	M1_vs_M0	HSALNG0130783	anti_sense	Not conserved	NA	Heel bone mineral density,Duchenne muscular dystrophy; Disease progression measurement	RIPOR3	ZNF266
ENSG00000287188	ENSG00000287188	2.24097987319299	5.3420861646176396e-18	M1_vs_M0	HSALNG0038414	anti_sense	Q50	NA	-	DDX60	SH3PXD2B
ENSG00000237596	ENSG00000237596	5.31972882956124	7.8803554905245e-14	M1_vs_M0	HSALNG0053689	anti_sense	Q50	hsa-miR-185-3p,hsa-miR-5572,hsa-miR-6763-5p	Hemoglobin measurement,Red blood cell distribution width,Erythrocyte count,Body height; Heel bone mineral density,Heel bone mineral density; Blood phosphate measurement,Heel bone mineral density,Age at menarche,Blood phosphate measurement,Alcoholic liver cirrhosis,Calcium measurement,Facial morphology measurement,Brcax breast cancer,Sphingomyelin 22:0 measurement,Aspartate aminotransferase measurement,Adolescent idiopathic scoliosis,Open-angle glaucoma,Glaucoma; Open-angle glaucoma; Intraocular pressure measurement,Intraocular pressure measurement,Diverticulitis,Response to corticosteroid; Response to synacthen; Cortisol measurement,Bipolar disorder; Body mass index,-	MTFR2	THAP6
ENSG00000248677	LINC02102	6.31615764118831	2.23794478794438e-5	M1_vs_M0	HSALNG0039917	integenic	Not conserved	hsa-miR-619-5p,hsa-miR-7160-3p	Body height,-	NSUN2	SLC22A1
ENSG00000288951	ENSG00000288951	6.24172863136941	3.74744546086903e-5	M1_vs_M0	HSALNG0033010	integenic	Not conserved	NA	NA	BOD1L1	SLC22A1
ENSG00000230185	HSDL2-AS1	2.33996794527659	0.0111197787737384	M1_vs_M0	HSALNG0073771	anti_sense	Q75	hsa-miR-4279,hsa-miR-4741,hsa-miR-6089	Epstein-barr virus infection,Chronotype measurement,Fev/fec ratio; Response to bronchodilator,Hip bone mineral density; Hip bone size,-	PTBP3	PPM1E
ENSG00000178977	LINC00324	-2.72668741267129	9.32875443277353e-10	M1_vs_M0	HSALNG0114404	overlap_sense,sense	Q75	hsa-miR-23a-5p,hsa-miR-1260b,hsa-miR-4526	Apolipoprotein a 1 measurement,Mitochondrial dna measurement,Panic disorder; Anxiety disorder,Diastolic blood pressure,-,Neuroticism measurement,Monocyte count	CTC1	ZNF519
ENSG00000291122	CASTOR3P	-1.83715531258644	5.89531415507555e-14	M1_vs_M0	HSALNG0150011	sense	Not conserved	hsa-miR-125a-3p	NA	GPC2	PTPN2
ENSG00000230943	LINC02541	1.60186601896005	5.74367228639063e-5	M1_vs_M0	HSALNG0052910	integenic	Not conserved	NA	NA	HDAC2	SMAD2
ENSG00000224614	TNK2-AS1	4.03029755371807	4.3390862211654e-22	M1_vs_M0	HSALNG0031857	anti_sense	Q90	hsa-miR-619-5p,hsa-miR-4505,hsa-miR-5787,hsa-miR-6089	Blood urea nitrogen measurement; Creatinine measurement	MUC20	LONRF3
ENSG00000286004	ENSG00000286004	1.73854920288013	2.97858156578785e-5	M1_vs_M0	HSALNG0031856	anti_sense	Not conserved	NA	Creatinine measurement; Glomerular filtration rate,-	MUC20	DENND2C
ENSG00000281769	LINC01230	-2.32278223361127	0.00314679070209795	M1_vs_M0	HSALNG0069570	integenic	Q50	NA	-	DMRT2	MBLAC2
ENSG00000174403	CRMA	2.50239473472773	7.04932991734498e-5	M1_vs_M0	HSALNG0131539	integenic	Q50	hsa-miR-612,hsa-miR-762,hsa-miR-4472,hsa-miR-1343-3p,hsa-miR-6775-3p,hsa-miR-6810-3p,hsa-miR-6877-3p	Brain stem volume measurement; Brain volume measurement,Brain volume measurement,-	GATA5	YES1
ENSG00000273253	TRABD-AS1	-2.01786092446679	0.00877547591237337	M1_vs_M0	HSALNG0147439	anti_sense	Q50	hsa-miR-4508	Mitochondrial dna measurement,Platelet count,-	TUBGCP6	EID2
ENSG00000178722	C5orf64	-1.78678609975818	0.0370075035683284	M1_vs_M0	HSALNG0148619	integenic	Q50	hsa-miR-665	-	ZSWIM6	CCDC121
ENSG00000285895	ENSG00000285895	6.3009834501216	9.20155283568703e-6	M1_vs_M0	HSALNG0143182	integenic	Not conserved	hsa-miR-363-5p,hsa-miR-1268b,hsa-miR-6089	NA	OR5B21	LINC00303
ENSG00000290060	ENSG00000290060	5.32173985197569	0.00191797823808238	M1_vs_M0	HSALNG0022124	integenic	Q75	NA	NA	SMARCAL1	LINC00303
ENSG00000291086	LGALS17A	5.89407684088278	8.27827061200339e-5	M1_vs_M0	HSALNG0126029	integenic	Not conserved	NA	NA	LGALS14	LINC00303
ENSG00000282885	ENSG00000282885	-1.62326717948311	0.0274232952378539	M1_vs_M0	HSALNG0101122	integenic	Q90	hsa-miR-328-5p,hsa-miR-619-5p,hsa-miR-4430,hsa-miR-4747-5p,hsa-miR-5585-3p	-	NEMF	RUFY1
ENSG00000261420	MPC1-DT	-3.23522315371315	0.0091466201236284	M1_vs_M0	HSALNG0055096	integenic	Q50	hsa-miR-619-5p	NA	CEP43	VSIG10
ENSG00000197989	SNHG12	1.1431671413816	1.7076685569168395e-25	M1_vs_M0	HSALNG0002075	anti_sense	Q50	hsa-miR-363-5p,hsa-miR-324-5p,hsa-miR-3178,hsa-miR-4466,hsa-miR-6089,hsa-miR-6890-3p	-	TAF12	TYMS
ENSG00000286989	ENSG00000286989	-1.9740443295417	2.81330522716435e-6	M1_vs_M0	HSALNG0000179	overlap_antisense	Q50	hsa-miR-338-3p,hsa-miR-4292,hsa-miR-4472,hsa-miR-1343-3p,hsa-miR-5572,hsa-miR-5587-3p,hsa-miR-6511b-3p,hsa-miR-6754-5p,hsa-miR-6803-5p,hsa-miR-6804-3p,hsa-miR-6890-3p	Serum alanine aminotransferase measurement; Sex hormone-binding globulin measurement; Low density lipoprotein triglyceride measurement; Body fat percentage; High density lipoprotein cholesterol measurement; Aspartate aminotransferase measurement,-	MIB2	PNMA1
ENSG00000225964	NRIR	4.71526092736219	6.87669917067681e-277	M1_vs_M0	HSALNG0012717	integenic	Q75	NA	Depressive symptom measurement,-	CMPK2	KCNA3
ENSG00000175728	LINC02873	-6.14510153555554	1.77992631849237e-5	M1_vs_M0	HSALNG0088239	integenic	Q75	NA	-	ADAMTS15	TOP3A
ENSG00000260256	ENSG00000260256	1.27480863226428	0.0164676318590093	M1_vs_M0	HSALNG0133530	integenic	Not conserved	hsa-miR-1178-5p	-	CFAP410	ZBTB38
ENSG00000261671	ENSG00000261671	-2.82925484682069	0.00408467178864702	M1_vs_M0	HSALNG0076631	integenic	Q75	NA	-	COMMD3	TIMM22
ENSG00000265010	ENSG00000265010	-4.42776186272222	0.0477085746213085	M1_vs_M0	HSALNG0145150	sense	Not conserved	NA	-	C17orf80	OR2T8
ENSG00000265100	ENSG00000265100	3.87955244613703	1.3330377344503e-4	M1_vs_M0	HSALNG0118356	anti_sense	Not conserved	hsa-miR-6089	NA	SLC16A6	IRX3
ENSG00000270164	LINC01480	-1.87175622859819	0.00403721759280737	M1_vs_M0	HSALNG0126205	sense	Not conserved	hsa-miR-619-5p,hsa-miR-6803-5p	NA	CEACAM21	CD163
ENSG00000253177	ENSG00000253177	-4.98383215519329	2.56571204521885e-34	M1_vs_M0	HSALNG0066950	integenic	Q50	NA	-	CIBAR1	NECTIN3
ENSG00000289426	ENSG00000289426	3.06751790054843	2.15244186840311e-8	M1_vs_M0	HSALNG0008532	anti_sense	Q50	NA	Intelligence,-	TEX50	TENM3-AS1
ENSG00000204581	ACOXL-AS1	-3.35805204430185	0.00462960370906767	M1_vs_M0	HSALNG0017866	anti_sense	Q50	hsa-miR-6741-5p	Bmi-adjusted waist circumference,Chronic lymphocytic leukemia,Churg-strauss syndrome,Prostate carcinoma,Igf-1 measurement,Triglyceride measurement; Serum gamma-glutamyl transferase measurement,Mean corpuscular volume; Lymphocyte count,Hodgkins lymphoma; Chronic lymphocytic leukemia; Multiple myeloma,Drugs used in diabetes use measurement; Erythrocyte count,-	BUB1	BET1L
ENSG00000225342	LRRK2-DT	1.61300772819939	1.6020855151966e-4	M1_vs_M0	HSALNG0090483	anti_sense	Q50	NA	Serum gamma-glutamyl transferase measurement,Crohn's disease,Mean platelet volume,Cathepsin l1 measurement,Low density lipoprotein cholesterol measurement,Total cholesterol measurement; Low density lipoprotein cholesterol measurement,-	SLC2A13	SH2D4B
ENSG00000228340	MIR646HG	-4.61648646898175	1.44828331022642e-23	M1_vs_M0	HSALNG0131404	integenic	Not conserved	NA	-	CDH26	CTNNBIP1
ENSG00000215039	CD27-AS1	-1.7398692386059	7.39972836486408e-24	M1_vs_M0	HSALNG0088857	anti_sense	Q50	hsa-miR-642a-5p,hsa-miR-4292,hsa-miR-3620-5p,hsa-miR-4447,hsa-miR-1587,hsa-miR-6514-3p,hsa-miR-6752-3p,hsa-miR-6784-5p,hsa-miR-6890-3p	-	VAMP1	CTNNBIP1
ENSG00000197301	HMGA2-AS1	-1.13581362152815	4.814378299949e-24	M1_vs_M0	HSALNG0092012	anti_sense	Not conserved	NA	NA	LLPH	NSUN3
ENSG00000228172	ENSG00000228172	-1.40146493574638	0.0429849009504189	M1_vs_M0	HSALNG0001828	anti_sense	Q50	hsa-miR-6873-3p	-	AUNIP	CPNE7
ENSG00000287203	ENSG00000287203	-3.08842448214203	6.6521961666253e-4	M1_vs_M0	HSALNG0045515	integenic	Not conserved	hsa-miR-619-5p	Diabetic retinopathy	FGF1	GDPD4
ENSG00000269821	KCNQ1OT1	-2.12375573685503	3.2737608335465896e-30	M1_vs_M0	HSALNG0082235	anti_sense	Q75	hsa-miR-6510-5p	Qt interval,Qt interval; Electrocardiography; T wave morphology measurement,Electrocardiography,Bmi-adjusted waist-hip ratio,Familial long qt syndrome,Trauma exposure measurement,Platelet aggregation,Body height,Anthranilic acid measurement,Lip morphology measurement,Birth weight,Drugs used in diabetes use measurement,Parental genotype effect measurement; Birth weight,Platelet count; Platelet crit,Mean platelet volume,Stressful life event measurement; Depressive symptom measurement,Mouth morphology measurement; Nose morphology measurement,Mean arterial pressure; Response to high sodium diet; Systolic blood pressure,Glucose measurement; Hba1c measurement,-,Hyperuricemia; Creatinine measurement; Glomerular filtration rate; Chronic kidney disease	TRPM5	MRFAP1
ENSG00000251230	MIR3945HG	9.85611203958375	1.03848326809185e-57	M1_vs_M0	HSALNG0039050	integenic	Not conserved	hsa-miR-619-5p	Mean platelet volume,Mean reticulocyte volume,-	ACSL1	EXOC3L1
ENSG00000213468	FIRRE	5.23459222247675	5.26190004395186e-13	M1_vs_M0	HSALNG0140173	integenic	Not conserved	hsa-miR-6089	NA	IGSF1	PXT1
ENSG00000216863	LY86-AS1	1.95063049098519	0.0286314306628169	M1_vs_M0	HSALNG0047825	integenic	Not conserved	NA	NA	F13A1	RAB39A
ENSG00000272669	ENSG00000272669	1.92215177632401	2.31888498869201e-10	M1_vs_M0	HSALNG0135442	anti_sense	Not conserved	hsa-miR-210-5p,hsa-miR-6763-3p	NA	GTPBP1	EIF3J-DT
ENSG00000237797	MACORIS	-4.89101179358688	0.0435807140291805	M1_vs_M0	HSALNG0077098	integenic	Q50	NA	Waist-hip ratio; Sex interaction measurement; Age at assessment; Bmi-adjusted waist-hip ratio	ARHGAP12	SPEN-AS1
ENSG00000276116	FUT8-AS1	-1.14331389341243	0.00301815922369445	M1_vs_M0	HSALNG0144243	anti_sense	Q75	NA	Serum igg glycosylation measurement,-	MAX	ZNF154
ENSG00000249307	LINC01088	-4.43741266068097	3.26242784880829e-26	M1_vs_M0	HSALNG0035427	integenic	Not conserved	hsa-miR-619-5p	NA	BMP2K	PNPLA1
ENSG00000287543	ENSG00000287543	3.55698970008483	1.49551214682557e-25	M1_vs_M0	HSALNG0144564	anti_sense	Q50	NA	Bmi-adjusted hip circumference,-	GOLGA6A	TIGD2
ENSG00000256268	LINC02454	-1.53046658143968	7.39700847383395e-8	M1_vs_M0	HSALNG0091990	integenic	Q75	NA	Differentiated thyroid carcinoma; Papillary thyroid carcinoma,Heel bone mineral density,Fev/fec ratio; Response to bronchodilator,-	MSRB3	ARHGAP45
ENSG00000242516	LINC00960	-1.28002789153917	7.46738961054956e-8	M1_vs_M0	HSALNG0026938	anti_sense	Not conserved	hsa-miR-619-5p	NA	FRG2C	ARHGAP45
ENSG00000226800	CACTIN-AS1	-1.23957686079485	0.0199535395936174	M1_vs_M0	HSALNG0123289	anti_sense	Q90	hsa-miR-4279,hsa-miR-4286,hsa-miR-6089,hsa-miR-6803-5p,hsa-miR-6813-5p,hsa-miR-6840-5p,hsa-miR-6886-5p	Igfbp-3 measurement,-	GIPC3	PIPSL
ENSG00000253671	ENSG00000253671	-2.50433102735035	1.41742063828804e-14	M1_vs_M0	HSALNG0063682	anti_sense	Q50	hsa-miR-1268b,hsa-miR-6089,hsa-miR-6769b-3p,hsa-miR-6867-5p	Body height,Blood protein measurement,Fev change measurement; Response to bronchodilator,-	PCM1	CHST13
ENSG00000268205	ENSG00000268205	1.16935186863467	6.739731211561721e-15	M1_vs_M0	HSALNG0127823	integenic	Not conserved	NA	NA	ZNF460	WDFY3-AS2
ENSG00000233338	TLR8-AS1	-2.95246990243318	0.0302370364954816	M1_vs_M0	HSALNG0136678	anti_sense	Q50	NA	Bmi-adjusted hip circumference,Systemic lupus erythematosus,Monocyte count,Celiac disease,C-reactive protein measurement,-	FAM9C	ZFP3
ENSG00000271857	ENSG00000271857	1.28379605358084	2.92588342765707e-11	M1_vs_M0	HSALNG0050324	anti_sense	Q90	hsa-miR-4467,hsa-miR-4686	-	SUPT3H	BHLHE22
ENSG00000287063	ENSG00000287063	-3.18971688165853	6.13081587642201e-6	M1_vs_M0	HSALNG0070806	integenic	Not conserved	hsa-miR-505-5p,hsa-miR-3960,hsa-miR-6765-5p	-	PRSS3	CAPS2
ENSG00000226791	LINC02611	-2.80731651682258	1.03744465360702e-11	M1_vs_M0	HSALNG0017221	integenic	Q50	hsa-miR-6090,hsa-miR-7113-3p	Eosinophil count; Bipolar disorder,Bipolar disorder,Myositis,-	CRACDL	BBS12
ENSG00000250274	ENSG00000250274	4.32352508461367	3.0131522127271e-11	M1_vs_M0	NA	NA	NA	NA	NA	LCP2	FKRP
ENSG00000226688	ENTPD1-AS1	-1.06237484669888	0.0437036466064696	M1_vs_M0	HSALNG0079858	overlap_antisense,anti_sense	Not conserved	NA	Diverticular disease,White matter hyperintensity measurement,Bmi-adjusted waist circumference,Total blood protein measurement,Age at menopause,Mean corpuscular volume,-	TCTN3	H2AC25
ENSG00000235531	MSC-AS1	3.37876269797408	6.555183128823999e-262	M1_vs_M0	HSALNG0066120	anti_sense	Not conserved	NA	Lung carcinoma,Gout,Clinical treatment,Attention deficit hyperactivity disorder,Smoking behaviour measurement,Mental development measurement,Diastolic blood pressure,Forced expiratory volume; Response to bronchodilator,-	KCNB2	ACBD4
ENSG00000287789	ENSG00000287789	-6.03376322011817	9.01783530627691e-23	M1_vs_M0	HSALNG0149201	anti_sense	Q75	NA	NA	GJA10	SGSH
ENSG00000286326	ENSG00000286326	-3.10022515894321	0.0171045741378499	M1_vs_M0	HSALNG0134651	anti_sense	Q90	hsa-miR-23a-5p,hsa-miR-7113-3p,hsa-miR-8072	Triacylglycerol 52:2 measurement; Diacylglycerol 36:2 measurement,Linguistic error measurement; Specific language impairment,-	CRYBA4	FANCB
ENSG00000225234	TRAPPC12-AS1	1.72881418340108	0.0102698299361783	M1_vs_M0	HSALNG0012576	anti_sense	Not conserved	hsa-miR-3620-5p,hsa-miR-1587	Neurofibrillary tangles measurement,Neuritic plaque measurement; Cerebral amyloid angiopathy; Neurofibrillary tangles measurement,-	ADI1	GPR135
ENSG00000272842	ENSG00000272842	-3.47216302808853	0.00329579552080944	M1_vs_M0	HSALNG0070291	anti_sense	Q75	NA	-	RPS6	RELL1
ENSG00000267121	FMNL1-DT	1.4233274920758	2.39742282852229e-47	M1_vs_M0	HSALNG0116830	anti_sense	Q75	hsa-miR-30b-3p,hsa-miR-185-3p,hsa-miR-619-5p,hsa-miR-675-5p,hsa-miR-5589-5p,hsa-miR-6089,hsa-miR-6791-5p,hsa-miR-7108-3p,hsa-miR-8485	Body fat distribution,White matter microstructure measurement,Body height,Thyroid stimulating hormone measurement,Bmi-adjusted hip circumference,-	SPATA32	RNF41
ENSG00000273669	ENSG00000273669	-5.95809294043589	2.90017090302855e-21	M1_vs_M0	HSALNG0122476	integenic	Q50	hsa-miR-4650-5p,hsa-miR-4695-5p,hsa-miR-6763-5p	Total blood protein measurement; Insomnia,-	ZNF407	ZNF101
ENSG00000226674	TEX41	2.06323440705857	1.76607267634891e-18	M1_vs_M0	HSALNG0019370	integenic	Q90	hsa-miR-619-5p,hsa-miR-4313,hsa-miR-4257,hsa-miR-4463,hsa-miR-6089,hsa-miR-6131,hsa-miR-6512-3p,hsa-miR-7150	Retinal nerve fibre layer thickness measurement; Retinal layer thickness measurement,Pr interval,Optic disc size measurement,Central corneal thickness; Neutrophil count; Intraocular pressure measurement; Leukocyte count; Monocyte count,Smoking initiation; Intraocular pressure measurement,Neutrophil count,Crohn's disease; Inflammatory bowel disease,Platelet count,Monocyte count,Urate measurement,Intelligence,Body weight; Body mass index,Mathematical ability,Breast carcinoma,Self reported educational attainment; Body mass index,Grip strength measurement,Smoking initiation,Hematocrit; Erythrocyte count,Hemoglobin measurement,Hematocrit,Triglyceride measurement,Hematocrit; Hemoglobin measurement; Chin morphology measurement; Balding measurement,Diastolic blood pressure,Facial morphology measurement,Body height,Hemoglobin measurement; Diastolic blood pressure,Reaction time measurement,Alopecia; Smoking behavior,Risk-taking behaviour; Arterial stiffness measurement,Hematocrit; Hemoglobin measurement,Electrocardiography,Skin aging measurement,Red blood cell density measurement; Erythrocyte count,Heel bone mineral density,Mean arterial pressure,Leukocyte count,Risk-taking behaviour,Atrial fibrillation,Blood phosphate measurement,Systolic blood pressure,Cortical surface area measurement,Lobe attachment; Myeloid white cell count,Arterial stiffness measurement,Neuroimaging measurement; Myeloid white cell count; Cortical thickness,Peak expiratory flow; Fev/fec ratio,Cortical thickness,Self reported educational attainment,Fev/fec ratio,Coronary artery disease,Smoking behavior,Hemorrhoid,Aortic stenosis,Antithrombotic agent use measurement,Creatinine measurement,Lobe attachment,Diet measurement,Protein measurement,Body mass index,Hypermetropia; Myopia,Psoriasis; Ulcerative colitis; Ankylosing spondylitis; Crohn's disease; Sclerosing cholangitis,Cortical surface area measurement; Neuroimaging measurement; Brain measurement,Aortic stenosis; Aortic valve calcification,Response to antihypertensive drug; Left ventricular mass,-	ARHGAP15	UNC5C
ENSG00000240405	SAMMSON	1.76045470789991	0.0171351606310057	M1_vs_M0	HSALNG0026723	integenic	Not conserved	NA	NA	MITF	RGMA
ENSG00000290865	RRN3P3	1.41210081271018	2.05716922446725e-14	M1_vs_M0	HSALNG0110195	intronic_sense	Not conserved	hsa-miR-6763-5p	NA	CDR2	SYNM
ENSG00000203688	LINC02487	-6.22617353713579	5.20541731967022e-6	M1_vs_M0	HSALNG0055190	integenic	Not conserved	NA	-	FRMD1	FIGN
ENSG00000258521	ENSG00000258521	7.01274922082416	1.6826577870989395e-105	M1_vs_M0	HSALNG0103731	anti_sense	Not conserved	NA	NA	SLC25A47	C1S
ENSG00000258183	LINC02392	1.29986858361588	3.79690429340288e-5	M1_vs_M0	HSALNG0092974	integenic	Not conserved	hsa-miR-6756-5p,hsa-miR-6803-5p	Interleukin 2 receptor antagonist measurement,Heel bone mineral density,Family history of lung cancer; Lung adenocarcinoma,-	TMTC3	NPLOC4
ENSG00000288926	ENSG00000288926	-1.23953527800955	0.0199056071449637	M1_vs_M0	HSALNG0024956	anti_sense	Q90	hsa-miR-4301	-	OSBPL10	RXFP3
ENSG00000230537	LINC02937	-2.96394633915559	4.4284395145572594e-11	M1_vs_M0	HSALNG0072707	integenic	Not conserved	NA	Eosinophil count	AUH	RGS6
ENSG00000230426	LINC01036	-3.50914760183744	7.00717807473536e-8	M1_vs_M0	HSALNG0009116	integenic	Q50	hsa-miR-619-5p,hsa-miR-3940-5p,hsa-miR-6802-5p	Asthma exacerbation measurement,Diet measurement,Unipolar depression,Fatty acid measurement; Fasting blood insulin measurement,Mouth morphology measurement,Non-alcoholic steatohepatitis,Protein measurement,5-hiaa measurement,Adolescent idiopathic scoliosis,Response to tenofovir,Corneal endothelial cell measurement,Interleukin 13 measurement,-	PLA2G4A	BEGAIN
ENSG00000246898	LINC00920	-3.24114298061938	1.39930308478767e-9	M1_vs_M0	HSALNG0112089	integenic	Not conserved	hsa-miR-5003-3p	NA	CDH5	ARHGEF37
ENSG00000246331	ENSG00000246331	-4.89386268734254	0.0117031079560106	M1_vs_M0	HSALNG0090149	integenic	Q50	hsa-miR-619-5p,hsa-miR-4447,hsa-miR-6089,hsa-miR-6132,hsa-miR-6803-5p,hsa-miR-10392-3p	Macrophage inflammatory protein 1a measurement,Macrophage colony stimulating factor measurement,Optic disc size measurement,Parental genotype effect measurement; Birth weight,Colorectal cancer,-	TSPAN11	CALN1
ENSG00000269970	ENSG00000269970	-1.75262380219424	0.0106483497170102	M1_vs_M0	HSALNG0074238	sense	Not conserved	NA	NA	PTGS1	RIMBP3C
ENSG00000236753	MKLN1-AS	1.35470877884099	1.70538774236177e-14	M1_vs_M0	HSALNG0061408	anti_sense	Q75	hsa-miR-619-5p,hsa-miR-4525	Skin aging measurement,Balding measurement,Puberty onset measurement,Alopecia; Androgenetic alopecia,-	PODXL	ASB7
ENSG00000197536	IRF1-AS1	4.125282856537	3.4911916440666488e-171	M1_vs_M0	HSALNG0044848	anti_sense,sense	Q50	hsa-miR-33b-5p,hsa-miR-4257,hsa-miR-4463,hsa-miR-6748-3p,hsa-miR-6803-5p	Fibrinogen measurement,Chronic obstructive pulmonary disease,Metabolite measurement,Apolipoprotein b measurement,Glycine measurement,Red blood cell distribution width,Neutrophil percentage of leukocytes,Ulcerative colitis; Diastolic blood pressure; Inflammatory bowel disease; Crohn's disease,Psoriasis; Inflammatory bowel disease; Ulcerative colitis; Ankylosing spondylitis; Crohn's disease; Adult onset asthma; Sclerosing cholangitis,Fibrinogen measurement; Sex hormone-binding globulin measurement,Urinary albumin to creatinine ratio,Diastolic blood pressure; Crohn's disease,Atopic asthma,Eosinophil count; Eosinophil percentage of leukocytes,Mean corpuscular hemoglobin,Nasal cavity polyp; Perceived unattractiveness to mosquitos measurement; Adult onset asthma,Serum metabolite measurement; Low density lipoprotein cholesterol measurement; Crohn's disease; Eczema; Systemic juvenile idiopathic arthritis, polyarticular juvenile idiopathic arthritis, rheumatoid factor negative, oligoarticular juvenile idiopathic arthritis; Rheumatoid arthritis; Aspartate aminotransferase measurement,Respiratory system disease; Adult onset asthma,Carotid plaque build,Low density lipoprotein cholesterol measurement,Chronic obstructive pulmonary disease; Smoking status measurement,Neutrophil count,Fibrinogen measurement; Lymphocyte count,Polycystic ovary syndrome,Fibrinogen measurement; Sex hormone-binding globulin measurement; Balding measurement,Neutrophil percentage of granulocytes; Eosinophil percentage of granulocytes; Mosquito bite reaction itch intensity measurement; Basophil count; Mosquito bite reaction size measurement; Eosinophil percentage of leukocytes; Eosinophil count,Mitochondrial dna measurement,Estrogen-receptor positive breast cancer; Breast carcinoma,Inhalant adrenergic use measurement,Cardiovascular disease,Eosinophil count,Diastolic blood pressure,Lymphocyte percentage of leukocytes,Total cholesterol measurement; Low density lipoprotein cholesterol measurement,Platelet count,Platelet crit,Psoriasis; Ulcerative colitis; Ankylosing spondylitis; Crohn's disease; Sclerosing cholangitis,Eczema; Allergic rhinitis,Fev/fec ratio,Autoimmune thyroid disease; Psoriasis; Common variable immunodeficiency; Mosquito bite reaction itch intensity measurement; Ulcerative colitis; Ankylosing spondylitis; Basophil count; Systemic lupus erythematosus; Crohn's disease; Mosquito bite reaction size measurement; Celiac disease; Autoimmune disease; Juvenile idiopathic arthritis,Psoriasis; Ulcerative colitis; Ankylosing spondylitis; Leukocyte count; Crohn's disease; Eosinophil percentage of leukocytes; Eosinophil count; Sclerosing cholangitis; Aspartate aminotransferase measurement,Hemoglobin a1 measurement,Reticulocyte count; Reticulocyte measurement,-	NA	ACSM5
ENSG00000287125	ENSG00000287125	-3.23572175922335	0.011498983143827	M1_vs_M0	HSALNG0113228	anti_sense	Not conserved	hsa-miR-3187-3p,hsa-miR-8072	NA	GSE1	SERHL2
ENSG00000186594	MIR22HG	1.13273408021197	1.46956055458232e-24	M1_vs_M0	HSALNG0113835	anti_sense	Q90	hsa-miR-30d-3p,hsa-miR-30e-3p,hsa-miR-4268,hsa-miR-4433a-3p,hsa-miR-4468,hsa-miR-6735-5p	C-reactive protein measurement; Sex hormone-binding globulin measurement; Alkaline phosphatase measurement; Testosterone measurement; Calcium measurement; Urinary albumin to creatinine ratio; Serum albumin measurement; Triglyceride measurement,Calcium measurement; Blood protein measurement; Sex hormone-binding globulin measurement; Serum albumin measurement,-	TLCD2	SETD3
ENSG00000233321	LINC02669	-3.10008694663896	0.0171875212281117	M1_vs_M0	HSALNG0142700	integenic	Q50	NA	NA	PITRM1	NIPSNAP1
ENSG00000283504	ENSG00000283504	7.80362205324075	1.65675832400463e-16	M1_vs_M0	HSALNG0062073	anti_sense	Q50	hsa-miR-6791-3p	Protein measurement,Parkinson's disease symptom measurement,Psoriasis; Inflammatory bowel disease; Ulcerative colitis; Ankylosing spondylitis; Crohn's disease; Sclerosing cholangitis,Gut microbiome measurement,Crohn's disease,Asparagine measurement,Uterine fibroid measurement,Chronic kidney disease; Diabetic nephropathy,Cardiovascular event measurement; Response to angiotensin-converting enzyme inhibitor; Response to angiotensin receptor blocker,-	EZH2	USP18
ENSG00000228318	ENSG00000228318	6.67729709285586	5.08604478189979e-8	M1_vs_M0	HSALNG0133209	anti_sense,sense	Not conserved	hsa-miR-1268b,hsa-miR-6089	Serum alanine aminotransferase measurement,3-hydroxypropylmercapturic acid measurement,Atrial fibrillation; Diastolic blood pressure; Ventricular rate measurement; Diabetes mellitus; Heart failure; Cancer; Body mass index; Stroke; Total cholesterol measurement; Systolic blood pressure; Mortality; High density lipoprotein cholesterol measurement; Triglyceride measurement; Hematocrit; Glucose measurement; Coronary artery disease,-	TMPRSS2	RFX6
ENSG00000271869	DCTN6-DT	-1.3725120006257	0.0352824389154421	M1_vs_M0	HSALNG0064342	anti_sense	Not conserved	NA	NA	MBOAT4	RPS27L
ENSG00000230615	ENSG00000230615	4.27255354080174	3.21596102230545e-6	M1_vs_M0	HSALNG0003151	integenic	Not conserved	hsa-miR-619-5p,hsa-miR-1224-3p	-	KLF17	MFSD6L
ENSG00000231877	ENSG00000231877	-7.50103558296079	2.24201701224647e-51	M1_vs_M0	HSALNG0011827	integenic	Q75	hsa-miR-4308,hsa-miR-3620-5p,hsa-miR-4505,hsa-miR-1587,hsa-miR-2467-3p,hsa-miR-6089,hsa-miR-6510-5p,hsa-miR-6877-3p	Adolescent idiopathic scoliosis,White matter microstructure measurement,Neurofibrillary tangles measurement,Intelligence,Protein measurement,Frontal pole volume measurement,Serum selenium measurement,Economic and social preference,Dysphagia,Cognitive decline measurement,C-peptide measurement,Hippocampal volume,Serum alanine aminotransferase measurement; Response to combination chemotherapy,Caudate nucleus measurement; Functional brain measurement; Response to reward,-	RYR2	SV2B
ENSG00000236008	LINC01814	-2.57904957046857	4.60155039078283e-9	M1_vs_M0	HSALNG0012834	integenic	Not conserved	hsa-miR-7160-3p	NA	KIDINS220	DNAH14
ENSG00000270049	ATP6V0D1-DT	-1.66603700762094	1.28311135174154e-7	M1_vs_M0	HSALNG0112213	anti_sense	Q75	hsa-miR-619-5p,hsa-miR-4433a-3p,hsa-miR-4740-3p	Agouti-related protein measurement,Mean corpuscular hemoglobin concentration,Mean reticulocyte volume; Mean corpuscular volume; Mean corpuscular hemoglobin,-	RIPOR1	C16orf54
ENSG00000271474	UNC5C-AS1	4.79245524526339	2.0833226417464103e-9	M1_vs_M0	HSALNG0035909	anti_sense	Q50	NA	-	PDHA2	CDIN1
ENSG00000246859	STARD4-AS1	-2.67644945310795	7.067512316054658e-54	M1_vs_M0	HSALNG0044138	integenic	Not conserved	NA	NA	CAMK4	ANKRD46
ENSG00000249685	ENSG00000249685	1.78071349079247	1.8269660372855e-4	M1_vs_M0	HSALNG0033928	integenic	Q50	NA	Acute lymphoblastic leukemia	KLHL5	CCDC30
ENSG00000287110	ACAD9-DT	-1.30731465334106	0.0080236293239011	M1_vs_M0	HSALNG0147926	integenic	Not conserved	NA	Heel bone mineral density,-	CFAP92	SMYD4
ENSG00000267655	ENSG00000267655	1.93673756624275	1.1733736448176e-4	M1_vs_M0	HSALNG0122734	sense	Not conserved	NA	NA	ATP9B	CXCR3
ENSG00000258667	HIF1A-AS3	1.87121788627544	7.93636482040542e-9	M1_vs_M0	HSALNG0101781	anti_sense	Q50	hsa-miR-619-5p	-	TMEM30B	TNFRSF4
ENSG00000285973	ENSG00000285973	-3.75038448867841	5.1534616941007305e-15	M1_vs_M0	HSALNG0081190	anti_sense	Q50	hsa-miR-4277	Pathological myopia	NSMCE4A	GABRD
ENSG00000291028	LINC00933	-4.6794095321981	0.0196665706546534	M1_vs_M0	HSALNG0107794	integenic	Not conserved	hsa-miR-766-3p,hsa-miR-4749-3p	Appendicular lean mass,Bmi-adjusted waist circumference,Bipolar disorder,-	ZSCAN2	COL14A1
ENSG00000228162	ENSG00000228162	-4.67941046842177	0.0206410028402749	M1_vs_M0	HSALNG0023160	integenic	Q50	hsa-miR-4472,hsa-miR-6838-3p	Family history of lung cancer; Lung adenocarcinoma,-	SPP2	COL14A1
ENSG00000254531	FLJ20021	-1.87399536271115	6.07374910038412e-18	M1_vs_M0	HSALNG0148159	anti_sense	Not conserved	hsa-miR-6780a-3p	-	BANK1	ZC3H6
ENSG00000290578	ENSG00000290578	6.37391063731499	3.98036796469789e-6	M1_vs_M0	HSALNG0142325	integenic	Not conserved	hsa-miR-4492,hsa-miR-6873-5p,hsa-miR-6873-3p	NA	PPIAL4H	IDO2
ENSG00000214353	VAC14-AS1	1.12435578508945	0.0343892960193948	M1_vs_M0	HSALNG0112453	anti_sense	Not conserved	hsa-miR-4456,hsa-miR-6891-3p	NA	IL34	SLC4A5
ENSG00000260448	LCMT1-AS1	1.37699867528975	0.0430961541240798	M1_vs_M0	HSALNG0110334	integenic	Not conserved	hsa-miR-619-5p,hsa-miR-3620-5p,hsa-miR-4467,hsa-miR-1587,hsa-miR-3960,hsa-miR-7108-3p	-	ARHGAP17	TMEM201
ENSG00000267074	ENSG00000267074	8.39444746373965	2.1370679735617696e-25	M1_vs_M0	HSALNG0115953	sense	Not conserved	NA	Macrophage inflammatory protein 1b measurement	SLFN12L	CALHM6
ENSG00000236120	ENSG00000236120	-2.45960555805619	0.0010563364477757	M1_vs_M0	HSALNG0136490	integenic	Not conserved	NA	Facial morphology measurement	NLGN4X	LINC00910
ENSG00000250167	ENSG00000250167	-2.08781041755121	0.00507845470594402	M1_vs_M0	HSALNG0045048	sense	Not conserved	hsa-miR-4313	NA	SLC25A48	FBF1
ENSG00000231971	CT69	3.41929579522123	2.39143214828129e-5	M1_vs_M0	HSALNG0053626	integenic	Q90	hsa-miR-619-5p,hsa-miR-3652,hsa-miR-4447,hsa-miR-4486,hsa-miR-6089	Mean corpuscular hemoglobin,Urate measurement,Erythrocyte count,Glomerular filtration rate,Abnormality of refraction,Mean corpuscular volume,Melanoma,Varicose veins,Hair colour measurement,Eosinophil count,Electrocardiography,Monocyte count,Platelet component distribution width; Platelet crit; Platelet count,Reticulocyte count,Leukocyte count,Platelet count,Triacylglycerol 52:5 measurement; Triacylglycerol 54:8 measurement,Calcium measurement,Platelet crit,Lymphocyte count,Coronary artery calcification,Red blood cell distribution width,Platelet-to-lymphocyte ratio,Cirrhosis of liver; Non-alcoholic fatty liver disease,Mean corpuscular hemoglobin; Erythrocyte count,Pulse pressure measurement,-	SGK1	RNFT1
ENSG00000224616	RTCA-AS1	-1.70328186715523	4.69497100821169e-10	M1_vs_M0	HSALNG0005524	integenic	Not conserved	hsa-miR-4514	Lung carcinoma,-	DBT	LITAF
ENSG00000261036	ENSG00000261036	3.41384303096561	1.40029535019416e-58	M1_vs_M0	HSALNG0044432	integenic	Not conserved	NA	NA	DTWD2	HMGB1
ENSG00000204860	FAM201A	-2.45495702171434	2.19925673788055e-7	M1_vs_M0	HSALNG0071146	anti_sense	Not conserved	hsa-miR-1205,hsa-miR-4281	Obsessive-compulsive disorder; Tourette syndrome,-	ALDH1B1	CPNE4
ENSG00000262001	DLGAP1-AS2	1.16730599361158	6.30909163342781e-9	M1_vs_M0	HSALNG0119714	anti_sense	Q75	hsa-miR-619-5p,hsa-miR-4481,hsa-miR-4505,hsa-miR-1587,hsa-miR-6089,hsa-miR-7111-5p,hsa-miR-7150	Mean corpuscular volume,Mean reticulocyte volume,Blood urea nitrogen measurement; Serum urea measurement,Fat body mass,Mean reticulocyte volume; Mean corpuscular volume,Lip morphology measurement,Alanine measurement; Amino acid measurement,-	TGIF1	PTPN1
ENSG00000254703	SENCR	-2.47263101406642	1.11520838001009e-10	M1_vs_M0	HSALNG0088110	intronic_antisense	Q90	hsa-miR-4472,hsa-miR-6803-5p	Platelet count; Platelet crit,Basophil count,-	ETS1	ZNF765
ENSG00000291006	ENSG00000291006	-2.91381382427345	1.0529178918093199e-81	M1_vs_M0	NA	NA	NA	NA	NA	TMEM14A	MYO18A
ENSG00000228824	MIR4500HG	-2.00196160809947	1.8140747359554e-4	M1_vs_M0	HSALNG0144006	overlap_antisense	Not conserved	NA	Varicose veins,-	SLITRK6	AJAP1
ENSG00000281468	ENSG00000281468	-1.6893225376793	0.0169664995892284	M1_vs_M0	HSALNG0125122	integenic	Not conserved	hsa-miR-762,hsa-miR-3155b,hsa-miR-5047,hsa-miR-6797-5p,hsa-miR-6858-3p	-	VSTM2B	MRTFA
ENSG00000287126	ENSG00000287126	-1.38650883113854	1.0040994128181e-7	M1_vs_M0	HSALNG0012585	integenic	Q75	hsa-miR-619-5p,hsa-miR-4505	-	NA	HRH1
ENSG00000231064	THBS3-AS1	-1.73271590298866	0.00317609188272942	M1_vs_M0	HSALNG0007477	anti_sense	Q90	hsa-miR-4667-3p,hsa-miR-6089,hsa-miR-6803-5p,hsa-miR-6769b-5p	Gastric carcinoma,Treatment-resistant hypertension,Carpal tunnel syndrome,Occipital lobe volume measurement; Calcium measurement; Heel bone mineral density,Hemoglobin a1 measurement; Mean corpuscular hemoglobin concentration,Cancer antigen 15.3 measurement; Fev/fec ratio,Glomerular filtration rate; Bmi-adjusted waist circumference; Cancer antigen 15.3 measurement; Creatinine measurement; Cortical thickness,-	MTX1	LINC01560
ENSG00000280560	LINC01374	-3.10022047780226	0.0171263829361096	M1_vs_M0	HSALNG0079606	integenic	Q50	hsa-miR-6803-5p	Carotid plaque build,Functional brain measurement,Myopia,Bone mineral content measurement,Coronary artery calcification,Systolic blood pressure change measurement,Cryptococcosis,Economic and social preference,Growth rate measurement,Hearing threshold measurement; Hearing measurement,Forced expiratory volume; Response to bronchodilator,Hiv-1 infection; Peripheral neuropathy; Response to reverse transcriptase inhibitor,Peripheral arterial disease; Traffic air pollution measurement,-	KIF20B	CTBP1-DT
ENSG00000260121	ENSG00000260121	-2.03943765264515	7.6565733227036e-9	M1_vs_M0	HSALNG0144821	anti_sense	Q90	hsa-miR-4685-5p,hsa-miR-6848-5p	Reticulocyte count; Hba1c measurement; Bilirubin measurement,-	CTU2	SLC39A10
ENSG00000285163	ENSG00000285163	-3.76659369994571	8.6033603721799e-4	M1_vs_M0	HSALNG0113249	integenic	Q50	hsa-miR-92a-2-5p,hsa-miR-525-5p,hsa-miR-4466,hsa-miR-6855-5p	Qrs duration,Monocyte count,Primary biliary cirrhosis,Systemic lupus erythematosus,Monocyte percentage of leukocytes; Monocyte count,Chronic lymphocytic leukemia,Systemic scleroderma,Systemic lupus erythematosus; Systemic scleroderma; Monocyte count,Granulocyte percentage of myeloid white cells; Monocyte count,Granulocyte percentage of myeloid white cells; Monocyte percentage of leukocytes,Monocyte percentage of leukocytes,Neutrophil percentage of leukocytes; Neutrophil count,Neutrophil percentage of leukocytes,Bladder exstrophy; Monocyte percentage of leukocytes,Anti-centromere-antibody-positive systemic scleroderma; Limited scleroderma; Systemic scleroderma,Granulocyte percentage of myeloid white cells; Monocyte percentage of leukocytes; Monocyte count,Ulcerative colitis; Monocyte count,Ulcerative colitis; Inflammatory bowel disease,Eosinophil count; Inflammatory bowel disease; Monocyte percentage of leukocytes,Crohn's disease,Systemic lupus erythematosus; Inflammatory bowel disease,Leukocyte count; Rheumatoid arthritis; Monocyte percentage of leukocytes,Psoriasis; Ulcerative colitis; Ankylosing spondylitis; Systemic lupus erythematosus; Crohn's disease; Sclerosing cholangitis,Neutrophil count; Granulocyte percentage of myeloid white cells; Myeloid white cell count; Leukocyte count; Monocyte count; Monocyte percentage of leukocytes,Lymphocyte count,Eosinophil count,Eosinophil percentage of leukocytes,Neutrophil percentage of granulocytes; Neutrophil percentage of leukocytes; Eosinophil percentage of granulocytes,Systemic lupus erythematosus; Biliary liver cirrhosis; Primary biliary cirrhosis,Rheumatoid arthritis,Rheumatoid arthritis; Monocyte count,Oral ulcer,Autoimmune disease; Systemic lupus erythematosus; Primary biliary cirrhosis,Behcet's syndrome,Hypothyroidism,Adolescent idiopathic scoliosis,Aspartate aminotransferase measurement,Unipolar depression,Fev/fec ratio,Rheumatoid arthritis; Systemic lupus erythematosus; Myositis; Systemic scleroderma,Hodgkins lymphoma; Chronic lymphocytic leukemia; Multiple myeloma,Psoriasis; Ulcerative colitis; Ankylosing spondylitis; Crohn's disease; Sclerosing cholangitis,-,Leukocyte count; Lymphocyte count	IRF8	TPSB2
ENSG00000281398	SNHG4	-1.66490886773057	6.598880154527499e-36	M1_vs_M0	HSALNG0045213	anti_sense,sense	Q50	hsa-miR-3170,hsa-miR-6089,hsa-miR-6736-5p	-	MATR3	ZNF655
ENSG00000254777	ENSG00000254777	-6.37658976020745	3.09597327939315e-6	M1_vs_M0	HSALNG0150218	integenic	Not conserved	hsa-miR-574-5p	NA	CHD7	SLC28A3
ENSG00000286017	ENSG00000286017	-3.28841594503553	1.68918582848573e-6	M1_vs_M0	HSALNG0031982	integenic	Not conserved	NA	NA	NCBP2AS2	TTC30A
ENSG00000231426	FILNC1	-2.73512898753345	8.254433218965929e-12	M1_vs_M0	HSALNG0053896	integenic	Q50	hsa-miR-619-5p	Serum igg glycosylation measurement,Age at onset,Response to simvastatin; Pcsk9 protein measurement,-	HECA	GPX1P1
ENSG00000257702	LBX2-AS1	1.12456753058455	1.3920323758178098e-19	M1_vs_M0	HSALNG0016063	anti_sense	Q90	hsa-miR-4492,hsa-miR-6726-5p	-	TTC31	ENTPD6
ENSG00000258035	ENSG00000258035	6.06942000633666	9.26235939832329e-5	M1_vs_M0	HSALNG0093159	anti_sense	Q90	hsa-miR-296-5p	-	CEP83	ZNF433
ENSG00000260479	ENSG00000260479	-2.90867228680576	1.5783215043023e-4	M1_vs_M0	HSALNG0112882	sense	Q75	NA	NA	WWOX	FAM114A1
ENSG00000291144	ENSG00000291144	2.19027364807663	1.73372458135043e-39	M1_vs_M0	HSALNG0082349	overlap_sense	Not conserved	NA	Lung carcinoma,Mean corpuscular hemoglobin concentration,Hip bone mineral density; Hip bone size,Diastolic blood pressure,-	OR52K1	RPE
ENSG00000290763	SDHAP1	-1.04146915757101	0.00732946110431722	M1_vs_M0	HSALNG0031873	integenic	Not conserved	NA	NA	TFRC	FAM118B
ENSG00000229950	TFAP2A-AS1	1.58910818499255	0.0089788357959639	M1_vs_M0	HSALNG0048011	anti_sense	Q90	NA	Human papilloma virus infection; Oral cavity cancer; Oropharynx cancer,Squamous cell lung carcinoma,-	GCNT2	NKIRAS1
ENSG00000214293	APTR	1.07361558421094	5.24810631695448e-7	M1_vs_M0	HSALNG0059132	anti_sense	Q90	hsa-miR-4279,hsa-miR-4283,hsa-miR-1268b,hsa-miR-6791-3p	Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio,Bmi-adjusted waist-hip ratio,Lymphocyte count,Electrocardiography,Brain volume measurement,Facial morphology measurement,Body height,Serum gamma-glutamyl transferase measurement,Creatinine measurement; Glomerular filtration rate,-,Creatinine measurement,Eosinophil count	TMEM60	NKIRAS1
ENSG00000272168	CASC15	-3.13771571707643	1.15748562262302e-5	M1_vs_M0	HSALNG0048556	integenic	Not conserved	NA	NA	HDGFL1	ZNF823
ENSG00000204876	ENSG00000204876	2.45547941645975	1.1935455263798e-4	M1_vs_M0	NA	NA	NA	NA	NA	RBM33	ZNF311
ENSG00000270426	ENSG00000270426	2.63278657610908	2.25764131237475e-7	M1_vs_M0	HSALNG0039018	sense	Q90	NA	NA	IRF2	ZNF71
ENSG00000247774	PCED1B-AS1	-2.28457427268838	2.50693537847709e-75	M1_vs_M0	HSALNG0090741	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-3940-5p,hsa-miR-6089	Antihypertensive use measurement,Body height,-	AMIGO2	MBP
ENSG00000234076	TPRG1-AS1	-2.68127191638007	1.60519001674866e-7	M1_vs_M0	HSALNG0031482	anti_sense	Q50	hsa-miR-619-5p	-	P3H2	CHSY3
ENSG00000291054	ENSG00000291054	2.05300966445634	0.001655355678751	M1_vs_M0	HSALNG0140357	integenic	Q50	NA	NA	CD40LG	ZNF544
ENSG00000223764	LINC02593	-3.55658122193164	1.28496637638757e-16	M1_vs_M0	HSALNG0000054	integenic	Not conserved	hsa-miR-550a-5p,hsa-miR-550a-3-5p,hsa-miR-3188,hsa-miR-3620-5p,hsa-miR-1587	-	NOC2L	SVIP
ENSG00000245468	LINC02447	-1.8134246696505	0.00658263991427586	M1_vs_M0	HSALNG0032671	integenic	Q50	NA	-	GRPEL1	SVIP
ENSG00000257027	ENSG00000257027	1.48344638996836	5.89903380799644e-12	M1_vs_M0	HSALNG0089164	integenic	Not conserved	NA	NA	CLEC2D	ANKRD35
ENSG00000282851	BISPR	2.08719291785082	4.50928645908155e-69	M1_vs_M0	HSALNG0124521	sense	Not conserved	hsa-miR-6775-3p	Blood phosphate measurement,-	MVB12A	STK39
ENSG00000291064	RPL23AP7	-1.16411296730332	5.13138328272519e-6	M1_vs_M0	HSALNG0136334	anti_sense	Not conserved	hsa-miR-4469	NA	ACR	TUSC1
ENSG00000248309	MEF2C-AS1	-1.62000829744691	5.62633986352758e-8	M1_vs_M0	HSALNG0043388	integenic	Not conserved	NA	NA	POLR3G	MT-ND6
ENSG00000253641	LINC03022	-1.67111357010025	5.37548906244758e-5	M1_vs_M0	HSALNG0063375	anti_sense	Not conserved	NA	Bmi-adjusted waist circumference; White matter microstructure measurement,Bmi-adjusted waist-hip ratio,Neuroticism measurement,Bmi-adjusted waist circumference,-	PRSS55	IPO9
ENSG00000232533	FAM131B-AS2	-2.92535802174286	8.12733763959108e-127	M1_vs_M0	HSALNG0061960	integenic	Not conserved	hsa-miR-10392-3p	-	EPHA1	PNP
ENSG00000213373	LINC00671	-6.57586032861904	4.26984850090882e-7	M1_vs_M0	HSALNG0116587	integenic	Q50	hsa-miR-30b-3p,hsa-miR-363-5p,hsa-miR-331-3p,hsa-miR-619-5p,hsa-miR-1587,hsa-miR-6089,hsa-miR-1273h-5p	Triglyceride measurement,-	BECN1	STYXL2
ENSG00000288990	ENSG00000288990	-1.08547127255048	6.918880117174139e-16	M1_vs_M0	HSALNG0031952	anti_sense	Q50	NA	Inhalant adrenergic use measurement,Respiratory system disease,-	CEP19	MT-ND4
ENSG00000253161	LINC01605	-6.79096430482692	1.75811436545333e-38	M1_vs_M0	HSALNG0150382	integenic	Q90	hsa-miR-149-3p,hsa-miR-4486	Body height,Endometriosis,-	BRF2	MT-ATP6
ENSG00000273486	ENSG00000273486	-2.16714738214633	3.87892863471842e-7	M1_vs_M0	HSALNG0029189	anti_sense	Q90	hsa-miR-23a-5p,hsa-miR-135a-3p,hsa-miR-619-5p,hsa-miR-1268b,hsa-miR-4447,hsa-miR-3960,hsa-miR-6089	Lymphocyte count,Body mass index,-	STAG1	RN7SKP160
ENSG00000288856	ENSG00000288856	-2.01212257957714	1.44979560434391e-13	M1_vs_M0	HSALNG0137398	anti_sense	Q50	NA	NA	ATP6AP2	SNORD48
ENSG00000285693	ENSG00000285693	1.82165891313756	5.15724001517917e-5	M1_vs_M0	HSALNG0085586	sense	Q50	hsa-miR-4279,hsa-miR-4492,hsa-miR-5589-5p	Protein measurement,Platelet count,Aspartate aminotransferase measurement,Serum alanine aminotransferase measurement	STARD10	EFCAB2
ENSG00000291038	ENSG00000291038	-4.71273728773779	7.75711290225702e-15	M1_vs_M0	NA	NA	NA	NA	NA	APEX1	MIR29B2CHG
ENSG00000291019	AACSP1	2.5956983937143	0.0141840275447564	M1_vs_M0	HSALNG0149043	integenic	Not conserved	NA	-	ZNF354A	H2BC18
ENSG00000267026	ENSG00000267026	-5.65098344854287	3.7490705274228e-4	M1_vs_M0	HSALNG0073203	anti_sense	Not conserved	hsa-miR-6729-3p	NA	ANKS6	GDI1
ENSG00000285744	ENSG00000285744	8.48256810803507	3.6542037695655993e-206	M1_vs_M0	HSALNG0066417	integenic	Not conserved	NA	NA	ZC2HC1A	HLA-DOA
ENSG00000291073	ENSG00000291073	1.7808461918921	1.8351485973131e-4	M1_vs_M0	HSALNG0110122	integenic	Not conserved	hsa-miR-619-5p,hsa-miR-4673	NA	NPIPB3	ZNF814
ENSG00000265975	ENSG00000265975	1.25149542325792	2.3020105134221e-4	M1_vs_M0	HSALNG0114480	integenic	Not conserved	NA	NA	NTN1	POLR1HASP
ENSG00000229484	LINC02766	-2.77681250793909	3.25500601001885e-6	M1_vs_M0	HSALNG0000944	integenic	Not conserved	NA	-	VPS13D	HLA-F
ENSG00000214894	LINC00243	3.72714904426054	5.64192010939538e-7	M1_vs_M0	HSALNG0049199	integenic	Not conserved	hsa-miR-619-5p,hsa-miR-6744-3p	Breast carcinoma,Mean platelet volume,Sleep duration,Cutaneous lupus erythematosus,Intelligence,Angina pectoris,Bmi-adjusted waist-hip ratio,Response to vaccine,Bmi-adjusted hip circumference,Reticulocyte count,Autoimmune thyroid disease; Bipolar disorder,Age-related macular degeneration,Reaction time measurement,Decreased fine motor function,17-hydroxyprogesterone measurement,Cytokine measurement,Protein measurement; Bmi-adjusted hip circumference,Bmi-adjusted hip circumference; Arterial stiffness measurement,Susceptibility to cold sores measurement,Susceptibility to plantar warts measurement,Susceptibility to chickenpox measurement,Susceptibility to shingles measurement,Autism spectrum disorder,Serum igg glycosylation measurement,Response to candesartan,Rosacea severity measurement,Cervical carcinoma,Eosinophil count,Glomerular filtration rate,Susceptibility to urinary tract infection measurement,Tonsillectomy risk measurement,Qrs amplitude; Qrs complex,Mosquito bite reaction size measurement; Mosquito bite reaction itch intensity measurement,-	IER3	TRIM27
ENSG00000289104	ENSG00000289104	-3.67786459626993	0.00263196144466806	M1_vs_M0	HSALNG0064676	integenic	Q75	NA	Pancreatic carcinoma; Chronic mountain sickness; Platelet aggregation,-	TACC1	SPIRE2
ENSG00000275630	ENSG00000275630	2.66217367553938	9.53007099044497e-5	M1_vs_M0	HSALNG0102240	integenic	Not conserved	NA	NA	PCNX1	TMEM240
ENSG00000283646	LINC02009	5.04713152748546	2.3564415379494797e-11	M1_vs_M0	HSALNG0025684	integenic	Not conserved	hsa-miR-3620-5p,hsa-miR-1587,hsa-miR-6786-5p,hsa-miR-6828-3p	Macula measurement; Lymphocyte percentage of leukocytes; Inflammatory bowel disease; Ulcerative colitis; Protein measurement; Neutrophil-to-lymphocyte ratio; Platelet-to-lymphocyte ratio; Macrophage inflammatory protein 1b measurement,Oral ulcer,Ccl2 measurement,Monocyte count,Monocyte percentage of leukocytes,Eotaxin measurement,Bmi-adjusted hip circumference	LTF	EXOC3L4
ENSG00000238078	LINC01352	1.60463205562609	3.22075875990628e-9	M1_vs_M0	HSALNG0010764	sense	Not conserved	NA	NA	NA	LINC01446
ENSG00000186019	ZNF225-AS1	1.67933607882735	6.4596964245967e-4	M1_vs_M0	HSALNG0126426	anti_sense	Not conserved	NA	Cytokine measurement,-	ZNF235	SMIM11
ENSG00000286796	ENSG00000286796	-6.05848681600427	3.24651704722582e-5	M1_vs_M0	HSALNG0014524	integenic	Q50	hsa-miR-4323,hsa-miR-4472,hsa-miR-6756-3p,hsa-miR-6783-3p,hsa-miR-6836-3p	Gastric carcinoma,Resistin measurement; Monocyte count,Monocyte count,Neutrophil percentage of leukocytes; Lymphocyte percentage of leukocytes,Neutrophil count	MTA3	HCG27
ENSG00000273143	DUSP5-DT	1.64052329025465	1.1214095634438e-4	M1_vs_M0	HSALNG0080582	integenic	Q50	NA	Heel bone mineral density,Bone density,-	SMNDC1	ZCWPW2
ENSG00000253853	ENSG00000253853	-1.3372639957622	0.0114759672499982	M1_vs_M0	HSALNG0063032	integenic	Not conserved	NA	NA	MYOM2	MT-TY
ENSG00000260086	ENSG00000260086	-2.19563813457794	5.6045374820036e-4	M1_vs_M0	HSALNG0111257	integenic	Not conserved	NA	NA	LONP2	GNRHR2
ENSG00000232628	ENSG00000232628	-2.20233723124277	0.02583652387236	M1_vs_M0	HSALNG0010945	integenic	Not conserved	NA	Ceramide measurement	NVL	CRIP1
ENSG00000230647	ENSG00000230647	8.44064696594548	2.4936870757942492e-23	M1_vs_M0	HSALNG0145008	integenic	Q75	hsa-miR-619-5p	Heel bone mineral density,-	HS3ST3B1	ENSG00000213172
ENSG00000277548	ENSG00000277548	2.21000572824909	9.66200682588741e-5	M1_vs_M0	HSALNG0106069	anti_sense,sense	Not conserved	NA	NA	CCPG1	CCDC183
ENSG00000255045	ENSG00000255045	-7.00258004783174	3.38913766719866e-10	M1_vs_M0	HSALNG0087906	anti_sense	Q50	hsa-miR-593-5p,hsa-miR-1237-3p,hsa-miR-6792-3p	Anorexia nervosa; Self reported educational attainment; Intelligence; Autism spectrum disorder; Obsessive-compulsive disorder; Attention deficit hyperactivity disorder; Unipolar depression; Bipolar disorder; Tourette syndrome,Smoking status measurement,-	VSIG2	GSTM2
ENSG00000262185	LINC02861	-5.24601920653565	0.00396255184061151	M1_vs_M0	HSALNG0109194	integenic	Q50	hsa-miR-619-5p,hsa-miR-1268b,hsa-miR-6089	Breast carcinoma,Cleft lip; Cleft palate	ADCY9	GSTM2
ENSG00000280721	LINC01943	-4.71275419785376	8.062731909068771e-15	M1_vs_M0	HSALNG0016641	integenic	Not conserved	hsa-miR-6803-5p	-	RGPD2	CENPBD2P
ENSG00000233384	CNIH3-AS2	-2.50378768948183	6.89663154518567e-24	M1_vs_M0	HSALNG0010968	anti_sense	Q75	hsa-miR-4467,hsa-miR-3960,hsa-miR-7156-3p	-	WDR26	MYCBP
ENSG00000226281	ENSG00000226281	-3.37439978744436	5.53235628170218e-5	M1_vs_M0	HSALNG0047836	integenic	Not conserved	hsa-miR-762,hsa-miR-5787	NA	F13A1	SCART1
ENSG00000266976	ENSG00000266976	1.4890296909029	1.4322228118205399e-9	M1_vs_M0	HSALNG0145715	integenic	Not conserved	NA	NA	VSTM2B	SOGA3
ENSG00000271780	ENSG00000271780	-1.10174794574661	0.0315711765035711	M1_vs_M0	HSALNG0103867	sense	Not conserved	hsa-miR-363-5p,hsa-miR-6089,hsa-miR-7160-3p	Body mass index,-,Age at menopause	DYNC1H1	RPS3AP21
ENSG00000236939	BAALC-AS2	4.14040705133166	4.56503662511979e-21	M1_vs_M0	HSALNG0067505	anti_sense	Q50	hsa-miR-4447	Pelvic organ prolapse,Cognitive function measurement,Myopia,Late-onset alzheimers disease,Mathematical ability,Colorectal cancer; Breast carcinoma,Triglyceride measurement; Response to diuretic,Hemoglobin a1 measurement,-	AZIN1	SMTNL1
ENSG00000253768	ENSG00000253768	-2.29757433799124	0.0183176565249288	M1_vs_M0	HSALNG0046699	integenic	Q50	hsa-miR-762,hsa-miR-3195,hsa-miR-4281,hsa-miR-4685-5p,hsa-miR-4734,hsa-miR-5587-3p,hsa-miR-6085,hsa-miR-6721-5p,hsa-miR-6813-5p,hsa-miR-7112-5p,hsa-miR-7113-5p	Sitting height ratio,Waist-hip ratio; Body height; Bmi-adjusted hip circumference,Body height; Bmi-adjusted hip circumference,Bmi-adjusted hip circumference,Heel bone mineral density,Body height,Bmi-adjusted waist circumference; Sitting height ratio; Urate measurement,-	CPEB4	ENSG00000215156
ENSG00000250657	ENSG00000250657	-4.75483336246518	5.7265826448903415e-9	M1_vs_M0	HSALNG0034131	integenic	Q50	hsa-miR-4516	Mhpg measurement; 5-hiaa measurement,-	GRXCR1	DDX3X
ENSG00000215067	ALOX12-AS1	1.17674045213746	1.50400913455323e-10	M1_vs_M0	HSALNG0114242	integenic	Not conserved	hsa-miR-3944-5p	NA	SLC16A11	EFCAB8
ENSG00000274565	ENSG00000274565	-1.96631858935258	8.87554876593019e-6	M1_vs_M0	HSALNG0117970	anti_sense	Q75	NA	-	MARCHF10	ENSG00000215835
ENSG00000253217	ENSG00000253217	1.43301557280662	0.0293347226002212	M1_vs_M0	HSALNG0067281	anti_sense	Q75	NA	Unipolar depression,Lymphocyte count,-	SPAG1	ARIH2OS
ENSG00000287616	ENSG00000287616	-3.10121459106148	0.0181605233483601	M1_vs_M0	HSALNG0052338	integenic	Q50	NA	-	HACE1	ENSG00000222012
ENSG00000235257	ITGA9-AS1	-1.50314653110685	0.0343849198484385	M1_vs_M0	HSALNG0025195	anti_sense	Not conserved	NA	NA	PLCD1	ENSG00000222031
ENSG00000254290	ENSG00000254290	-3.10050760732786	0.015699873238145	M1_vs_M0	HSALNG0064563	integenic	Q50	hsa-miR-4447,hsa-miR-4508,hsa-miR-4539,hsa-miR-3960,hsa-miR-6501-3p,hsa-miR-6780a-3p,hsa-miR-8072	Mathematical ability,Adolescent idiopathic scoliosis,Interleukin-6 measurement,Body height,Endometriosis,Sex hormone-binding globulin measurement,Triglyceride measurement,Empathy measurement,Leukocyte count; Lymphocyte count,Body mass index,-	BRF2	WHAMMP1
ENSG00000235706	DICER1-AS1	-1.25645800859872	0.00355528775380505	M1_vs_M0	HSALNG0103422	anti_sense	Q90	hsa-miR-4472,hsa-miR-4787-5p,hsa-miR-6089,hsa-miR-6803-5p	-	GLRX5	ENSG00000223559
ENSG00000223826	LINC01870	-4.67941292095972	0.0236849953009878	M1_vs_M0	HSALNG0017377	integenic	Q50	hsa-miR-211-3p	-	CNOT11	LINC01870
ENSG00000272716	SLC30A6-DT	-4.67941126174327	0.0215508488936832	M1_vs_M0	HSALNG0014059	anti_sense	Q90	hsa-miR-619-5p	Blood protein measurement,Response to bisphosphonate; Atypical femoral fracture,Apolipoprotein a 1 measurement,-	NLRC4	LINC01870
ENSG00000255666	LINC02700	-1.2317931662463	1.39377174418244e-6	M1_vs_M0	HSALNG0086530	integenic	Not conserved	hsa-miR-382-5p	Allantoin measurement	PIWIL4	LINC02561
ENSG00000167912	TOX-DT	-3.95413381286048	3.4016391085554e-8	M1_vs_M0	HSALNG0065583	anti_sense	Q75	hsa-miR-1237-5p,hsa-miR-4467,hsa-miR-3960,hsa-miR-1199-5p,hsa-miR-6763-5p	-	SDCBP	PPM1F-AS1
ENSG00000251165	F11-AS1	4.61831657354347	0.0421981332836791	M1_vs_M0	HSALNG0039179	intronic_sense	Not conserved	NA	NA	NA	WARS2-IT1
ENSG00000215765	ENSG00000215765	4.6153061047891	0.0351007353259647	M1_vs_M0	HSALNG0127569	sense	Not conserved	NA	Blood protein measurement,Monocyte percentage of leukocytes,-	KIR2DL1	WARS2-IT1
ENSG00000260807	CEROX1	5.58721867626016	9.5282026447219e-4	M1_vs_M0	HSALNG0108830	sense	Q50	hsa-miR-505-5p,hsa-miR-615-5p,hsa-miR-762,hsa-miR-3620-5p,hsa-miR-4505,hsa-miR-1587,hsa-miR-7106-3p,hsa-miR-7160-3p	Body height,-	LMF1	WARS2-IT1
ENSG00000231652	CD109-AS1	-1.13733526310198	0.0045682025541501	M1_vs_M0	HSALNG0051248	anti_sense	Q75	hsa-miR-4677-5p,hsa-miR-4783-5p	Angina pectoris; Myocardial infarction; Heel bone mineral density,-	SLC17A5	RASAL2-AS1
ENSG00000274833	ENSG00000274833	4.82104170652288	0.0241704868062292	M1_vs_M0	HSALNG0119253	integenic	Q50	hsa-miR-1296-3p,hsa-miR-4508,hsa-miR-7106-5p	Dental caries; Bmi-adjusted hip circumference; Dentures	BAHCC1	ENSG00000224969
ENSG00000224969	ENSG00000224969	4.82260783099626	0.0149795970523946	M1_vs_M0	HSALNG0000070	anti_sense	Not conserved	NA	Blood protein measurement,-	HES4	ENSG00000224969
ENSG00000230852	LINC02857	4.82283554894826	0.0141254069901388	M1_vs_M0	HSALNG0051633	integenic	Q50	NA	NA	MRAP2	ENSG00000224969
ENSG00000267882	ENSG00000267882	4.82038291676428	0.0309726526098586	M1_vs_M0	NA	NA	NA	NA	NA	EYA2	ENSG00000224969
ENSG00000281756	C2-AS1	4.53845985894414	2.5802340654142193e-18	M1_vs_M0	HSALNG0049350	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-4492	Age-related macular degeneration,Von willebrand factor measurement,Bmi-adjusted waist circumference; Autism spectrum disorder,Blood protein measurement,Atrophic macular degeneration; Age-related macular degeneration; Wet macular degeneration,-	NELFE	BOLA3-DT
ENSG00000247092	SNHG10	-1.32275958526536	2.60734851442086e-7	M1_vs_M0	HSALNG0103440	anti_sense	Q50	hsa-miR-6089,hsa-miR-6779-5p,hsa-miR-6780a-3p	Corneal endothelial cell measurement,Erythrocyte count,-	SYNE3	SIRPAP1
ENSG00000243176	ENSG00000243176	1.51779597179714	1.70785614308936e-9	M1_vs_M0	HSALNG0030112	anti_sense	Q75	NA	NA	PTX3	TRAM2-AS1
ENSG00000125462	MIR9-1HG	3.77928087962914	8.88901304392313e-13	M1_vs_M0	HSALNG0007588	sense	Not conserved	NA	NA	MEF2D	SNX10-AS1
ENSG00000276672	ENSG00000276672	-1.96627901219661	0.00458831205285006	M1_vs_M0	HSALNG0096294	sense	Not conserved	NA	NA	RFC3	TMEM30A-DT
ENSG00000238160	LINC02863	-1.31709821215601	0.00385344287751171	M1_vs_M0	HSALNG0044838	anti_sense	Q50	hsa-miR-4436a	Fibrinogen measurement,Chronic obstructive pulmonary disease,Metabolite measurement,Apolipoprotein b measurement,Glycine measurement,Red blood cell distribution width,Neutrophil percentage of leukocytes,Psoriasis; Ulcerative colitis; Ankylosing spondylitis; Crohn's disease; Sclerosing cholangitis,-	IRF1	PIGBOS1
ENSG00000232931	LINC00342	-3.17216358918445	1.6720641704541302e-74	M1_vs_M0	HSALNG0146543	integenic	Not conserved	NA	NA	ANKRD36C	LINC00623
ENSG00000204682	MIR1915HG	-1.38075591400866	0.00380177104706831	M1_vs_M0	HSALNG0076590	integenic	Q50	hsa-miR-619-5p	Smoking initiation; Parental longevity; Body mass index,-	SKIDA1	RPL17P6
ENSG00000271830	ENSG00000271830	2.25065851604126	9.5366869061796e-4	M1_vs_M0	HSALNG0067527	anti_sense,sense	Q90	hsa-miR-1233-5p,hsa-miR-6089,hsa-miR-6726-3p,hsa-miR-6748-3p,hsa-miR-7150,hsa-miR-8485	-	NA	ENSG00000226089
ENSG00000247317	LY6E-DT	5.56500205390818	8.326216812066539e-36	M1_vs_M0	HSALNG0069213	anti_sense	Not conserved	hsa-miR-6132,hsa-miR-6779-5p,hsa-miR-6784-5p,hsa-miR-6869-3p,hsa-miR-8485	-	LY6S	LINC00937
ENSG00000288046	ENSG00000288046	-3.54295077386854	2.03339873229635e-12	M1_vs_M0	HSALNG0047831	integenic	Q75	hsa-miR-151a-5p,hsa-miR-151b,hsa-miR-4710	Serum alanine aminotransferase measurement,Reticulocyte count; Reticulocyte measurement,Bmi-adjusted hip circumference,Mean reticulocyte volume; Mean corpuscular volume; Erythrocyte count,Mean corpuscular volume,Monocyte count,Pelvic organ prolapse,Bmi-adjusted waist-hip ratio; Bmi-adjusted hip circumference; Urate measurement,-	LY86	LINC01907
ENSG00000236790	LINC00299	-3.09880686836019	0.0268180376796128	M1_vs_M0	HSALNG0012827	integenic	Not conserved	hsa-miR-761	NA	KIDINS220	ENSG00000226149
ENSG00000274225	LINC03038	2.34720787383538	0.0173745901668702	M1_vs_M0	HSALNG0133544	integenic	Not conserved	hsa-miR-612	NA	LRRC3	WASH8P
ENSG00000289483	ENSG00000289483	-6.95549193213656	8.6608393568247e-10	M1_vs_M0	HSALNG0005183	anti_sense	Q90	NA	-	SETSIP	ENSG00000226241
ENSG00000257599	OVCH1-AS1	2.28464620171727	9.53156101396985e-6	M1_vs_M0	HSALNG0090102	anti_sense	Q90	hsa-miR-517-5p,hsa-miR-619-5p,hsa-miR-6071	Age at onset,Protein measurement,Gut microbiome measurement,-	FAR2	LINC02608
ENSG00000267980	ENSG00000267980	2.80767463205563	1.80256292120798e-5	M1_vs_M0	HSALNG0145651	anti_sense	Q90	NA	-	MPND	ENSG00000226332
ENSG00000255046	ENSG00000255046	1.72881434480865	0.0102698299361783	M1_vs_M0	HSALNG0063460	anti_sense	Q50	hsa-miR-619-5p	Alkaline phosphatase measurement,C-reactive protein measurement; Alkaline phosphatase measurement; Serum non-albumin protein measurement,Triglyceride measurement; Mean reticulocyte volume; Mean corpuscular volume,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio; Monocyte count; Ejection fraction measurement; Neuroticism measurement,Non-melanoma skin carcinoma,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio,Bmi-adjusted waist circumference,-	CTSB	SLC16A1-AS1
ENSG00000226527	ENSG00000226527	-4.89496757076768	0.0251595114452805	M1_vs_M0	HSALNG0132741	integenic	Not conserved	NA	NA	C21orf62	ENSG00000226527
ENSG00000235908	RHOA-IT1	-4.89520024576817	0.0330435648000723	M1_vs_M0	HSALNG0025938	sense	Not conserved	hsa-miR-5787	Intelligence,-	NA	ENSG00000226527
ENSG00000257038	ARHGEF17-AS1	-3.2353015056085	0.00920886304397745	M1_vs_M0	HSALNG0143218	anti_sense	Q90	NA	-	FAM168A	ENSG00000226690
ENSG00000226711	FAM66C	-2.30108767388155	0.0196798118527849	M1_vs_M0	HSALNG0089052	integenic	Q50	NA	-	ZNF705A	FAM66C
ENSG00000222042	ENSG00000222042	3.34461399584339	0.00633018443927515	M1_vs_M0	HSALNG0132366	integenic	Not conserved	NA	NA	MRPL39	MAGOH-DT
ENSG00000281920	ENSG00000281920	5.31790655899854	0.00542647982337091	M1_vs_M0	HSALNG0015543	integenic	Q90	hsa-miR-128-2-5p,hsa-miR-194-3p,hsa-miR-619-5p,hsa-miR-3190-5p,hsa-miR-4258,hsa-miR-4447,hsa-miR-4685-3p,hsa-miR-4763-3p,hsa-miR-6130,hsa-miR-6132,hsa-miR-6730-5p,hsa-miR-6752-3p,hsa-miR-6858-5p	Systemic lupus erythematosus,Neutrophil percentage of leukocytes,Crohn's disease; Inflammatory bowel disease,Lymphocyte percentage of leukocytes; Myeloid white cell count; Granulocyte count,Monocyte percentage of leukocytes; Monocyte count,Bell's palsy,Body height; Bipolar disorder,Bipolar disorder,Body height,Pulse pressure measurement,Systolic blood pressure,Waist-hip ratio,Protein measurement,Iron biomarker measurement,Nicotine dependence symptom count,Cognitive decline measurement,Neuroimaging measurement,Fev/fec ratio,Brain volume measurement,Isthmus cingulate cortex volume measurement,Bmi-adjusted waist circumference,Bmi-adjusted hip circumference,Cortical surface area measurement,Cortical surface area measurement; Cortical thickness,Facial morphology measurement; Gut microbiome measurement,Serum gamma-glutamyl transferase measurement,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio,Serum gamma-glutamyl transferase measurement; Vital capacity,White matter microstructure measurement,Bmi-adjusted waist-hip ratio,Waist-hip ratio; Smoking behavior; Bmi-adjusted waist-hip ratio,Calcium measurement,Sex hormone-binding globulin measurement,Susceptibility to chickenpox measurement,Sex interaction measurement; Age at assessment; Bmi-adjusted waist-hip ratio,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio; Waist-hip ratio,Myocardial infarction,Heel bone mineral density,Psoriasis; Ulcerative colitis; Ankylosing spondylitis; Crohn's disease; Sclerosing cholangitis,Electroencephalogram measurement; Theta wave measurement,Squamous cell lung carcinoma; Family history of lung cancer,Covid-19; Mortality,Forced expiratory volume; Response to bronchodilator,Post-operative delirium; Response to surgery,Neuroimaging measurement; Brain measurement,Cortical surface area measurement; Neuroimaging measurement; Brain measurement,Cortical surface area measurement; Neuroimaging measurement,Bipolar disorder; Body mass index,Response to ketamine; Dissociation measurement,-	ACTR2	THORLNC
ENSG00000272316	ENSG00000272316	-1.29433769544425	0.0430677387152768	M1_vs_M0	HSALNG0050860	integenic	Not conserved	NA	NA	RAB23	ENSG00000227076
ENSG00000255028	ENSG00000255028	5.01059517877331	0.0116924386463454	M1_vs_M0	HSALNG0087023	overlap_antisense,sense	Q50	hsa-miR-4447	Self reported educational attainment,Mathematical ability,Antibody measurement,Late-onset alzheimers disease,Vision disorder,Self reported educational attainment; Intelligence,Forced expiratory volume; Smoking status measurement,Psoriasis; Ulcerative colitis; Ankylosing spondylitis; Crohn's disease; Sclerosing cholangitis,-	RDX	LINC01364
ENSG00000225764	P3H2-AS1	5.00969111692956	0.00742977680203939	M1_vs_M0	HSALNG0031535	anti_sense	Q90	hsa-miR-619-5p,hsa-miR-4257,hsa-miR-4433b-3p	-	CLDN16	LINC01364
ENSG00000267659	LINC01482	4.60944973075524	0.0278463356255646	M1_vs_M0	HSALNG0118381	integenic	Not conserved	NA	Chromosome-type aberration frequency	PRKAR1A	LINC01364
ENSG00000288899	ENSG00000288899	5.00998683257811	0.00852466745519417	M1_vs_M0	HSALNG0127822	integenic	Not conserved	NA	NA	ZNF460	LINC01364
ENSG00000290915	KLKP1	4.60936208911733	0.0270403630198642	M1_vs_M0	NA	NA	NA	NA	NA	KLK4	LINC01364
ENSG00000289198	ENSG00000289198	5.01033393271629	0.0101458309156498	M1_vs_M0	HSALNG0052920	integenic	Q90	NA	-	MARCKS	LINC01364
ENSG00000254602	MIR130AHG	6.44117668147589	2.14948373116471e-6	M1_vs_M0	HSALNG0084300	overlap_antisense,sense	Q90	hsa-miR-619-5p,hsa-miR-6880-5p	Alcohol use disorder measurement; Mean corpuscular hemoglobin; Mean corpuscular volume,Glomerular filtration rate,-	CLP1	LINC01364
ENSG00000269826	ENSG00000269826	4.60954876827907	0.0287802764797781	M1_vs_M0	HSALNG0113288	integenic	Q75	NA	Response to statin,-	FOXF1	LINC01364
ENSG00000228203	GRASLND	4.60938085798933	0.0272042498764943	M1_vs_M0	HSALNG0012734	anti_sense	Q50	hsa-miR-4710	NA	CMPK2	LINC01364
ENSG00000255557	ENSG00000255557	4.61037880494665	0.0397358665414417	M1_vs_M0	HSALNG0084943	integenic	Not conserved	NA	Atopic eczema,Blood urea nitrogen measurement; Creatinine measurement; Glomerular filtration rate; Chronic kidney disease,Glomerular filtration rate	OVOL1	LINC01364
ENSG00000251301	LINC02384	7.7783162262311	2.73512838025125e-16	M1_vs_M0	HSALNG0092162	integenic	Not conserved	hsa-miR-6089	NA	MDM1	LINC01364
ENSG00000289440	ENSG00000289440	-1.49900011813717	0.00874569361655022	M1_vs_M0	HSALNG0072095	anti_sense	Q50	hsa-miR-378a-5p,hsa-miR-619-5p	-	GNAQ	TP73-AS3
ENSG00000281501	SEPSECS-AS1	-1.70747717441192	1.8638672366734e-9	M1_vs_M0	HSALNG0033386	anti_sense,sense	Q75	hsa-miR-6089,hsa-miR-6816-5p	Idiopathic osteonecrosis of the femoral head,Cannabis dependence measurement,-	PI4K2B	LINC01736
ENSG00000255446	ENSG00000255446	-4.21897755747605	7.15683672014758e-6	M1_vs_M0	HSALNG0084600	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-6879-5p	Bmi-adjusted waist-hip ratio,Waist-hip ratio,Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Waist-hip ratio; Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Lymphocyte count,Reticulocyte count; Reticulocyte measurement,Bmi-adjusted waist circumference,Comparative body size at age 10, self-reported,Chronic obstructive pulmonary disease; Cc16 measurement,-	AHNAK	ATF4P3
ENSG00000231628	ENSG00000231628	-2.09140977109378	0.0152668199024562	M1_vs_M0	HSALNG0052370	anti_sense	Not conserved	NA	-	LIN28B	MT-ATP8
ENSG00000258807	ENSG00000258807	-1.39316543432641	8.79542563882334e-6	M1_vs_M0	HSALNG0103005	sense	Q50	hsa-miR-129-1-3p,hsa-miR-129-2-3p,hsa-miR-4505,hsa-miR-1587,hsa-miR-6838-5p	Suicide,Borderline personality disorder,Epstein-barr virus infection,Breast carcinoma,Body height; Body mass index,-	GALC	SDAD1P1
ENSG00000230606	APPAT	-5.08030214687306	0.00456376430823913	M1_vs_M0	HSALNG0017139	integenic	Not conserved	hsa-miR-612,hsa-miR-4742-5p,hsa-miR-4787-5p,hsa-miR-6803-5p,hsa-miR-6860	NA	ANKRD36B	ENSG00000228470
ENSG00000259928	ENSG00000259928	-6.63655873914076	2.11303629769155e-7	M1_vs_M0	HSALNG0115645	integenic	Not conserved	hsa-miR-940	NA	CRLF3	ENSG00000228470
ENSG00000253490	LINC02099	-5.39367609974912	0.00105185228126799	M1_vs_M0	HSALNG0064314	integenic	Q50	NA	Balding measurement,-	LEPROTL1	ENSG00000228470
ENSG00000259219	ENSG00000259219	-4.67941593192429	0.028511814508606	M1_vs_M0	HSALNG0108568	anti_sense	Not conserved	NA	NA	MEF2A	ENSG00000228470
ENSG00000237250	ENSG00000237250	-4.67941116239586	0.0214380242734615	M1_vs_M0	HSALNG0011815	integenic	Not conserved	NA	NA	RYR2	ENSG00000228470
ENSG00000263443	ENSG00000263443	-5.08031423758499	0.0129652170985358	M1_vs_M0	HSALNG0068121	integenic	Q50	hsa-miR-4281,hsa-miR-4284,hsa-miR-4463,hsa-miR-4632-5p,hsa-miR-4758-5p,hsa-miR-6873-3p	Sleep duration,Body weight,Chin morphology measurement,Complement factor h-related protein 5 measurement,Atherosclerosis,Cortical surface area measurement,Common carotid intimal medial thickness,Age at onset,Autism spectrum disorder,Diabetic nephropathy,Cadasil; White matter hyperintensity measurement,-	DERL1	ENSG00000228470
ENSG00000229922	LINC02865	3.09487563735568	8.7605598119119e-4	M1_vs_M0	HSALNG0053801	integenic	Q50	hsa-miR-6873-3p	Eosinophil count; Ejection fraction measurement; Eosinophil percentage of leukocytes,Cardiac troponin t measurement,Rheumatoid arthritis,Phosphatidylcholine ether measurement,-	TNFAIP3	BACH1-IT2
ENSG00000272482	ENSG00000272482	-3.30793068570638	1.1944543603977e-4	M1_vs_M0	HSALNG0000950	integenic	Q90	hsa-miR-6756-5p	NA	DHRS3	SEPTIN7-DT
ENSG00000259810	ENSG00000259810	2.69157013655668	0.00851450726473658	M1_vs_M0	HSALNG0110903	sense	Not conserved	NA	NA	KRBOX5	LINC02041
ENSG00000267122	ENSG00000267122	-2.73192689643787	0.0147962177007752	M1_vs_M0	HSALNG0123136	anti_sense	Q90	hsa-miR-125a-5p,hsa-miR-4324,hsa-miR-1343-3p	Gamma-linolenic acid measurement,Bmi-adjusted hip circumference,-	PLEKHJ1	PGBD4P8
ENSG00000291034	ENSG00000291034	5.3255190090193	0.00247374087852928	M1_vs_M0	HSALNG0141205	integenic	Not conserved	hsa-miR-1273h-5p	NA	UTY	RRN3P4
ENSG00000260303	ENSG00000260303	-1.32216260808693	1.3855742997751e-4	M1_vs_M0	HSALNG0037692	integenic	Q50	NA	Cortical surface area measurement,-	ZNF827	ENSG00000229939
ENSG00000289470	ENSG00000289470	5.53082959551741	1.83388662572923e-86	M1_vs_M0	HSALNG0062298	integenic	Not conserved	hsa-miR-4483	Testosterone measurement; Sex hormone-binding globulin measurement,-	TMEM176B	ENSG00000230149
ENSG00000249917	LINC00536	8.44036155644624	5.7684877375630986e-24	M1_vs_M0	HSALNG0067917	integenic	Not conserved	NA	NA	TRPS1	IFITM3P4
ENSG00000253182	LINC02948	5.57586850568965	0.00182230891653968	M1_vs_M0	HSALNG0064277	integenic	Q50	hsa-miR-6876-5p	Colorectal cancer,High density lipoprotein cholesterol measurement; Response to statin,Body height,Mean arterial pressure,-	HMBOX1	MTND5P14
ENSG00000274776	ENSG00000274776	-2.39026149836896	0.0458914020499211	M1_vs_M0	HSALNG0121350	integenic	Not conserved	NA	NA	PIAS2	ARMC2-AS1
ENSG00000267751	BSG-AS1	-1.1895886477458	0.0235128441498244	M1_vs_M0	HSALNG0122891	integenic	Not conserved	NA	NA	POLRMT	TPI1P2
ENSG00000247400	DNAJC3-DT	-1.04443575188051	0.00393126820606983	M1_vs_M0	HSALNG0098734	integenic	Q50	hsa-miR-4472,hsa-miR-6803-5p	Alkaline phosphatase measurement	DZIP1	ENSG00000230387
ENSG00000177699	ENSG00000177699	1.87733563037913	6.50325278535245e-14	M1_vs_M0	HSALNG0107519	anti_sense	Q90	NA	Rr interval,-	MORF4L1	ENSG00000230647
ENSG00000198221	AFDN-DT	-4.89400576448429	0.0163806367674771	M1_vs_M0	HSALNG0055209	integenic	Q50	NA	-	FRMD1	ENSG00000230730
ENSG00000287016	ENSG00000287016	-4.89379204038924	0.0101240212338049	M1_vs_M0	HSALNG0078110	integenic	Not conserved	hsa-miR-619-5p	NA	CISD1	ENSG00000230730
ENSG00000237836	PHKA2-AS1	-4.89384231837939	0.0112078814736825	M1_vs_M0	HSALNG0136885	anti_sense	Q50	NA	-	PPEF1	ENSG00000230730
ENSG00000230730	ENSG00000230730	-4.89383385525591	0.0110166646923308	M1_vs_M0	HSALNG0013891	anti_sense	Not conserved	NA	Heel bone mineral density	TRMT61B	ENSG00000230730
ENSG00000248371	LINC02056	1.6375989450772	0.0059393245461863	M1_vs_M0	HSALNG0042592	integenic	Not conserved	NA	NA	ZNF366	PSAT1P3
ENSG00000253821	ENSG00000253821	1.29982921651659	1.2478107525093396e-40	M1_vs_M0	HSALNG0065531	integenic	Not conserved	NA	NA	FAM110B	HLA-K
ENSG00000196741	LINC01560	-1.28346042203931	0.0055481999513455	M1_vs_M0	HSALNG0137712	anti_sense	Not conserved	NA	NA	ZNF157	THBS3-AS1
ENSG00000267940	ENSG00000267940	-2.39294194168587	3.2618760000747e-4	M1_vs_M0	HSALNG0082398	anti_sense	Q75	NA	-	FHIP1B	ITPR1-DT
ENSG00000291061	ENSG00000291061	-5.39166726110226	0.00621679143245205	M1_vs_M0	HSALNG0071141	anti_sense	Not conserved	hsa-miR-4492	Ischemic stroke,-	ALDH1B1	DLG3-AS1
ENSG00000285675	ENSG00000285675	-5.76126139507658	0.0034511052981192	M1_vs_M0	HSALNG0063365	anti_sense	Not conserved	NA	Venous thromboembolism	PRSS51	DOC2GP
ENSG00000261770	ENSG00000261770	1.89067457881218	0.00268005320559598	M1_vs_M0	HSALNG0125113	integenic	Not conserved	hsa-miR-619-5p,hsa-miR-920	Testicular germ cell tumor,-	UQCRFS1	RFX3-DT
ENSG00000290979	ENSG00000290979	-5.09266289055045	6.08552382813067e-27	M1_vs_M0	NA	NA	NA	NA	NA	TNFRSF13B	ASCL5
ENSG00000226571	ENSG00000226571	-5.86926553008971	6.59015759763852e-5	M1_vs_M0	HSALNG0053886	integenic	Q90	NA	-	HECA	RPL4P2
ENSG00000232618	HIVEP2-DT	5.0097333421012	0.00756996617676688	M1_vs_M0	HSALNG0054003	anti_sense	Q50	hsa-miR-4279	Mean platelet volume,-	AIG1	HIVEP2-DT
ENSG00000290021	ENSG00000290021	2.74673569400841	2.88488585881749e-10	M1_vs_M0	HSALNG0148005	anti_sense,sense	Q90	hsa-miR-4467	-	BCL6	LINC01705
ENSG00000284700	ENSG00000284700	-2.02745706534366	0.00271850164034452	M1_vs_M0	HSALNG0003531	integenic	Q75	hsa-miR-6085	Triglyceride measurement,Testosterone measurement,-	ELAVL4	ENSG00000232855
ENSG00000213888	LINC01521	-1.87482180597953	1.5925418983065e-4	M1_vs_M0	HSALNG0147275	integenic	Q50	hsa-miR-619-5p	Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio,-	DRG1	ENSG00000232995
ENSG00000254416	LINC02732	5.00608716107771	0.0105469189838054	M1_vs_M0	HSALNG0087054	integenic	Q75	hsa-miR-4505	Cognition,Serum metabolite measurement; Coronary artery disease,Angina pectoris; Antithrombotic agent use measurement; Aspirin use measurement; Myocardial infarction,Angina pectoris; Vasodilators used in cardiac diseases use measurement; Aspirin use measurement,Body height,Coronary artery disease,-	FDX1	UBE2E2-DT
ENSG00000254659	LINC02715	5.0052761900014	0.0120439222865628	M1_vs_M0	HSALNG0087023	overlap_antisense,sense	Q50	hsa-miR-4447	Self reported educational attainment,Mathematical ability,Antibody measurement,Late-onset alzheimers disease,Vision disorder,Self reported educational attainment; Intelligence,Forced expiratory volume; Smoking status measurement,Psoriasis; Ulcerative colitis; Ankylosing spondylitis; Crohn's disease; Sclerosing cholangitis,-	RDX	UBE2E2-DT
ENSG00000257924	LINC02416	5.0039183593442	0.0153804734279346	M1_vs_M0	HSALNG0090757	integenic	Not conserved	hsa-miR-619-5p	-	PCED1B	UBE2E2-DT
ENSG00000271259	ENSG00000271259	5.00764853406771	0.00834130510812903	M1_vs_M0	HSALNG0092941	anti_sense	Q90	hsa-miR-619-5p,hsa-miR-4312,hsa-miR-4447,hsa-miR-548an,hsa-miR-8485	Attention deficit hyperactivity disorder,Self reported educational attainment; Attention deficit hyperactivity disorder,Body mass index,Brain volume measurement,Self reported educational attainment; Serum alanine aminotransferase measurement; Sex hormone-binding globulin measurement; Low density lipoprotein triglyceride measurement; Body mass index; Attention deficit hyperactivity disorder; Body fat percentage; Waist-hip ratio; Unipolar depression; Visceral adipose tissue measurement; High density lipoprotein cholesterol measurement; Platelet count; Aspartate aminotransferase measurement,Body weight; Body mass index,Sleep quality,Eosinophil count,Monocyte count,Hair colour measurement,Blood protein measurement; Lymphocyte count,Lymphocyte count,Attention deficit hyperactivity disorder; Cannabis use,Attention deficit hyperactivity disorder; Antisocial behaviour measurement; Substance abuse,Systolic blood pressure; Diastolic blood pressure; Mean arterial pressure; Alcohol drinking,-	TMTC3	UBE2E2-DT
ENSG00000233153	UBE2E2-DT	5.00530189396203	0.011993714321431	M1_vs_M0	HSALNG0024658	integenic	Q75	hsa-miR-486-3p,hsa-miR-1224-3p,hsa-miR-6089,hsa-miR-6891-5p	Reaction time measurement,-	NKIRAS1	UBE2E2-DT
ENSG00000244586	WNT5A-AS1	6.37173888725409	5.29704873714389e-6	M1_vs_M0	HSALNG0147531	anti_sense	Q90	hsa-miR-7108-3p	-	CACNA2D3	HMGB1P31
ENSG00000248318	ENSG00000248318	-3.66702344348393	2.03868322213139e-6	M1_vs_M0	HSALNG0068083	anti_sense	Q75	NA	-	MTBP	CHRM3-AS2
ENSG00000270332	SMC2-DT	-4.40154433770387	5.49187081389813e-6	M1_vs_M0	HSALNG0073384	integenic	Q75	NA	-	OR13C4	LINC00513
ENSG00000273824	ENSG00000273824	5.58043389641124	9.2019857506559e-4	M1_vs_M0	HSALNG0092162	integenic	Not conserved	hsa-miR-6089	NA	MDM1	ENSG00000233674
ENSG00000260265	LINC02562	6.56516039165575	4.96044956976601e-7	M1_vs_M0	HSALNG0035237	anti_sense	Q75	NA	Nephrotic syndrome,Calcium measurement,C-x-c motif chemokine 10 measurement,Qt interval,-	BTC	ENSG00000233674
ENSG00000253147	LINC03023	5.79764284463639	1.2889314689569e-4	M1_vs_M0	HSALNG0063824	integenic	Q50	hsa-miR-6779-5p,hsa-miR-6889-3p	Sphingomyelin measurement,Cervical carcinoma,Response to tamsulosin,Body height; Body mass index,Body mass index,Attention function measurement,Cholesteryl ester 18:0 measurement; Sphingomyelin 16:1 measurement,Beta-amyloid 1-42 measurement,Sphingomyelin 18:1 measurement,Microglial activation measurement,Diabetes mellitus biomarker,Interleukin-6 measurement,Entorhinal cortical volume,Visceral adipose tissue measurement,Influenza a (h1n1),Protein measurement,Cognitive inhibition measurement,Self reported educational attainment; Intelligence; Cognitive function measurement; Mathematical ability,Irritable bowel syndrome,Mathematical ability,Diastolic blood pressure; Sodium measurement,Squamous cell lung carcinoma; Family history of lung cancer,Preterm premature rupture of the membranes; Spontaneous preterm birth,-	ATP6V1B2	ENSG00000233674
ENSG00000258777	HIF1A-AS1	5.32402783074108	0.00497609929962833	M1_vs_M0	HSALNG0101776	anti_sense	Q75	hsa-miR-619-5p,hsa-miR-5088-5p	Cd40 ligand measurement,Creatinine measurement,-	TMEM30B	ENSG00000233674
ENSG00000291139	DPY19L2P2	-2.90850353773057	1.5306779342077e-4	M1_vs_M0	HSALNG0060242	integenic	Not conserved	hsa-miR-760,hsa-miR-6720-3p,hsa-miR-6889-3p	NA	NAPEPLD	ENSG00000234286
ENSG00000289110	ENSG00000289110	5.1811146716295	0.00549582875027446	M1_vs_M0	NA	NA	NA	NA	NA	SYNRG	ENSG00000234318
ENSG00000223511	LINC02968	1.96146752575942	4.43959402252862e-6	M1_vs_M0	HSALNG0151032	integenic	Not conserved	hsa-miR-512-5p	NA	ASMT	ENSG00000234318
ENSG00000290041	ENSG00000290041	4.21220899094638	5.42214967662664e-6	M1_vs_M0	HSALNG0003215	anti_sense,sense	Q75	hsa-miR-619-5p	Soluble triggering receptor expressed on myeloid cells 2 measurement,Intraocular pressure measurement,-	BTBD19	LINC01506
ENSG00000232104	RFX3-DT	1.44381617577743	9.349343807991022e-9	M1_vs_M0	HSALNG0069687	integenic	Q75	NA	NA	KCNV2	LINC01506
ENSG00000289465	ENSG00000289465	1.6950403731146	0.026978331232905	M1_vs_M0	HSALNG0087040	sense	Q50	hsa-miR-619-5p	NA	RDX	C5orf58
ENSG00000251615	ENSG00000251615	1.20477064165602	0.01059938243412	M1_vs_M0	NA	NA	NA	NA	NA	ACOX3	EIF4A1P2
ENSG00000280383	ENSG00000280383	-1.22135819005933	0.0137602212253164	M1_vs_M0	HSALNG0135964	integenic	Q50	hsa-miR-1237-5p,hsa-miR-6089	Tonsillectomy risk measurement,Fev/fec ratio,-	ATXN10	LINC01366
ENSG00000224137	LINC01857	5.17485587809141	1.87906804615039e-12	M1_vs_M0	HSALNG0021881	integenic	Q50	hsa-miR-619-5p,hsa-miR-1285-3p,hsa-miR-6089	-	CCNYL1	TATDN2P3
ENSG00000285280	ENSG00000285280	-1.68544717830372	0.00910150329270753	M1_vs_M0	HSALNG0142391	integenic	Not conserved	NA	NA	UCHL5	KRT18P63
ENSG00000228956	SATB1-AS1	-1.35349713009016	3.4867467559039e-8	M1_vs_M0	HSALNG0147471	integenic	Q50	NA	NA	KCNH8	KRT18P63
ENSG00000258101	ENSG00000258101	-2.95210683737288	0.0310129736683781	M1_vs_M0	HSALNG0090930	anti_sense	Q75	NA	Ovarian serous carcinoma; Squamous cell lung carcinoma; Colorectal cancer; Estrogen-receptor negative breast cancer; Breast carcinoma; Ovarian endometrioid carcinoma; Ovarian carcinoma; Lung carcinoma; Lung adenocarcinoma; Prostate carcinoma; Reaction time measurement,Mean platelet volume; Platelet count; Heel bone mineral density,Bone density,-	TUBA1A	ENSG00000235813
ENSG00000243055	GK-AS1	3.32432966020905	1.30750064247028e-10	M1_vs_M0	HSALNG0151186	anti_sense	Q50	hsa-miR-619-5p	-	TAB3	BHLHE40-AS1
ENSG00000276855	ENSG00000276855	1.99082734454532	1.45189468564201e-6	M1_vs_M0	HSALNG0114817	integenic	Not conserved	hsa-miR-6803-5p	NA	TBC1D26	B3GALT4
ENSG00000214106	PAXIP1-AS2	-1.29768808270495	1.25765198607806e-9	M1_vs_M0	HSALNG0062534	anti_sense	Q75	NA	Corneal endothelial cell measurement,Cognitive function measurement,-	DPP6	TSPEAR-AS1
ENSG00000235978	ENSG00000235978	2.18302604897435	0.00714335709087069	M1_vs_M0	HSALNG0023883	anti_sense	Q75	hsa-miR-3155b	Systolic blood pressure,Serum gamma-glutamyl transferase measurement,Thrombin activatable fibrinolysis inhibitor activation peptide measurement,-	SUMF1	ENSG00000235978
ENSG00000272468	ENSG00000272468	2.49987823843361	4.9640538646942e-4	M1_vs_M0	HSALNG0048836	integenic	Not conserved	NA	NA	H2BC11	COX10-DT
ENSG00000237505	PKN2-AS1	2.86835897481014	0.00302422375740659	M1_vs_M0	HSALNG0004980	anti_sense	Q75	hsa-miR-338-3p,hsa-miR-619-5p,hsa-miR-5680,hsa-miR-6779-5p	Platelet count; Platelet crit,Platelet count,Sleep apnea measurement,Memory performance,Platelet crit,Response to tnf antagonist,Protein measurement,Educational attainment,Breast carcinoma,Autosomal dominant compelling helio-ophthalmic outburst syndrome,Diastolic blood pressure,Intraocular pressure measurement,Prostate specific antigen measurement,Prostate carcinoma,Brain volume measurement,Glaucoma; Open-angle glaucoma; Intraocular pressure measurement,Cortical surface area measurement,Cognition,Open-angle glaucoma,Response to paclitaxel,Gut microbiome measurement,Clostridium difficile infection,Adolescent idiopathic scoliosis,Cytokine measurement,Cortical surface area measurement; Brain volume measurement; Neuroimaging measurement,Brain volume measurement; Cortical thickness,Cortical surface area measurement; Neuroimaging measurement; Brain measurement,Diet measurement,Microglial activation measurement,Body mass index,Body height,Periodontitis; Systolic blood pressure,Hematocrit; Hemoglobin measurement,Serum st2 measurement; Systolic blood pressure,Irritable bowel syndrome,Cannabis dependence measurement,Risk-taking behaviour,Susceptibility to childhood ear infection measurement,Neuropsychological test,Age at first sexual intercourse measurement,Age at first birth measurement,Coronary artery disease,Nicotine dependence symptom count,Self reported educational attainment,Pulse pressure measurement,Bmi-adjusted waist circumference,Abnormality of refraction,Serum gamma-glutamyl transferase measurement,Body height; Serum gamma-glutamyl transferase measurement,Serum alanine aminotransferase measurement; Bmi-adjusted waist circumference; Serum gamma-glutamyl transferase measurement; Body height; Aspartate aminotransferase measurement,Serum alanine aminotransferase measurement; Serum gamma-glutamyl transferase measurement; Red blood cell density measurement; Aspartate aminotransferase measurement,Systolic blood pressure; Mean arterial pressure,Platelet component distribution width,Attention deficit hyperactivity disorder; Antisocial behaviour measurement; Substance abuse,Parental genotype effect measurement; Vitamin d measurement,Peripheral arterial disease; Traffic air pollution measurement,Obsessive-compulsive disorder; Autism spectrum disorder,-	GTF2B	COX10-DT
ENSG00000272269	NUP153-AS1	1.27170773941662	0.00921942474748679	M1_vs_M0	HSALNG0048366	anti_sense	Q90	hsa-miR-619-5p,hsa-miR-3960,hsa-miR-4787-5p,hsa-miR-6769b-5p	-	FAM8A1	ADORA2BP1
ENSG00000287736	PTCSC1	-4.67980848622235	0.0258325269669752	M1_vs_M0	HSALNG0068717	anti_sense,sense	Not conserved	NA	Eosinophil percentage of leukocytes	TG	RRAS2P1
ENSG00000288842	ENSG00000288842	-4.68042115678431	0.0490026926542205	M1_vs_M0	HSALNG0133618	integenic	Q50	hsa-miR-92b-5p,hsa-miR-619-5p,hsa-miR-1205,hsa-miR-3692-5p,hsa-miR-3934-5p,hsa-miR-4472,hsa-miR-4505,hsa-miR-6751-3p,hsa-miR-6803-5p	Systemic lupus erythematosus,Bmi-adjusted waist-hip ratio,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio,Bmi-adjusted waist circumference,-	COL18A1	RRAS2P1
ENSG00000272516	ENSG00000272516	-4.67993143288609	0.0287983310328993	M1_vs_M0	NA	NA	NA	NA	NA	BMI1	RRAS2P1
ENSG00000233086	LNCARSR	-6.05913723966611	8.22561299186361e-5	M1_vs_M0	HSALNG0072133	integenic	Q50	hsa-miR-30b-3p,hsa-miR-6089	Pr interval,Balding measurement,Eczema,Neuroimaging measurement; Brain measurement,-	GNAQ	ENSG00000236393
ENSG00000257178	ENSG00000257178	-4.67870846041974	0.0351007353259647	M1_vs_M0	HSALNG0145317	sense	Q90	NA	-	HOXB3	ENSG00000236452
ENSG00000287133	ENSG00000287133	-4.67915477235922	0.0230649386112336	M1_vs_M0	HSALNG0146315	anti_sense	Q90	NA	-	CDK15	ENSG00000236452
ENSG00000271913	TAGAP-AS1	2.83814561576816	1.14295457025202e-24	M1_vs_M0	HSALNG0054719	anti_sense	Q50	hsa-miR-485-5p,hsa-miR-4467,hsa-miR-4516,hsa-miR-4530,hsa-miR-3960,hsa-miR-4707-3p,hsa-miR-6791-5p,hsa-miR-6858-3p,hsa-miR-7108-3p,hsa-miR-7112-5p	Leukocyte count,Lymphocyte count,Myeloid white cell count; Celiac disease,Lipoprotein a measurement,Nicotine dependence symptom count,Autoimmune disease; Systemic lupus erythematosus; Celiac disease,Hypothyroidism,Leukocyte count; Neutrophil count,Neutrophil count; Leukocyte count; Neutrophil percentage of leukocytes; Eosinophil count; Granulocyte count,Eczema,Crohn's disease; Inflammatory bowel disease; Celiac disease,Rheumatoid arthritis; Crohn's disease,Gut microbiome measurement,Psoriasis; Ulcerative colitis; Ankylosing spondylitis; Crohn's disease; Rheumatoid arthritis; Sclerosing cholangitis,Celiac disease,Rheumatoid arthritis,Rheumatoid arthritis; Celiac disease,-,Systemic lupus erythematosus,Cognitive inhibition measurement,Eosinophil percentage of leukocytes	FNDC1	LINC01010
ENSG00000226149	ENSG00000226149	-2.75129941374405	5.18341511150898e-5	M1_vs_M0	HSALNG0053423	anti_sense	Q50	hsa-miR-6763-5p,hsa-miR-8485	Sporadic amyotrophic lateral sclerosis,Hypermetropia; Self reported educational attainment; Refractive error; Retinal break; Retinal detachment; Age at onset; Myopia; Axial length measurement,Abnormality of refraction,Refractive error,Cortical surface area measurement,Body height,Cortical thickness,Sleep duration,Body mass index,Periodontitis,Cytokine measurement,Response to alcohol,-	ARHGAP18	LINC00299
ENSG00000236841	ENSG00000236841	5.01031932417655	0.0100682248317417	M1_vs_M0	HSALNG0020020	overlap_antisense,anti_sense	Q90	NA	Cognitive function measurement; Mathematical ability,-	GCA	ENSG00000236841
ENSG00000276814	ENSG00000276814	5.01041181012358	0.0105764912606223	M1_vs_M0	HSALNG0090822	integenic	Q90	hsa-miR-4269	NA	SENP1	ENSG00000236841
ENSG00000250116	RHOQ-AS1	3.8593412726301	8.90404146273119e-8	M1_vs_M0	HSALNG0014691	anti_sense	Q75	NA	-	PIGF	ENSG00000236985
ENSG00000247796	MOCS2-DT	-1.34828872021942	0.0291767971904148	M1_vs_M0	HSALNG0041764	anti_sense	Q50	hsa-miR-6807-5p	Systemic juvenile idiopathic arthritis,Intelligence,Anorexia nervosa; Autism spectrum disorder; Obsessive-compulsive disorder; Attention deficit hyperactivity disorder; Unipolar depression; Bipolar disorder; Tourette syndrome,-	ITGA2	RPL12P12
ENSG00000225975	ZNF567-DT	-1.00034948230743	0.00597469966156838	M1_vs_M0	HSALNG0125780	anti_sense	Not conserved	hsa-miR-4463,hsa-miR-6869-3p,hsa-miR-1273h-5p	NA	ZNF461	FTH1P11
ENSG00000291133	ENSG00000291133	-5.24512415250715	0.00317338738246501	M1_vs_M0	HSALNG0057196	integenic	Q90	hsa-miR-101-3p	NA	TBX20	ENSG00000237346
ENSG00000237361	TUSC8	-1.37620964617416	0.0164081732853876	M1_vs_M0	HSALNG0096756	integenic	Not conserved	hsa-miR-3940-5p,hsa-miR-6132	Sex hormone-binding globulin measurement,-	TSC22D1	TUSC8
ENSG00000253591	KCNIP1-AS1	-5.76491853629634	7.271178417549e-4	M1_vs_M0	HSALNG0046523	anti_sense	Q75	hsa-miR-505-5p,hsa-miR-1301-3p,hsa-miR-4300,hsa-miR-4687-5p	Viral load,Abruptio placentae,Sclerosing cholangitis,Memory performance,-	KCNMB1	RPL17P24
ENSG00000291027	UBE2Q2P1	-2.72877748974891	0.010533214809373	M1_vs_M0	HSALNG0107792	integenic	Not conserved	NA	Bmi-adjusted waist circumference; Bmi-adjusted hip circumference,Bmi-adjusted waist circumference,Bmi-adjusted hip circumference,Coronary artery disease,Body height,Appendicular lean mass,Bipolar disorder,-	WDR73	LINC03081
ENSG00000203364	ENSG00000203364	5.56537393278103	0.00186042193258402	M1_vs_M0	HSALNG0072823	anti_sense	Not conserved	hsa-miR-4488,hsa-miR-6089,hsa-miR-6763-5p	Serum alanine aminotransferase measurement; Aspartate aminotransferase measurement,Aspartate aminotransferase measurement,Dna methylation,Response to tenofovir	CARD19	DNAJB12P1
ENSG00000262979	ENSG00000262979	5.56880172004268	0.00122023370869944	M1_vs_M0	HSALNG0119186	sense	Not conserved	NA	-	RNF213	DNAJB12P1
ENSG00000262580	ENSG00000262580	2.98217536876864	4.8486258047041086e-30	M1_vs_M0	HSALNG0119173	anti_sense	Q50	NA	Fasting blood glucose measurement,-,Psoriasis; Hirschsprung disease	SGSH	LINC02773
ENSG00000231233	CFAP58-DT	2.31787199169236	0.0024663412923675602	M1_vs_M0	HSALNG0080427	integenic	Q50	NA	NA	ITPRIP	PSME2P1
ENSG00000233539	ENSG00000233539	3.90873190794411	2.7916334639363e-11	M1_vs_M0	HSALNG0057793	integenic	Not conserved	NA	Response to diisocyanate,Glomerular filtration rate,Uric acid measurement,Lobe attachment,Igf-1 measurement,Igfbp-3 measurement; Igf-1 measurement,Glomerular filtration rate; Thyroid stimulating hormone measurement; Blood urea nitrogen measurement; Creatinine measurement; Igfbp-3 measurement; Urate measurement,Blood urea nitrogen measurement; Glomerular filtration rate,Cytokine measurement,Comparative body size at age 10, self-reported	TNS3	ENSG00000238015
ENSG00000229618	ENSG00000229618	3.80155949903651	2.5770080914258e-4	M1_vs_M0	HSALNG0056278	integenic	Q90	NA	NA	ARL4A	ENSG00000238015
ENSG00000287910	ENSG00000287910	-4.68041757598144	0.0487929736706875	M1_vs_M0	HSALNG0114911	integenic	Q75	hsa-miR-619-5p	Cortical surface area measurement,-	TNFRSF13B	GM2AP2
ENSG00000276570	ENSG00000276570	-1.24878406773321	0.00148137852103166	M1_vs_M0	HSALNG0145984	sense	Q50	NA	Systemic lupus erythematosus; Mean reticulocyte volume,Phosphatidylethanolamine ether measurement,-	TMEM86B	RN7SL333P
ENSG00000287367	ENSG00000287367	-4.6797181546631	0.0239476161520939	M1_vs_M0	HSALNG0041841	integenic	Q50	NA	-	SNX18	RPL21P39
ENSG00000245105	A2M-AS1	-2.15414093113936	0.00306355819272472	M1_vs_M0	HSALNG0089113	anti_sense	Not conserved	hsa-miR-1228-5p,hsa-miR-4307,hsa-miR-3620-5p,hsa-miR-4505,hsa-miR-6090	-	KLRG1	GET4
ENSG00000241743	XACT	2.51981815349522	7.60630900416971e-13	M1_vs_M0	HSALNG0139599	integenic	Not conserved	NA	NA	AMOT	ENSG00000240219
ENSG00000288927	ENSG00000288927	-1.82333278614481	1.4008880166402699e-11	M1_vs_M0	HSALNG0000949	anti_sense	Q90	NA	-	AADACL4	COX19
ENSG00000224307	LINC02975	-5.39518877774542	9.51796614276178e-22	M1_vs_M0	HSALNG0074715	integenic	Not conserved	hsa-miR-520a-5p,hsa-miR-4492,hsa-miR-4684-3p,hsa-miR-4748,hsa-miR-5693	NA	NA	TCAM1P
ENSG00000260273	ENSG00000260273	-1.50617763761656	5.23975889730936e-8	M1_vs_M0	HSALNG0052637	integenic	Q50	hsa-miR-4447,hsa-miR-6803-5p	-	SMPD2	TCAM1P
ENSG00000286216	ENSG00000286216	2.25055430964037	0.0190100955061547	M1_vs_M0	HSALNG0012258	integenic	Not conserved	hsa-miR-619-5p	-	ZNF496	SETP14
ENSG00000272908	ENSG00000272908	-1.07075619819017	2.5061100785087e-4	M1_vs_M0	HSALNG0057329	integenic	Not conserved	NA	-	TARP	PCDHGC5
ENSG00000290872	ENSG00000290872	-1.15517467672514	0.00117043841851039	M1_vs_M0	NA	NA	NA	NA	NA	PGAM2	UBQLN4P1
ENSG00000240219	ENSG00000240219	3.02173958677538	1.09903371664264e-6	M1_vs_M0	HSALNG0009887	anti_sense	Q75	hsa-miR-650,hsa-miR-1301-3p,hsa-miR-4252,hsa-miR-5047,hsa-miR-6744-3p	Body height,Neuropsychological test,Household income,Upper aerodigestive tract neoplasm,Prostate carcinoma,Mathematical ability,Self reported educational attainment; Sodium measurement,Intelligence,Biological sex,Platelet crit,Diet measurement,Self reported educational attainment,Motor function measurement; Response to levodopa; Response to zonisamide,Self reported educational attainment; Intelligence; Cognitive function measurement; Mathematical ability,Self reported educational attainment; Intelligence; Household income; Mathematical ability,Social interaction measurement,-	MDM4	XACT
ENSG00000261451	ENSG00000261451	-2.75143286162894	5.12584587291833e-5	M1_vs_M0	HSALNG0063368	integenic	Not conserved	NA	Neuroticism measurement	MSRA	EOLA1-DT
ENSG00000288919	ENSG00000288919	5.15498515483301	0.0142139107411448	M1_vs_M0	HSALNG0126003	integenic	Q75	hsa-miR-1237-5p,hsa-miR-4492,hsa-miR-6803-3p	-	MED29	CTDNEP1P1
ENSG00000256433	ENSG00000256433	1.95018938911402	0.0289967211679609	M1_vs_M0	HSALNG0088854	integenic	Not conserved	NA	Psoriasis; Ulcerative colitis; Ankylosing spondylitis; Crohn's disease; Eosinophil count; Sclerosing cholangitis,Lymphocyte count; Platelet crit; Leukocyte count; Neutrophil-to-lymphocyte ratio; Platelet count,Neutrophil percentage of leukocytes; Lymphocyte percentage of leukocytes; Lymphocyte count; Platelet crit	LTBR	ELOCP19
ENSG00000245812	LINC02202	2.78433569432563	0.00479111082479999	M1_vs_M0	HSALNG0046188	integenic	Q75	hsa-miR-3178,hsa-miR-4290,hsa-miR-4534,hsa-miR-4737,hsa-miR-6068,hsa-miR-6089,hsa-miR-6769b-3p	-	UBLCP1	LINC00960
ENSG00000235831	BHLHE40-AS1	1.67044912540781	0.015786784766102	M1_vs_M0	HSALNG0023884	anti_sense	Q50	NA	Psoriasis vulgaris,Keratoconus,Autoimmune thyroid disease,-	SUMF1	GK-AS1
ENSG00000233038	PTPRN2-AS1	-3.79255198148417	2.19823819577191e-15	M1_vs_M0	HSALNG0062762	anti_sense	Not conserved	hsa-miR-762,hsa-miR-3195,hsa-miR-4297,hsa-miR-5787,hsa-miR-6813-5p,hsa-miR-7113-3p	-	DNAJB6	INAVAP1
ENSG00000244158	CALHM6-AS1	4.8335425373089	0.0214785134616383	M1_vs_M0	HSALNG0053007	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-1285-5p	-	TRAPPC3L	CALHM6-AS1
ENSG00000289295	ENSG00000289295	-1.18948441664448	0.0234739550273946	M1_vs_M0	NA	NA	NA	NA	NA	EXOSC3	ETV5
ENSG00000285331	ENSG00000285331	-2.32579368835921	1.9237215513239e-52	M1_vs_M0	HSALNG0106164	sense	Not conserved	NA	NA	NA	NEAT1
ENSG00000245598	DACT3-AS1	3.10892806900398	0.0193981754640538	M1_vs_M0	HSALNG0145768	anti_sense	Q90	NA	-	CALM3	DACT3-AS1
ENSG00000245685	FRG1-DT	-1.37251603955051	0.0352824389154421	M1_vs_M0	HSALNG0039382	integenic	Not conserved	NA	-	FRG2	ENSG00000245667
ENSG00000258859	LINC02296	-2.21786938783795	0.00171391169362751	M1_vs_M0	HSALNG0103005	sense	Q50	hsa-miR-129-1-3p,hsa-miR-129-2-3p,hsa-miR-4505,hsa-miR-1587,hsa-miR-6838-5p	Suicide,Borderline personality disorder,Epstein-barr virus infection,Breast carcinoma,Body height; Body mass index,-	GALC	MINDY2-DT
ENSG00000259712	ENSG00000259712	1.35502016347959	0.0234557637689618	M1_vs_M0	HSALNG0105950	anti_sense	Not conserved	NA	Adolescent idiopathic scoliosis,C-reactive protein measurement,Rostral middle frontal gyrus volume measurement,Heel bone mineral density,Fat body mass,Uric acid measurement; Response to allopurinol,-	BCL2L10	LINC01096
ENSG00000224666	ETV7-AS1	6.62388022541993	1.22506035853317e-7	M1_vs_M0	HSALNG0049748	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-3652,hsa-miR-4674,hsa-miR-6089	Rheumatoid arthritis,Leukocyte count,Mean platelet volume,Eczema; Allergic rhinitis,-	KCTD20	CIBAR1-DT
ENSG00000267136	ENSG00000267136	-1.46222271770505	0.0283377142420779	M1_vs_M0	HSALNG0120178	anti_sense	Not conserved	NA	-	FAM210A	CSTF3-DT
ENSG00000226091	LINC00937	5.43806397860166	3.4293806530262495e-25	M1_vs_M0	HSALNG0089057	integenic	Not conserved	hsa-miR-619-5p,hsa-miR-6089,hsa-miR-6735-5p	Viral load,-	FAM90A1	LY6E-DT
ENSG00000230387	ENSG00000230387	-7.79834779471299	3.56009080047995e-17	M1_vs_M0	HSALNG0129227	integenic	Q50	hsa-miR-151b,hsa-miR-3620-5p,hsa-miR-4492,hsa-miR-4505,hsa-miR-1587,hsa-miR-5006-5p,hsa-miR-8485	Serum alanine aminotransferase measurement,Susceptibility to mycobacterium tuberculosis infection measurement,Venous thromboembolism	SSTR4	DNAJC3-DT
ENSG00000289984	ENSG00000289984	-1.55555252014524	3.7482503092373e-4	M1_vs_M0	NA	NA	NA	NA	NA	ARHGEF15	ENSG00000247853
ENSG00000250073	ESAM-AS1	-2.08582490876034	0.00162619411662644	M1_vs_M0	HSALNG0087909	anti_sense	Q50	hsa-miR-4447	-	NRGN	NRAV
ENSG00000248464	FGF10-AS1	5.69519142454934	5.2243031732421e-4	M1_vs_M0	HSALNG0041545	anti_sense	Q90	hsa-miR-3622a-5p	Keratinocyte carcinoma; Basal cell carcinoma; Non-melanoma skin carcinoma,Balding measurement,Alopecia,Forced expiratory volume,Breast carcinoma,Lip morphology measurement,Dental caries; Dentures,-	MRPS30	FGF10-AS1
ENSG00000289947	ENSG00000289947	5.69337604747209	2.8089209418504e-4	M1_vs_M0	NA	NA	NA	NA	NA	ODF3B	FGF10-AS1
ENSG00000248693	LINC02100	5.69340571049111	2.8351221476617e-4	M1_vs_M0	HSALNG0040483	integenic	Not conserved	NA	NA	CDH18	FGF10-AS1
ENSG00000277232	GTSE1-DT	-2.47804177861786	0.00521500991020407	M1_vs_M0	HSALNG0136018	integenic	Q50	hsa-miR-939-3p	-	PKDREJ	STIMATE-MUSTN1
ENSG00000224397	PELATON	3.45934762796511	5.01595017161676e-14	M1_vs_M0	HSALNG0130749	integenic	Q50	hsa-miR-619-5p,hsa-miR-665,hsa-miR-4258,hsa-miR-4284,hsa-miR-4491,hsa-miR-4701-3p,hsa-miR-4733-3p,hsa-miR-6090,hsa-miR-6132,hsa-miR-6748-3p,hsa-miR-6769b-5p,hsa-miR-6887-3p	Hair colour measurement,Monocyte percentage of leukocytes; Mammographic density measurement; Monocyte count,Granulocyte percentage of myeloid white cells; Monocyte count,Gut microbiome measurement,Monocyte percentage of leukocytes,Monocyte count,-	CEBPB	HMGA1P2
ENSG00000237927	ENSG00000237927	8.32789033881905	9.393292706304048e-23	M1_vs_M0	HSALNG0054755	integenic	Not conserved	hsa-miR-183-5p,hsa-miR-5585-3p,hsa-miR-6089	Lipoprotein a measurement,Atrophic macular degeneration,-	SOD2	LINC02100
ENSG00000290727	ALMS1P1	8.14066220590045	2.38838760121599e-20	M1_vs_M0	HSALNG0015975	anti_sense	Not conserved	NA	Serum metabolite measurement; Urinary metabolite measurement,-	ALMS1	LINC02100
ENSG00000225792	SNX10-AS1	3.19536957727198	3.71122908063058e-6	M1_vs_M0	HSALNG0056814	anti_sense	Q90	hsa-miR-4505,hsa-miR-1587,hsa-miR-3960	Bmi-adjusted waist-hip ratio,Blood urea nitrogen measurement; Bmi-adjusted waist circumference,Body weight; Body mass index,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio,Vaginal microbiome measurement,-	HNRNPA2B1	KRT8P46
ENSG00000286838	ENSG00000286838	5.45566826519888	0.00242733351674118	M1_vs_M0	HSALNG0002885	integenic	Not conserved	NA	-	RIMS3	ENSG00000249171
ENSG00000249171	ENSG00000249171	5.45651489929668	9.0240172832288e-4	M1_vs_M0	HSALNG0035597	integenic	Not conserved	NA	Autism spectrum disorder	ABRAXAS1	ENSG00000249171
ENSG00000289588	ENSG00000289588	3.0138560183637	1.30064257800167e-35	M1_vs_M0	HSALNG0062635	integenic	Not conserved	hsa-miR-4731-5p	Caudate nucleus measurement; Functional brain measurement; Response to reward	SHH	LINC02223
ENSG00000287691	ENSG00000287691	3.1049246838446	0.0140664663580596	M1_vs_M0	HSALNG0002358	anti_sense	Q50	hsa-miR-4448	Mosaic loss of chromosome y measurement,-	HPCA	SLC7A11-AS1
ENSG00000250033	SLC7A11-AS1	3.10492445027972	0.0140664663580596	M1_vs_M0	HSALNG0037355	anti_sense	Q75	hsa-miR-6089	Body height,Neuroticism measurement,Neurotic disorder,Wellbeing measurement; Neuroticism measurement,Eosinophil count; Serum metabolite measurement; Depressive symptom measurement; Eosinophil percentage of leukocytes,Eosinophil count,Ccl2 measurement,Wellbeing measurement; Smoking behaviour measurement,-	NOCT	SLC7A11-AS1
ENSG00000260583	ENSG00000260583	3.40943606515732	1.97954660323489e-7	M1_vs_M0	HSALNG0147166	integenic	Not conserved	NA	NA	MRPL39	RHOQ-AS1
ENSG00000255571	MIR9-3HG	-2.91951545022429	0.00309660895837388	M1_vs_M0	HSALNG0108036	anti_sense	Q90	hsa-miR-619-5p,hsa-miR-1228-5p,hsa-miR-3178,hsa-miR-4529-5p,hsa-miR-4667-3p,hsa-miR-4710,hsa-miR-6089,hsa-miR-6736-5p,hsa-miR-6810-3p,hsa-miR-6816-5p,hsa-miR-6826-3p,hsa-miR-6887-3p	White matter microstructure measurement,Cortical surface area measurement; Cigarettes per day measurement,Mathematical ability,Body mass index,Comparative body size at age 10, self-reported,Dental caries; Dentures,-	FANCI	ENSG00000250132
ENSG00000270419	CAHM	-1.46383680787669	4.09637294059519e-5	M1_vs_M0	HSALNG0054937	anti_sense	Q50	hsa-miR-1237-5p,hsa-miR-3178,hsa-miR-4651,hsa-miR-5587-3p,hsa-miR-7108-3p,hsa-miR-10394-3p	-	PRKN	ABHD17AP3
ENSG00000285793	ANAPC1P2	1.30623989194045	0.00656130021819105	M1_vs_M0	HSALNG0016618	integenic	Not conserved	NA	NA	PLGLB1	ABHD17AP3
ENSG00000236449	ENSG00000236449	-1.31450605090922	0.0015944296983166	M1_vs_M0	HSALNG0020501	anti_sense	Q75	hsa-miR-642b-5p,hsa-miR-4488,hsa-miR-6873-3p	Mean platelet volume; Platelet component distribution width,Mean platelet volume,Pulse pressure measurement; Systolic blood pressure,Atrial fibrillation,Pulse pressure measurement; Platelet component distribution width; Systolic blood pressure,Protein measurement,Resting heart rate,Agents acting on the renin-angiotensin system use measurement,Response to radiation,Qrs amplitude; Qrs complex,Forced expiratory volume; Response to bronchodilator,-	SCRN3	ENSG00000250645
ENSG00000289268	ENSG00000289268	-2.20330339031385	0.0265442221710273	M1_vs_M0	NA	NA	NA	NA	NA	FADS1	REELD1
ENSG00000253944	MTUS1-DT	-3.55675816730987	7.77214031187235e-6	M1_vs_M0	HSALNG0063682	anti_sense	Q50	hsa-miR-1268b,hsa-miR-6089,hsa-miR-6769b-3p,hsa-miR-6867-5p	Body height,Blood protein measurement,Fev change measurement; Response to bronchodilator,-	PCM1	THAP9-AS1
ENSG00000242741	LINC02005	4.60963477704951	0.0296436007218465	M1_vs_M0	HSALNG0026866	integenic	Q50	NA	Forced expiratory volume; Fev/fec ratio; Hair colour measurement,Testosterone measurement,-	PPP4R2	ENSG00000251288
ENSG00000250222	TRIM7-AS2	-2.62634985813754	0.0125850364323744	M1_vs_M0	HSALNG0047235	anti_sense	Q75	hsa-miR-619-5p,hsa-miR-1249-3p,hsa-miR-1268b,hsa-miR-6085,hsa-miR-6089,hsa-miR-6838-3p,hsa-miR-7150	-	TRIM41	SHANK3
ENSG00000260792	LINC02280	-3.85063041969717	3.1007490645062e-4	M1_vs_M0	HSALNG0104115	integenic	Not conserved	hsa-miR-4649-5p	Peripheral arterial disease; Traffic air pollution measurement,-	TMEM179	SYT9-AS1
ENSG00000251632	LINC02172	-5.39312034604835	0.00424437554135603	M1_vs_M0	HSALNG0037341	integenic	Q50	NA	Abnormality of refraction,Ccl5 measurement,Obsessive-compulsive disorder; Autism spectrum disorder,-	NOCT	LINC02172
ENSG00000227544	LINC03013	-4.42741419479147	0.0485679690435715	M1_vs_M0	HSALNG0057229	integenic	Q90	hsa-miR-619-5p,hsa-miR-5006-3p	-	SEPTIN7	LINC02172
ENSG00000274370	ENSG00000274370	-1.00794426416404	0.0299264108717988	M1_vs_M0	HSALNG0119502	integenic	Not conserved	hsa-miR-6784-5p	NA	METRNL	ENSG00000253106
ENSG00000253207	ENSG00000253207	6.67617934007586	1.06555016954502e-7	M1_vs_M0	HSALNG0067821	integenic	Not conserved	NA	-	UTP23	ENSG00000253207
ENSG00000260898	ADPGK-AS1	2.23151057511591	7.19750963306264e-10	M1_vs_M0	HSALNG0107094	anti_sense	Q75	hsa-miR-484,hsa-miR-6089,hsa-miR-6848-5p,hsa-miR-8485	Urate measurement,Grip strength measurement,Body weight,Vital capacity,Body mass index,Body mass index; Visceral adipose tissue measurement,Triglyceride measurement; Body mass index,-	BBS4	MIR124-1HG
ENSG00000228060	PABPC4-AS1	1.21636312297138	0.0204419849325236	M1_vs_M0	HSALNG0002780	anti_sense	Q50	hsa-miR-619-5p	C-reactive protein measurement; Mean corpuscular hemoglobin concentration; Red blood cell distribution width; Testosterone measurement; Apolipoprotein a 1 measurement; Mean corpuscular hemoglobin; High density lipoprotein cholesterol measurement; Hdl cholesterol change measurement; Mean corpuscular volume; Physical activity,Bmi-adjusted waist circumference,High density lipoprotein cholesterol measurement; Fev/fec ratio; Mean corpuscular hemoglobin concentration; Bilirubin measurement,Mean corpuscular hemoglobin,C-reactive protein measurement; Drugs used in diabetes use measurement; Fev/fec ratio,Body mass index,-	BMP8A	SUMO2P19
ENSG00000260941	LINC00622	2.1364648486919	3.2775874857492897e-11	M1_vs_M0	HSALNG0006500	integenic	Not conserved	NA	NA	ZNF697	ENSG00000253557
ENSG00000279968	CCDC28A-AS1	-1.21454617474104	0.0421413177369218	M1_vs_M0	HSALNG0053839	sense	Q75	NA	NA	NHSL1	LINC03047
ENSG00000226004	LINC02528	11.2473476749519	8.496921598926568e-156	M1_vs_M0	HSALNG0053802	integenic	Q50	NA	Eosinophil count; Ejection fraction measurement; Eosinophil percentage of leukocytes,Cardiac troponin t measurement,Rheumatoid arthritis,-	PERP	ENSG00000253838
ENSG00000291137	GBAP1	-2.05852969647711	1.67610651170571e-8	M1_vs_M0	HSALNG0007483	integenic	Not conserved	NA	NA	THBS3	ENSG00000253858
ENSG00000228526	MIR34AHG	1.48404468382174	0.0327871808401814	M1_vs_M0	HSALNG0000682	integenic	Q50	hsa-miR-4279,hsa-miR-500b-3p,hsa-miR-4723-3p,hsa-miR-6724-5p,hsa-miR-6744-3p,hsa-miR-7150,hsa-miR-7152-5p	Granulocyte percentage of myeloid white cells; Monocyte percentage of leukocytes; Monocyte count; Aspartate aminotransferase measurement,Body height,Lean body mass,Linguistic error measurement; Specific language impairment,-	GPR157	THAP12P7
ENSG00000258082	ENSG00000258082	-1.87360608599552	7.7887681298768e-4	M1_vs_M0	HSALNG0011660	integenic	Q50	hsa-miR-6089,hsa-miR-6769b-3p	Serum gamma-glutamyl transferase measurement,Platelet count,Monocyte percentage of leukocytes; Monocyte count,Apolipoprotein a 1 measurement,Low density lipoprotein cholesterol measurement,Response to vaccine; Cytokine measurement,Cognitive function measurement,-	TOMM20	TNFRSF10A-AS1
ENSG00000255422	ENSG00000255422	-3.52667083620132	3.3050599410940804e-15	M1_vs_M0	HSALNG0087571	anti_sense	Q90	NA	-	PHLDB1	PCDHGB7
ENSG00000267344	ENSG00000267344	-1.55360773947563	0.0424453604255817	M1_vs_M0	HSALNG0116858	anti_sense	Q50	hsa-miR-6816-3p	Neuroticism measurement,-	FMNL1	LINC03018
ENSG00000254693	CD82-AS1	5.17951877021982	0.00927755831827067	M1_vs_M0	HSALNG0083881	anti_sense	Q75	hsa-miR-370-3p	-,White matter microstructure measurement	TP53I11	BBOX1-AS1
ENSG00000224563	LPP-AS1	5.17514658859359	0.00377553443145981	M1_vs_M0	HSALNG0031469	anti_sense	Q50	hsa-miR-6823-5p,hsa-miR-8485	Ccl11 measurement,Neoplasm of mature b-cells,-	BCL6	BBOX1-AS1
ENSG00000254560	BBOX1-AS1	5.1781985935443	0.00677492859464562	M1_vs_M0	HSALNG0083285	anti_sense	Q75	NA	Breast carcinoma,Serum metabolite measurement,Attempted suicide; Body mass index,Balding measurement,Testosterone measurement,-	CCDC34	BBOX1-AS1
ENSG00000287993	ENSG00000287993	-6.44578400635466	6.91813794762168e-7	M1_vs_M0	HSALNG0122517	integenic	Q75	NA	-	TSHZ1	CAPN1-AS1
ENSG00000245648	KLRK1-AS1	-5.52844720613229	9.5282026447219e-4	M1_vs_M0	HSALNG0089224	anti_sense	Q50	NA	Maximal oxygen uptake measurement,Nkg2-d type ii integral membrane protein measurement,-	KLRD1	ENSG00000254682
ENSG00000234390	USP27X-DT	1.48695405193672	0.0198904250063335	M1_vs_M0	HSALNG0151200	integenic	Q90	NA	NA	PAGE1	ENSG00000255026
ENSG00000236682	MAP3K2-DT	1.83108378707084	1.73546174167282e-6	M1_vs_M0	HSALNG0018617	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-1237-5p,hsa-miR-4292,hsa-miR-3180,hsa-miR-4488,hsa-miR-3960	Protein c measurement,Self reported educational attainment,-	PROC	CHKA-DT
ENSG00000286369	ENSG00000286369	2.1195600116416	2.78683684496243e-5	M1_vs_M0	HSALNG0085227	integenic	Not conserved	hsa-miR-619-5p,hsa-miR-4281,hsa-miR-3665,hsa-miR-4443,hsa-miR-4453,hsa-miR-5047,hsa-miR-6089,hsa-miR-6510-5p	Body height	LRP5	ENSG00000255299
ENSG00000281357	ARRDC3-AS1	1.2716559180933	0.00926123002726917	M1_vs_M0	HSALNG0043456	integenic	Not conserved	NA	NA	ADGRV1	ENSG00000255306
ENSG00000287083	ENSG00000287083	-1.78804550891637	0.0409474660692988	M1_vs_M0	HSALNG0038801	integenic	Q50	hsa-miR-4467,hsa-miR-3960	Multiple myeloma,-	AGA	ENSG00000255410
ENSG00000178803	ADORA2A-AS1	1.87761675206287	0.0187828806701543	M1_vs_M0	HSALNG0134495	anti_sense	Q50	hsa-miR-370-3p,hsa-miR-6807-3p	Alcohol consumption measurement,Acne,Sodium measurement,Glucagon measurement,Coffee consumption measurement,Supramarginal gyrus volume measurement,Tea consumption measurement,Cups of coffee per day measurement,Serum gamma-glutamyl transferase measurement,Coffee consumption measurement; Tea consumption measurement,Alcohol use disorder measurement; Alcohol consumption measurement,-	GUCD1	TAS2R20
ENSG00000287586	ENSG00000287586	-4.89412750849348	0.0231036228308965	M1_vs_M0	HSALNG0000406	anti_sense	Not conserved	NA	NA	C1orf174	ENSG00000256139
ENSG00000256139	ENSG00000256139	-4.8938137800547	0.0105764912606223	M1_vs_M0	HSALNG0093875	sense	Q50	hsa-miR-8077	-	UNG	ENSG00000256139
ENSG00000278214	LINC02139	-3.00608608221201	0.00153206398406305	M1_vs_M0	HSALNG0113191	integenic	Not conserved	NA	-	GSE1	C17orf100
ENSG00000236871	LINC00106	-1.45098580464616	1.5083820785252e-5	M1_vs_M0	HSALNG0136360	integenic	Not conserved	hsa-miR-1227-5p,hsa-miR-3178,hsa-miR-6089,hsa-miR-6816-5p,hsa-miR-8485	NA	IL3RA	ENSG00000256973
ENSG00000226251	LINC02608	-1.74507180958861	2.075126264741e-4	M1_vs_M0	HSALNG0010344	integenic	Q50	hsa-miR-619-5p,hsa-miR-4505,hsa-miR-4707-3p,hsa-miR-6773-5p,hsa-miR-7843-5p	Intelligence,Monocyte count,Hemoglobin measurement; Red blood cell density measurement; Erythrocyte count,Neutrophil percentage of leukocytes; Erythrocyte count,Body height,Granulocyte percentage of myeloid white cells; High density lipoprotein cholesterol measurement; Monocyte percentage of leukocytes,Hypermetropia,Astigmatism,Bmi-adjusted waist-hip ratio,Aspartate aminotransferase measurement,Basophil count; Basophil percentage of leukocytes,Basophil count,Self reported educational attainment,Reticulocyte count,Hair colour measurement,-	PACC1	OVCH1-AS1
ENSG00000287222	ENSG00000287222	1.28478151275385	3.6595014141088e-4	M1_vs_M0	HSALNG0069338	anti_sense	Q75	hsa-miR-331-3p,hsa-miR-1237-5p,hsa-miR-3186-3p,hsa-miR-4508,hsa-miR-4734	-	IQANK1	CD63-AS1
ENSG00000289504	ENSG00000289504	-1.16730704294014	0.0109665088325362	M1_vs_M0	NA	NA	NA	NA	NA	MAPKAPK3	CD63-AS1
ENSG00000235813	ENSG00000235813	3.09990123220825	1.20143858387594e-5	M1_vs_M0	HSALNG0140236	anti_sense	Not conserved	hsa-miR-619-5p	Leukocyte count,Blood urea nitrogen measurement,Hematocrit; Creatinine measurement; Glomerular filtration rate,Creatinine measurement,Birth weight	HPRT1	ENSG00000258101
ENSG00000289995	ENSG00000289995	-1.19478792997519	7.8972872738825e-22	M1_vs_M0	HSALNG0009283	integenic	Not conserved	NA	Colonic neoplasm; Overall survival	RGS13	LINC02392
ENSG00000289384	ENSG00000289384	4.15347398671998	1.18629120581571e-5	M1_vs_M0	HSALNG0143688	integenic	Q50	NA	-	KITLG	FBXO34-AS1
ENSG00000258413	FBXO34-AS1	4.1534679586698	1.18468353704283e-5	M1_vs_M0	HSALNG0101458	anti_sense	Q75	hsa-miR-4707-5p,hsa-miR-6763-3p,hsa-miR-6764-3p,hsa-miR-6791-3p,hsa-miR-6803-5p	Platelet count; Red blood cell distribution width,Eosinophil count,-	DLGAP5	FBXO34-AS1
ENSG00000255050	ENSG00000255050	-2.47101810870667	4.49558752655906e-6	M1_vs_M0	HSALNG0069297	anti_sense	Q50	hsa-miR-4505,hsa-miR-6744-3p	Interleukin 18 measurement	GSDMD	AJUBA-DT
ENSG00000290525	GBP1P1	11.986023019055	1.38427705214562e-224	M1_vs_M0	NA	NA	NA	NA	NA	GBP6	ENSG00000258521
ENSG00000290880	ENSG00000290880	-3.42424029465518	2.23487715077106e-15	M1_vs_M0	NA	NA	NA	NA	NA	APBA2	ENSG00000258623
ENSG00000245975	MINDY2-DT	-2.90873501838146	1.4634468922039e-4	M1_vs_M0	HSALNG0106254	anti_sense	Q90	NA	Parental longevity,-	ADAM10	LINC02296
ENSG00000273382	TMEM167B-DT	-2.25031072038675	2.45982807325709e-24	M1_vs_M0	HSALNG0005853	anti_sense	Q75	hsa-miR-619-5p	Apolipoprotein b measurement,Leukocyte count,-	TAF13	ENSG00000258976
ENSG00000287665	ENSG00000287665	1.94672909309949	0.0379034295016855	M1_vs_M0	HSALNG0149593	sense	Not conserved	NA	NA	FOXK1	ENSG00000259005
ENSG00000261468	ENSG00000261468	-4.43032231248575	6.08246003664877e-12	M1_vs_M0	HSALNG0024922	integenic	Not conserved	hsa-miR-6165	NA	TGFBR2	ENSG00000259081
ENSG00000278058	ENSG00000278058	-2.14238929425128	3.35935052727925e-6	M1_vs_M0	HSALNG0112904	anti_sense	Q50	hsa-miR-7109-5p	Eosinophil count,Eosinophil count; Eosinophil percentage of leukocytes,Uric acid measurement,Uric acid measurement; Renal system measurement,-	WWOX	ENSG00000259250
ENSG00000286067	ENSG00000286067	-1.30281872068772	7.797399229827e-4	M1_vs_M0	HSALNG0094501	anti_sense	Not conserved	hsa-miR-1227-5p,hsa-miR-6791-5p	NA	SIRT4	ENSG00000259347
ENSG00000225791	TRAM2-AS1	-1.4487352687162	5.16655144180672e-12	M1_vs_M0	HSALNG0050617	anti_sense	Q75	hsa-miR-520a-5p,hsa-miR-525-5p,hsa-miR-500b-3p,hsa-miR-6807-3p,hsa-miR-6829-3p,hsa-miR-4433b-3p	Resistin measurement; Total cholesterol measurement; Low density lipoprotein cholesterol measurement,Resistin measurement,Low density lipoprotein cholesterol measurement,Fasting blood glucose measurement,Oxalate measurement,Apolipoprotein b measurement,-	TMEM14A	ENSG00000259531
ENSG00000288098	ENSG00000288098	3.52872292627697	7.14925567927541e-6	M1_vs_M0	HSALNG0140454	integenic	Not conserved	NA	NA	MAGEC1	ENSG00000259668
ENSG00000248714	ZNF652-AS1	-5.2444250531333	0.00971825634310138	M1_vs_M0	HSALNG0117177	anti_sense	Q90	hsa-miR-219a-2-3p,hsa-miR-619-5p,hsa-miR-4430,hsa-miR-4787-5p,hsa-miR-6803-5p	Diastolic blood pressure; Neuroimaging measurement; Brain measurement; Systolic blood pressure; Atopic asthma; Body height; Atopic eczema; Coronary artery disease,Testosterone measurement; Body fat distribution; Family history of alzheimers disease; Late-onset alzheimers disease,Eosinophil percentage of leukocytes; Eczema; Inhalant adrenergic use measurement; Allergic rhinitis; Eosinophil count,Uric acid measurement; Testosterone measurement; Sex hormone-binding globulin measurement,Age at first sexual intercourse measurement; Diastolic blood pressure; Eczema; Systolic blood pressure,Diastolic blood pressure; Alcohol drinking; Systolic blood pressure; Mean arterial pressure; Coronary artery disease; Alcohol consumption measurement,Testosterone measurement,Diuretic use measurement,Cardiovascular disease,Prostate carcinoma,Comparative body size at age 10, self-reported; Self rated health; Monocyte count; Angina pectoris; Agents acting on the renin-angiotensin system use measurement,Eosinophil count; Basophil count; Adult onset asthma,Adult onset asthma,Systemic lupus erythematosus,Inhalant adrenergic use measurement,Glucocorticoid use measurement,Sex hormone-binding globulin measurement,Fev/fec ratio; Appendicular lean mass,Mean corpuscular hemoglobin concentration; Mean corpuscular volume; Red blood cell density measurement,Coronary artery disease,Behavior or behavioral disorder measurement,Systolic blood pressure,Lower body strength measurement,Cortical surface area measurement; Neuroimaging measurement,-,Hemoglobin measurement; Systolic blood pressure; Leukocyte count; Hematocrit; Coronary artery disease	NGFR	RPL7AP75
ENSG00000228952	LINC02041	2.70503099304639	7.1532965750074e-4	M1_vs_M0	HSALNG0031422	integenic	Not conserved	hsa-miR-4534	-	RTP4	ENSG00000259810
ENSG00000259881	ENSG00000259881	-6.80494421880588	9.57457946948443e-9	M1_vs_M0	HSALNG0113555	anti_sense	Q50	hsa-miR-1224-3p,hsa-miR-7108-3p	Non-melanoma skin carcinoma,-	TRAPPC2L	ENSG00000259881
ENSG00000231612	ENSG00000231612	-5.24566623758743	0.00398336692502624	M1_vs_M0	HSALNG0012153	anti_sense	Q50	hsa-miR-670-5p	Diverticular disease,-	SMYD3	ENSG00000259881
ENSG00000229334	TMEM44-AS2	-2.75016620538435	7.022718272250189e-11	M1_vs_M0	HSALNG0031749	anti_sense	Not conserved	NA	Progranulin measurement	FAM43A	ENSG00000260086
ENSG00000260148	CPNE2-DT	-6.37686314546098	5.37826475003361e-6	M1_vs_M0	HSALNG0144937	integenic	Not conserved	hsa-miR-6852-5p	NA	PSME3IP1	CPNE2-DT
ENSG00000272255	ENSG00000272255	1.01040593260572	0.0232284306090875	M1_vs_M0	HSALNG0045260	anti_sense	Q50	hsa-miR-3178	-	STING1	CD2BP2-DT
ENSG00000271992	ENSG00000271992	4.08734255664841	2.11872766680959e-5	M1_vs_M0	HSALNG0004379	integenic	Not conserved	NA	NA	CTH	ENSG00000260430
ENSG00000286940	MICB-DT	1.70001544395253	2.7861943849107e-4	M1_vs_M0	HSALNG0049272	anti_sense	Not conserved	hsa-miR-4701-3p,hsa-miR-6089	Renal system measurement,Myositis,Polymyositis; Physical activity measurement; Bmi-adjusted waist-hip ratio; Myositis,Eosinophil count; Platelet count,Squamous cell lung carcinoma; Mmr-related febrile seizures; Bmi-adjusted waist circumference; Lung carcinoma; Eosinophil count,Appendicular lean mass,Glucose measurement,Visual perception measurement,Carpal tunnel syndrome,Herpes zoster,Thyrotoxic periodic paralysis,Bmi-adjusted waist-hip ratio,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio,Eosinophil percentage of leukocytes,Bmi-adjusted hip circumference,Eosinophil count,Susceptibility to childhood ear infection measurement,Body height,Neonatal systemic lupus erythematosus; Myositis; Metabolic syndrome,Hodgkins lymphoma,Lymphocyte count; Basophil count; Myositis; Leukocyte count; Monocyte count,Ulcerative colitis,Atopic asthma,Serum alanine aminotransferase measurement,Bmi-adjusted waist-hip ratio; Mhc class i polypeptide-related sequence b measurement,Angina pectoris,Clinical treatment,Beta blocking agent use measurement,Blood protein measurement; Susceptibility to mumps measurement,Anti-tetanus toxoid igg measurement; Response to vaccine; Malaria,Arterial stiffness measurement,Bmi-adjusted waist circumference; Autism spectrum disorder; Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Susceptibility to plantar warts measurement,Mhc class i polypeptide-related sequence a measurement,Mhc class i polypeptide-related sequence b measurement,Susceptibility to chickenpox measurement,Susceptibility to shingles measurement,Autism spectrum disorder,Alcohol use disorder measurement,Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Cytokine measurement,Testosterone measurement,Monocyte count,Platelet crit,Lobe attachment; Lymphocyte count,Bmi-adjusted waist circumference,Response to thioamide; Drug-induced agranulocytosis,Prion disease; Psychotic symptoms,Response to bezlotoxumab; Clostridium difficile infection,Colorectal cancer; Colorectal adenoma,Mosquito bite reaction size measurement; Mosquito bite reaction itch intensity measurement,Human papilloma virus infection; Oropharynx cancer,Blood protein measurement,Bmi-adjusted waist circumference; Bmi-adjusted hip circumference	ATP6V1G2-DDX39B	ENSG00000260517
ENSG00000231609	EHBP1-AS1	-1.10087118793383	2.4323590187221e-4	M1_vs_M0	HSALNG0015409	anti_sense	Q90	hsa-miR-4292,hsa-miR-5698,hsa-miR-6728-3p,hsa-miR-6780a-3p	Balding measurement,Vital capacity,Low density lipoprotein cholesterol measurement,Alcohol use disorder measurement; Alcohol consumption measurement,-	WDPCP	FBXL19-AS1
ENSG00000253968	ENSG00000253968	-1.83198724199272	1.2440267638319998e-13	M1_vs_M0	HSALNG0046692	integenic	Q50	hsa-miR-198,hsa-miR-665,hsa-miR-4435,hsa-miR-4446-3p,hsa-miR-4505,hsa-miR-5787,hsa-miR-6728-3p	Antipsychotic drug related weight gain,Stroke,Cognitive function measurement,Prostate carcinoma; Cytokine measurement,Peripheral arterial disease; Traffic air pollution measurement,Mosquito bite reaction size measurement; Mosquito bite reaction itch intensity measurement,Oral cleft,Cleft lip; Cleft palate,Body height,Bmi-adjusted hip circumference,Adiponectin measurement,-	BNIP1	PDCD6IPP2
ENSG00000241769	EOLA1-DT	-2.71003003452464	9.9297149411185e-4	M1_vs_M0	HSALNG0140599	anti_sense,sense	Not conserved	hsa-miR-4257	NA	NA	ENSG00000261451
ENSG00000254682	ENSG00000254682	-2.39249299664943	0.00186659134771225	M1_vs_M0	HSALNG0085472	anti_sense	Not conserved	NA	Vitamin d measurement,-	NADSYN1	LINC01003
ENSG00000233355	CHRM3-AS2	-3.43801326761233	3.40992799840195e-5	M1_vs_M0	HSALNG0011884	anti_sense	Q50	NA	Chronic obstructive pulmonary disease,Fev/fec ratio,Breast milk measurement,-	GREM2	ENSG00000261468
ENSG00000288742	ENSG00000288742	1.33875409994414	0.0381702425967767	M1_vs_M0	HSALNG0127521	integenic	Not conserved	NA	NA	LAIR1	FSCN1P1
ENSG00000226445	THBS2-AS1	-1.19015133766079	1.2108085395335e-4	M1_vs_M0	HSALNG0055336	anti_sense	Not conserved	NA	NA	C6orf120	ENSG00000261783
ENSG00000233559	LINC00513	-1.69425331839318	0.0371835298666771	M1_vs_M0	HSALNG0061393	integenic	Not conserved	NA	Parental genotype effect measurement; Vitamin d measurement	MKLN1	PCDHGA9
ENSG00000255980	LINC02953	-1.0704083153539	5.2429297383012914e-9	M1_vs_M0	HSALNG0143008	integenic	Q50	NA	NA	MYEOV	ENSG00000262050
ENSG00000255224	ENSG00000255224	2.14061145644751	6.14382147901578e-18	M1_vs_M0	HSALNG0069369	anti_sense	Q75	NA	Mean corpuscular hemoglobin,-	OPLAH	ZNF213-AS1
ENSG00000245248	USP2-AS1	-1.19876761696702	6.86521793929221e-8	M1_vs_M0	HSALNG0143088	integenic	Not conserved	NA	-	RNF26	MIR4420
ENSG00000291097	HLA-L	1.94638535571164	0.011348990597693	M1_vs_M0	HSALNG0049134	integenic	Not conserved	NA	NA	TRIM39	ENSG00000266947
ENSG00000281189	GHET1	-1.49899645453263	0.00874569361655022	M1_vs_M0	HSALNG0062110	integenic	Not conserved	NA	NA	ZNF398	ENSG00000267002
ENSG00000267101	ENSG00000267101	-5.08030247886443	0.00466646918752365	M1_vs_M0	HSALNG0121248	anti_sense	Q50	hsa-miR-1229-5p,hsa-miR-4281,hsa-miR-6089,hsa-miR-6728-3p	Smoking status measurement,Smoking behavior,Alopecia,Self reported educational attainment,Balding measurement,Bmi-adjusted waist-hip ratio,Waist-hip ratio,Intelligence,Bmi-adjusted hip circumference,Smoking initiation,Urate measurement,Biological sex,Uric acid measurement,Cognitive function measurement; Parental longevity,Creatinine measurement,Attention deficit hyperactivity disorder; Antisocial behaviour measurement; Substance abuse,-	EPG5	ENSG00000267101
ENSG00000285936	ENSG00000285936	-6.05882529705997	2.46003993533452e-5	M1_vs_M0	HSALNG0144120	anti_sense	Q75	NA	NA	RGS6	ENSG00000267101
ENSG00000247151	CSTF3-DT	-1.91457013745878	0.0442089212988125	M1_vs_M0	HSALNG0083517	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-4755-3p,hsa-miR-6089	Alcohol use disorder measurement; Alcohol consumption measurement,-	TCP11L1	ENSG00000267136
ENSG00000253535	ADAM7-AS1	6.43378735944323	2.0274511118668398e-28	M1_vs_M0	HSALNG0064058	integenic	Not conserved	NA	NA	NEFL	TAF5LP1
ENSG00000269534	ENSG00000269534	3.23550836902324	0.014663144402685	M1_vs_M0	HSALNG0126833	anti_sense	Q50	NA	-	ZSWIM9	ENSG00000267387
ENSG00000267543	ENSG00000267543	2.97086307829518	0.0264772540950864	M1_vs_M0	HSALNG0118851	anti_sense,sense	Q75	hsa-miR-363-5p,hsa-miR-1205,hsa-miR-378g,hsa-miR-4505,hsa-miR-6089	Colorectal cancer,Adolescent idiopathic scoliosis,Macular telangiectasia type 2,Pulse pressure measurement,Reaction time measurement,Leukocyte count; Neutrophil count,Mathematical ability,Eye measurement,Diabetic nephropathy; Moderate albuminuria,-,Blood protein measurement	PRCD	ENSG00000267543
ENSG00000285918	ENSG00000285918	-3.2345381818145	0.00916879937894476	M1_vs_M0	HSALNG0112888	anti_sense	Q75	NA	Bmi-adjusted waist circumference,Body height,-	MAF	LIN37
ENSG00000179428	IL6-AS1	5.01305482745417	0.0088710662723855	M1_vs_M0	HSALNG0056610	anti_sense,sense	Q50	NA	Platelet count; Aspartate aminotransferase measurement,Cerebrospinal fluid clusterin measurement,C-reactive protein measurement,Leukocyte count,C-reactive protein measurement; Mean corpuscular hemoglobin,Serum albumin measurement,Unipolar depression,Lymphocyte percentage of leukocytes,Serum alanine aminotransferase measurement,Parental genotype effect measurement; Birth weight,Leukocyte count; C-reactive protein measurement; Lymphocyte count,Lymphocyte count,Lung carcinoma,Mean corpuscular hemoglobin,Albumin:globulin ratio measurement; Serum non-albumin protein measurement,Platelet count,Bilirubin measurement,Leukocyte count; Neutrophil count; Myeloid white cell count; 3-hydroxyphenylacetic acid measurement,Serum albumin measurement; C-reactive protein measurement; Body height,Tonsillectomy risk measurement,Longevity; Takayasu arteritis,Eosinophil count,Pulse pressure measurement,Systemic lupus erythematosus,Serum non-albumin protein measurement,Aortic stenosis; Aortic valve calcification,Pulse pressure measurement; Cerebrospinal fluid clusterin measurement,-	STEAP1B	ENSG00000267801
ENSG00000267801	ENSG00000267801	5.01535230481479	0.0110142999289713	M1_vs_M0	HSALNG0118795	anti_sense	Q90	hsa-miR-874-3p,hsa-miR-3178	Brain measurement,-	UNK	ENSG00000267801
ENSG00000266970	SOCS3-DT	5.99570676513025	1.4770370894651e-4	M1_vs_M0	HSALNG0119032	integenic	Q50	hsa-miR-619-5p,hsa-miR-4472,hsa-miR-4639-3p,hsa-miR-6089,hsa-miR-6794-5p,hsa-miR-6803-5p	Creativity measurement,Heel bone mineral density,C-reactive protein measurement,-	PGS1	ENSG00000267801
ENSG00000257242	LINC01619	1.98626989868556	5.3859248181755e-6	M1_vs_M0	HSALNG0093041	sense	Q75	hsa-miR-619-5p	Obstructive sleep apnea,Age at menarche,Rosacea severity measurement,Neutrophil percentage of granulocytes; Eosinophil percentage of granulocytes; Heel bone mineral density; Basophil count; Eosinophil percentage of leukocytes; Eosinophil count,Eosinophil count,Eosinophil percentage of leukocytes,Eosinophil count; Body height,-	BTG1	LINC00528
ENSG00000267387	ENSG00000267387	4.27372159902326	3.67283674394239e-6	M1_vs_M0	HSALNG0123890	anti_sense	Q75	NA	-	ANGPTL6	ENSG00000269534
ENSG00000291132	ENSG00000291132	-2.09198657021198	0.0152886425013677	M1_vs_M0	HSALNG0002304	anti_sense	Q50	hsa-miR-6089	Intelligence,-	TMEM234	TMEM185A
ENSG00000234432	LINC02983	-2.1793560104764	1.9326457178231e-4	M1_vs_M0	HSALNG0149872	integenic	Q50	hsa-miR-4733-3p	-	TNRC18	ZNF528-AS1
ENSG00000269952	ENSG00000269952	5.89498081377821	2.3330613143369e-4	M1_vs_M0	HSALNG0077270	sense	Q50	NA	NA	CREM	ENSG00000269952
ENSG00000253838	ENSG00000253838	9.19518051889787	7.193733423470488e-44	M1_vs_M0	HSALNG0150187	sense	Q50	NA	-	IDO1	ENSG00000269952
ENSG00000227920	ENSG00000227920	-5.65020106536242	9.1275757634971e-4	M1_vs_M0	HSALNG0049822	integenic	Not conserved	NA	-	CMTR1	ENSG00000270149
ENSG00000288720	ENSG00000288720	-4.67841824016153	0.0495778444338749	M1_vs_M0	HSALNG0147512	anti_sense	Not conserved	NA	Covid-19,Protein measurement	CCR9	ENSG00000270149
ENSG00000225365	ENSG00000225365	-4.67882220982405	0.0311359698014157	M1_vs_M0	HSALNG0062781	anti_sense	Not conserved	hsa-miR-4505,hsa-miR-1587	Hypermetropia,-	DYNC2I1	ENSG00000270149
ENSG00000267475	NUDT19-DT	-2.39387830351655	3.34851141274347e-8	M1_vs_M0	HSALNG0125387	anti_sense	Q50	NA	Mean corpuscular volume,-	ANKRD27	POC1B-AS1
ENSG00000217825	ENSG00000217825	5.16797607513459	0.00700047313895579	M1_vs_M0	HSALNG0062556	integenic	Not conserved	hsa-miR-3065-3p	NA	PAXIP1	ENSG00000270911
ENSG00000283064	ENSG00000283064	5.17196517807363	0.00426295841380749	M1_vs_M0	HSALNG0048737	anti_sense	Not conserved	hsa-miR-619-5p,hsa-miR-6089	Bmi-adjusted waist circumference; Body height; Bmi-adjusted waist-hip ratio,C-reactive protein measurement,Bmi-adjusted waist circumference; Bmi-adjusted hip circumference; Smoking status measurement; Mathematical ability,Bmi-adjusted waist circumference; Bmi-adjusted hip circumference,Brain volume measurement,-	H4C4	ENSG00000270911
ENSG00000234717	TMEM212-AS1	6.14997277963902	1.87467596335146e-5	M1_vs_M0	HSALNG0030700	anti_sense	Q50	hsa-miR-5004-3p,hsa-miR-6089	Sex hormone-binding globulin measurement,Body mass index,Colorectal cancer,Corneal resistance factor,White matter hyperintensity measurement; Hypertension,-	PLD1	ENSG00000270911
ENSG00000260367	ENSG00000260367	1.22319576991007	0.00650066943628189	M1_vs_M0	HSALNG0110551	anti_sense	Q50	hsa-miR-4800-3p	Body mass index,-	RABEP2	LPP-AS2
ENSG00000287100	ENSG00000287100	1.67748522710726	2.5328051895337e-4	M1_vs_M0	HSALNG0149240	integenic	Q75	NA	Stem cell growth factor beta measurement,-	ASF1A	ENSG00000271789
ENSG00000270108	ENSG00000270108	-1.40153557167914	0.0429849009504189	M1_vs_M0	HSALNG0104021	sense	Not conserved	NA	NA	KLC1	ENSG00000271795
ENSG00000236700	LINC01010	4.06940111379622	4.9421727122427185e-165	M1_vs_M0	HSALNG0053623	integenic	Q50	hsa-miR-619-5p,hsa-miR-4267,hsa-miR-4430,hsa-miR-6089	Dental caries,-	TBPL1	TAGAP-AS1
ENSG00000214401	KANSL1-AS1	-1.54594006317011	0.0057368614701318	M1_vs_M0	HSALNG0116913	anti_sense	Q75	hsa-miR-4665-3p,hsa-miR-9899	-	LRRC37A	ENSG00000271959
ENSG00000236404	VLDLR-AS1	3.59400291457839	2.89333224539789e-26	M1_vs_M0	HSALNG0150761	integenic	Q50	hsa-miR-4463	NA	PUM3	ENSG00000272156
ENSG00000227076	ENSG00000227076	-1.15815987307015	0.0492088043691602	M1_vs_M0	HSALNG0081497	sense	Not conserved	hsa-miR-548b-3p,hsa-miR-937-5p,hsa-miR-4472,hsa-miR-6780b-5p	Response to drug,-	PTPRE	ENSG00000272316
ENSG00000260751	ENSG00000260751	1.36849261889809	0.0145586638408817	M1_vs_M0	HSALNG0110262	sense	Not conserved	hsa-miR-619-5p	NA	UBFD1	CD24
ENSG00000270194	GOLGA4-AS1	2.45564247261969	6.08506840082905e-16	M1_vs_M0	HSALNG0025176	anti_sense	Q90	NA	-	LRRFIP2	ENSG00000272449
ENSG00000272541	ENSG00000272541	-4.6812584130603	0.0443321567369135	M1_vs_M0	HSALNG0050853	integenic	Not conserved	hsa-miR-1293	-	RAB23	ENSG00000272541
ENSG00000272666	KLHDC7B-DT	5.89646807239358	8.92193235145231e-5	M1_vs_M0	HSALNG0136305	integenic	Q50	hsa-miR-5589-5p	Erythrocyte count,Monocyte count	SYCE3	KLHDC7B-DT
ENSG00000235385	LINC02154	6.88372060527345	3.77523308734013e-9	M1_vs_M0	HSALNG0136703	overlap_sense	Not conserved	NA	NA	ATXN3L	KLHDC7B-DT
ENSG00000289005	ENSG00000289005	4.60932485584077	0.0267279462298403	M1_vs_M0	HSALNG0029808	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-1249-5p,hsa-miR-4492,hsa-miR-6807-3p,hsa-miR-6871-5p	Breast carcinoma; Brcax breast cancer,Breast carcinoma,Brcax breast cancer,Non-alcoholic fatty liver disease severity measurement,Serum igg glycosylation measurement,Leukocyte count; Neutrophil count,Visual perception measurement,Asthma exacerbation measurement,Chronotype measurement,-	SELENOT	ENSG00000273124
ENSG00000277566	ENSG00000277566	-3.37516729474858	6.44633401306691e-5	M1_vs_M0	HSALNG0094145	sense	Not conserved	NA	NA	TPCN1	ENSG00000273306
ENSG00000258976	ENSG00000258976	-5.76418313065367	1.7970033238623e-4	M1_vs_M0	HSALNG0102446	integenic	Q50	NA	NA	LTBP2	TMEM167B-DT
ENSG00000272275	ENSG00000272275	-2.30108797745865	0.0196803817486686	M1_vs_M0	HSALNG0013001	anti_sense	Q75	hsa-miR-619-5p	-	PDIA6	ENSG00000273486
ENSG00000205837	LINC00487	4.90713597514293	3.02549359743118e-10	M1_vs_M0	HSALNG0012718	integenic	Q50	hsa-miR-4430	NA	CMPK2	ENSG00000273573
ENSG00000285684	ENSG00000285684	-7.25593799291555	3.38307283136944e-12	M1_vs_M0	HSALNG0098173	integenic	Q75	hsa-miR-671-5p,hsa-miR-6089	Cleft lip,Cleft lip; Oral cleft; Cleft palate,Cleft lip; Cleft palate; Progranulin measurement,Drugs used in diabetes use measurement,Diastolic blood pressure,Fev/fec ratio,Glucose measurement; Hemoglobin a1 measurement,Systolic blood pressure; Mean arterial pressure,Cleft lip; Cleft palate,-	SPRY2	ENSG00000273669
ENSG00000291069	BMS1P1	-3.16623945015296	4.1614794641299e-4	M1_vs_M0	HSALNG0077766	integenic	Not conserved	NA	NA	PTPN20	LINC02970
ENSG00000224596	ZMIZ1-AS1	2.67422680561649	5.43354050458335e-82	M1_vs_M0	HSALNG0079114	anti_sense	Q50	hsa-miR-762,hsa-miR-939-3p,hsa-miR-3195,hsa-miR-4430,hsa-miR-4447,hsa-miR-4472,hsa-miR-4516,hsa-miR-4534,hsa-miR-3960,hsa-miR-6735-3p,hsa-miR-6780a-3p,hsa-miR-6788-5p,hsa-miR-6795-3p,hsa-miR-6803-5p,hsa-miR-6813-5p	Blood osmolality measurement,Hypermetropia,Interleukin 13 measurement,Susceptibility to rubella infection measurement,Body fat distribution,Waist-hip ratio; Bmi-adjusted waist-hip ratio,Testosterone measurement,Mean corpuscular volume; Mean corpuscular hemoglobin; Red blood cell density measurement; Erythrocyte count,Mean corpuscular hemoglobin concentration,Body weight,Mean corpuscular volume,Mean reticulocyte volume; Reticulocyte count; Mean corpuscular volume; Reticulocyte measurement; Erythrocyte count,Mean corpuscular hemoglobin,Red blood cell distribution width,Erythrocyte count,Colorectal cancer; C-reactive protein measurement; Colorectal adenoma,Prostate carcinoma,-	ZCCHC24	LINC01138
ENSG00000286431	ENSG00000286431	-1.91869325284657	8.01183582451418e-6	M1_vs_M0	HSALNG0136439	integenic	Not conserved	hsa-miR-619-5p	NA	ARSF	ENSG00000274270
ENSG00000291048	ENSG00000291048	1.12851417676702	6.81542887235082e-17	M1_vs_M0	HSALNG0063241	integenic	Not conserved	hsa-miR-331-3p,hsa-miR-4418,hsa-miR-378g,hsa-miR-6089,hsa-miR-6132,hsa-miR-7703,hsa-miR-8077	Heel bone mineral density,Body weight; Neuroticism measurement; Red blood cell distribution width,Bmi-adjusted waist-hip ratio,Diet measurement,Neuroticism measurement,Systemic lupus erythematosus; Basophil count,Bmi-adjusted waist circumference,Red blood cell distribution width,-	PRAG1	ZNF658
ENSG00000254510	ENSG00000254510	-4.40183008399969	8.69904965432461e-7	M1_vs_M0	HSALNG0085021	integenic	Q90	hsa-miR-637,hsa-miR-1237-5p,hsa-miR-4472	Bmi-adjusted waist circumference; Attention deficit hyperactivity disorder; Substance abuse; Risk-taking behaviour; Antisocial behaviour measurement,Vital capacity,Bmi-adjusted waist-hip ratio,-	NPAS4	H3C6
ENSG00000272941	ENSG00000272941	4.98527250440242	9.99078680570824e-66	M1_vs_M0	HSALNG0061535	anti_sense	Q50	NA	-	TMEM140	ENSG00000275993
ENSG00000287480	ENSG00000287480	-1.14384713168707	0.0276159779142224	M1_vs_M0	HSALNG0069526	integenic	Not conserved	NA	NA	ZNG1A	ENSG00000276071
ENSG00000238164	TNFRSF14-AS1	1.67010455368246	7.77894845747539e-27	M1_vs_M0	HSALNG0000275	anti_sense	Q75	hsa-miR-505-5p,hsa-miR-619-5p,hsa-miR-3620-5p,hsa-miR-4481,hsa-miR-1343-3p,hsa-miR-5589-5p,hsa-miR-6751-3p,hsa-miR-6769a-3p,hsa-miR-6813-5p,hsa-miR-6852-5p	Eosinophil count,Rheumatoid arthritis,Eosinophil count; Eosinophil percentage of leukocytes,-	HES5	ENSG00000276289
ENSG00000275880	ENSG00000275880	1.62517658094177	0.0413296601525463	M1_vs_M0	HSALNG0099381	integenic	Not conserved	hsa-miR-619-5p	NA	CARS2	H4C4
ENSG00000273306	ENSG00000273306	-1.56642100905973	0.0222538079438189	M1_vs_M0	HSALNG0017259	anti_sense	Not conserved	NA	NA	EIF5B	ENSG00000277566
ENSG00000227508	LINC01624	-3.57533766680255	0.00197030281625561	M1_vs_M0	HSALNG0055432	integenic	Not conserved	hsa-miR-342-5p	Anti-thyroglobulin antibody measurement,Lymphocyte count; Platelet crit; Leukocyte count; Platelet count; Monocyte count,Leukocyte count; Lymphocyte count; Monocyte count,Blood protein measurement,Testosterone measurement	FAM120B	ENSG00000277806
ENSG00000272848	ENSG00000272848	-2.51258185077709	0.0311359698014157	M1_vs_M0	HSALNG0055353	sense	Not conserved	hsa-miR-7976	Astigmatism,Insomnia,Coronary artery calcification,-	NA	CKAP2-DT
ENSG00000255320	ENSG00000255320	-1.76736706211312	0.0201271663413715	M1_vs_M0	HSALNG0084993	anti_sense	Q50	hsa-miR-644a,hsa-miR-4508	-	YIF1A	ENSG00000278330
ENSG00000289880	ENSG00000289880	4.6236543815163	2.76624735261867e-8	M1_vs_M0	NA	NA	NA	NA	NA	FAM177B	ENSG00000278383
ENSG00000269688	ENSG00000269688	1.30653296640447	0.0336771427616586	M1_vs_M0	HSALNG0125952	sense	Not conserved	hsa-miR-619-5p,hsa-miR-4505	NA	HNRNPL	DHRS11
ENSG00000238099	LINC01625	-2.51121980049184	0.0273820124538698	M1_vs_M0	HSALNG0053881	integenic	Q90	hsa-miR-33b-5p,hsa-miR-4281,hsa-miR-1268b	Fev/fec ratio; Response to bronchodilator,-	CITED2	ENSG00000278668
ENSG00000243799	PEX5L-AS1	-5.24405105449286	0.00666327385343944	M1_vs_M0	HSALNG0030989	anti_sense	Not conserved	NA	-	USP13	ENSG00000278817
ENSG00000279833	ENSG00000279833	-1.89433342584072	2.7565727272677e-4	M1_vs_M0	NA	NA	NA	NA	NA	APOBEC3H	H3C10
ENSG00000288954	ENSG00000288954	6.00138045867336	2.0689076526189e-4	M1_vs_M0	HSALNG0089060	integenic	Not conserved	hsa-miR-211-3p	Blood protein measurement,-	CLEC4E	BANCR
ENSG00000290399	ENSG00000290399	-2.00520011944762	0.0250104795433346	M1_vs_M0	HSALNG0104477	integenic	Not conserved	NA	NA	NIPA1	ENSG00000279059
ENSG00000227630	LINC01132	-6.37619944509025	5.75510571331068e-6	M1_vs_M0	HSALNG0011630	integenic	Q50	hsa-miR-4456,hsa-miR-4717-3p,hsa-miR-6752-3p	Urate measurement,Hmg coa reductase inhibitor use measurement,-	COA6	ENSG00000279164
ENSG00000246174	KCTD21-AS1	-1.02709499174775	0.04060279647989	M1_vs_M0	HSALNG0085965	anti_sense	Q50	hsa-miR-619-5p	-	USP35	ENSG00000279166
ENSG00000183154	ENSG00000183154	-2.37244856275111	2.69902561821968e-9	M1_vs_M0	HSALNG0150383	anti_sense	Q75	NA	-	BRF2	ENSG00000279667
ENSG00000267280	TBX2-AS1	-3.10351509420961	0.0278811905860796	M1_vs_M0	HSALNG0117877	anti_sense	Q90	hsa-miR-615-5p,hsa-miR-615-3p,hsa-miR-4447,hsa-miR-4505,hsa-miR-4747-3p,hsa-miR-6754-5p,hsa-miR-8485	Gout,Nephrolithiasis; Hemoglobin measurement; Gout,Glomerular filtration rate; Urate measurement; Creatinine measurement; Hematocrit; Erythrocyte count,Gout; Erythrocyte count,Creatinine measurement; Glomerular filtration rate,Red blood cell density measurement,Chronic kidney disease; Urolithiasis; Glomerular filtration rate; Vitamin c measurement; Cystatin c measurement; Renal system measurement; Beta blocking agent use measurement; Creatinine measurement; Calcium measurement; Hematocrit; Uric acid measurement; Hemoglobin measurement; Erythrocyte count; Red blood cell density measurement; Urate measurement,Urolithiasis; Glomerular filtration rate; Protein measurement; Blood metabolite measurement; Amino acid measurement; Urate measurement,Bmi-adjusted waist circumference; Myopia,Bmi-adjusted waist circumference,Body height,Reticulocyte count; Agents acting on the renin-angiotensin system use measurement,Pulse pressure measurement; Diastolic blood pressure; Hypertension; Systolic blood pressure; Mean arterial pressure; Creatinine measurement,Abnormality of refraction; Cardiovascular disease; Diuretic use measurement; Refractive error,Age-related hearing impairment,Calcium measurement,Diastolic blood pressure; Pulse pressure measurement; Mean arterial pressure; Systolic blood pressure; Calcium channel blocker use measurement,Fibroblast growth factor 23 measurement; Glomerular filtration rate; Calcium channel blocker use measurement,Spontaneous preterm birth,Urolithiasis; Coronary artery disease; Systolic blood pressure,Corneal hysteresis; Agents acting on the renin-angiotensin system use measurement; Corneal resistance factor,Creatinine measurement,Diastolic blood pressure; Mean arterial pressure,Bmi-adjusted waist circumference; Chloride measurement; Potassium measurement,-,Pulse pressure measurement; Diastolic blood pressure; Hypertension; Mean arterial pressure; Systolic blood pressure	NACA2	ENSG00000279673
ENSG00000244998	ENSG00000244998	-6.30276577202885	9.83045692740849e-6	M1_vs_M0	HSALNG0150503	anti_sense	Not conserved	NA	-	GPR20	ENSG00000279942
ENSG00000259865	ENSG00000259865	1.56879236560709	2.29034379213044e-7	M1_vs_M0	HSALNG0012240	integenic	Not conserved	NA	-	ZNF124	LINC03032
ENSG00000289293	ENSG00000289293	1.32721246553015	2.62624917268768e-6	M1_vs_M0	HSALNG0117931	integenic	Q90	hsa-miR-4296,hsa-miR-4322,hsa-miR-4265,hsa-miR-3960	NA	MED13	ENSG00000280003
ENSG00000290091	ENSG00000290091	-1.62715073605868	0.0142947120598084	M1_vs_M0	HSALNG0055874	anti_sense	Q50	hsa-miR-326,hsa-miR-762,hsa-miR-3195,hsa-miR-4505,hsa-miR-4632-3p,hsa-miR-5787,hsa-miR-6803-5p	Pcsk9 protein measurement,-	SLC29A4	ENSG00000280120
ENSG00000245750	DRAIC	-2.51296482116306	0.0242684287729395	M1_vs_M0	HSALNG0106878	integenic	Q75	NA	-	RPLP1	ENSG00000280132
ENSG00000230731	LINC02938	2.49047210713451	0.0249479876756933	M1_vs_M0	HSALNG0096739	integenic	Q50	hsa-miR-874-3p,hsa-miR-6764-3p	Hair colour measurement,Forced expiratory volume; Fev/fec ratio,Balding measurement,Fev/fec ratio,Dupuytren contracture; Chronic obstructive pulmonary disease,Heel bone mineral density,Body height,Peripheral arterial disease; Traffic air pollution measurement,-	SMIM2	GGT4P
ENSG00000222031	ENSG00000222031	5.0168580788285	0.012897218529527	M1_vs_M0	HSALNG0019597	integenic	Q75	hsa-miR-4717-5p	-	RBM43	ENSG00000280211
ENSG00000235172	LINC01366	2.37881663165931	0.045091596534886	M1_vs_M0	HSALNG0046513	integenic	Not conserved	NA	NA	KCNIP1	ENSG00000280383
ENSG00000280693	SH3PXD2A-AS1	-5.08303775480631	0.0219919825907021	M1_vs_M0	HSALNG0080389	anti_sense	Not conserved	hsa-miR-4291	NA	NEURL1	SH3PXD2A-AS1
ENSG00000255306	ENSG00000255306	1.33875497602181	0.0381702425967767	M1_vs_M0	HSALNG0085208	anti_sense	Not conserved	NA	Uric acid measurement,-	UNC93B1	ARRDC3-AS1
ENSG00000227896	WAPL-DT	-3.30857373503658	1.2061326334644e-4	M1_vs_M0	HSALNG0079399	anti_sense	Q90	hsa-miR-4660,hsa-miR-4687-3p,hsa-miR-6089,hsa-miR-6779-5p	Parental longevity,-	OPN4	ARRDC3-AS1
ENSG00000288739	ENSG00000288739	-5.08189781867463	0.0165563004072498	M1_vs_M0	HSALNG0138120	anti_sense	Q90	hsa-miR-3960,hsa-miR-6805-5p,hsa-miR-6838-5p	-	MAGEH1	ENSG00000281469
ENSG00000260441	ENSG00000260441	-5.08201174590147	0.0189314606938464	M1_vs_M0	HSALNG0112270	anti_sense	Q50	hsa-miR-23a-5p,hsa-miR-328-5p,hsa-miR-4447,hsa-miR-3960	Intelligence,Comparative body size at age 10, self-reported; Serum metabolite measurement,Self reported educational attainment; Cognitive function measurement; Glomerular filtration rate,-	ESRP2	ENSG00000281469
ENSG00000225439	BOLA3-DT	1.68450902474821	0.00390671874043224	M1_vs_M0	HSALNG0016018	anti_sense	Q90	hsa-miR-1237-5p,hsa-miR-4257,hsa-miR-4433a-3p,hsa-miR-4508,hsa-miR-6784-5p	-	MTHFD2	C2-AS1
ENSG00000249816	LINC00964	-1.03636109508511	0.0153313247803685	M1_vs_M0	HSALNG0068291	integenic	Not conserved	NA	NA	ZNF572	LINC01230
ENSG00000254154	CRYZL2P-SEC16B	1.57572206741945	0.00345553514045267	M1_vs_M0	HSALNG0008675	integenic	Q90	NA	Body mass index,Total blood protein measurement; Insomnia,-	SEC16B	ENSG00000281883
ENSG00000288885	ENSG00000288885	-2.01783015342149	0.00968471702697125	M1_vs_M0	HSALNG0133657	anti_sense	Not conserved	NA	NA	COL18A1	LINC01144
ENSG00000262712	ENSG00000262712	1.22608199666103	4.54513449282622e-6	M1_vs_M0	NA	NA	NA	NA	NA	PAM16	FAM157D
ENSG00000275532	ENSG00000275532	3.22461149685663	0.0110949234039299	M1_vs_M0	HSALNG0116178	anti_sense	Q75	hsa-miR-4281,hsa-miR-4508,hsa-miR-5088-3p,hsa-miR-7151-5p,hsa-miR-8072	Cognitive decline measurement,Cortical surface area measurement,Leukocyte count	PCGF2	ENSG00000282988
ENSG00000251293	ENSG00000251293	3.63083413090207	0.00126287787387931	M1_vs_M0	HSALNG0044415	integenic	Q75	hsa-miR-8485	Age at onset,Body mass index,Cognitive decline measurement,Response to carboplatin,Adolescent idiopathic scoliosis,Aging,Gut microbiome measurement,Body height; Fev/fec ratio; Body mass index,-	DTWD2	ENSG00000282988
ENSG00000283689	ENSG00000283689	-2.17250138330283	2.12346527300318e-6	M1_vs_M0	HSALNG0111560	anti_sense	Q90	hsa-miR-4456	Tonsillectomy risk measurement,Self reported educational attainment; Intelligence,-	FTO	DUX4L37
ENSG00000286981	ENSG00000286981	4.60715887983857	0.0299663654575096	M1_vs_M0	NA	NA	NA	NA	NA	PCGF5	ENSG00000283064
ENSG00000254041	ENSG00000254041	4.6061422369748	0.0323918217623134	M1_vs_M0	HSALNG0067574	anti_sense	Q90	hsa-miR-7151-5p	Lymphocyte count,Bipolar disorder; Attention deficit hyperactivity disorder; Autism spectrum disorder; Unipolar depression,-	LRP12	ENSG00000283064
ENSG00000283183	ENSG00000283183	-4.6812861238866	0.0450498423209786	M1_vs_M0	HSALNG0032158	integenic	Q90	hsa-miR-619-5p,hsa-miR-4430	NA	PDE6B	ENSG00000283183
ENSG00000253549	CA3-AS1	-3.26112346420032	1.79354142713211e-14	M1_vs_M0	HSALNG0066709	anti_sense	Q50	hsa-miR-491-5p,hsa-miR-4482-5p,hsa-miR-4707-5p,hsa-miR-6810-5p	Glomerular filtration rate,-	CA1	ENSG00000284391
ENSG00000225280	ENSG00000225280	-2.32517737614215	0.00400972487836108	M1_vs_M0	HSALNG0129109	anti_sense	Q90	NA	Body mass index,Body height; Body mass index,Bmi-adjusted hip circumference,Red blood cell distribution width,-	XRN2	ENSG00000284630
ENSG00000291015	ENSG00000291015	-1.80175608469979	5.36592732203761e-5	M1_vs_M0	HSALNG0135407	sense	Not conserved	NA	NA	TPTEP2-CSNK1E	LINC02811
ENSG00000232855	ENSG00000232855	4.82773844066489	0.0228012743286528	M1_vs_M0	HSALNG0132498	integenic	Q90	NA	NA	N6AMT1	ENSG00000284700
ENSG00000288765	ENSG00000288765	4.22890235449053	1.88780528284505e-10	M1_vs_M0	NA	NA	NA	NA	NA	PCDH17	ENSG00000284734
ENSG00000288767	ENSG00000288767	6.23173801178593	5.08512870827666e-6	M1_vs_M0	HSALNG0096284	integenic	Not conserved	NA	NA	RFC3	ARHGAP11B
ENSG00000251273	LINC02228	-2.84603241856907	3.0514177689293e-4	M1_vs_M0	HSALNG0040674	integenic	Q50	NA	-	CDH10	RALY-AS1
ENSG00000285823	LINC02793	4.99888037575358	0.0132320519982946	M1_vs_M0	HSALNG0001761	integenic	Not conserved	hsa-miR-762,hsa-miR-4534,hsa-miR-4676-5p,hsa-miR-8485	Alopecia,-	CLIC4	LINC02793
ENSG00000233251	ENSG00000233251	5.20114043026778	0.0168040456766748	M1_vs_M0	HSALNG0015066	anti_sense	Q50	hsa-miR-4279,hsa-miR-4472	Lysophosphatidylcholine 18:2 measurement; Lysophosphatidylcholine 18:1 measurement,Cleft lip,-	EFEMP1	ENSG00000285873
ENSG00000287431	RENO1	-1.06170053494567	5.61749133176091e-7	M1_vs_M0	HSALNG0119244	integenic	Q90	NA	-	SLC38A10	NIPBL-DT
ENSG00000287263	ENSG00000287263	1.03629490918087	4.21535737179715e-30	M1_vs_M0	HSALNG0041483	integenic	Not conserved	hsa-miR-6807-3p	Intelligence,Cytokine measurement	ANXA2R	ENSG00000286062
ENSG00000182257	PRR34	-1.10335784283713	0.0383895509271931	M1_vs_M0	HSALNG0147427	integenic	Not conserved	NA	-	WNT7B	ENSG00000286067
ENSG00000278017	ENSG00000278017	1.69508371247556	0.026978331232905	M1_vs_M0	HSALNG0121991	anti_sense	Q90	NA	NA	PIGN	ENSG00000286292
ENSG00000255299	ENSG00000255299	3.32756909764302	6.4077315047318e-7	M1_vs_M0	HSALNG0084342	sense	Q50	NA	Chronotype measurement,Psoriasis; Ulcerative colitis; Ankylosing spondylitis; Crohn's disease; Sclerosing cholangitis,-	OR5B21	ENSG00000286369
ENSG00000274270	ENSG00000274270	-1.53391533031931	0.0015737762275753	M1_vs_M0	HSALNG0097105	anti_sense	Q50	hsa-miR-30b-3p,hsa-miR-619-5p,hsa-miR-4286,hsa-miR-4710,hsa-miR-7152-5p,hsa-miR-8485	Bmi-adjusted waist-hip ratio,Appendicular lean mass; Monocyte count,Sex hormone-binding globulin measurement,Body height,Serum alanine aminotransferase measurement; Forced expiratory volume; Lean body mass; Body height; Vital capacity; Triglyceride measurement,Intelligence,Serum alanine aminotransferase measurement; Sex hormone-binding globulin measurement; Glomerular filtration rate; Creatinine measurement; Bmi-adjusted waist-hip ratio,Bmi-adjusted hip circumference,Monocyte percentage of leukocytes; Monocyte count,Diabetic maculopathy,Body height; Bmi-adjusted hip circumference,Basophil count,Lymphocyte percentage of leukocytes; Lymphocyte count,Leukocyte count,Electrocardiography,Psoriasis,Psoriasis; Bmi-adjusted hip circumference; Primary biliary cirrhosis; Bmi-adjusted waist-hip ratio; Autoimmune disease,Appendicular lean mass,Hematocrit; Hemoglobin measurement; Erythrocyte count,Hypothyroidism,Snoring measurement; Aortic root size,Eczema; Allergic rhinitis,High density lipoprotein cholesterol measurement,Celiac disease,Leukocyte count; Lymphocyte count,Tnf-related apoptosis-inducing ligand measurement,Fatty acid measurement,Diffuse large b-cell lymphoma; Bmi-adjusted hip circumference; Chronic lymphocytic leukemia; Triglyceride measurement,Hematocrit; Hemoglobin measurement,Thyroid peroxidase antibody measurement,Lipoprotein a measurement,Creatinine measurement; Glomerular filtration rate,Eosinophil count; Eosinophil percentage of granulocytes; Eosinophil percentage of leukocytes,Adiponectin measurement,Bmi-adjusted adiponectin measurement,Body mass index,Low density lipoprotein cholesterol measurement,Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Triglyceride measurement,Left ventricular structural measurement,Fear of severe pain measurement,Hemoglobin measurement,Gamma-aminoisobutyric acid measurement,Eosinophil count,Heel bone mineral density,Prostate carcinoma,Grip strength measurement,Prostate specific antigen measurement,Blood urea nitrogen measurement; Forced expiratory volume,Grip strength measurement; Appendicular lean mass,Magnesium measurement,Caudal anterior cingulate cortex volume measurement,Blood urea nitrogen measurement,Breast carcinoma,Puberty; Heel bone mineral density; Bmi-adjusted hip circumference; Body height; Height growth measurement,Body height; Diastolic blood pressure; Systolic blood pressure,Hip circumference,Body height; Cardiovascular disease; Bmi-adjusted hip circumference; Systolic blood pressure,Transforming growth factor beta measurement,Primary biliary cirrhosis,Appendicular lean mass; Bmi-adjusted hip circumference,Body weight,Waist-hip ratio; Bmi-adjusted waist-hip ratio,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio,Protein measurement,Tumor necrosis factor-alpha measurement,Urinary albumin to creatinine ratio,Body height; Attention deficit hyperactivity disorder,Hematocrit,Bmi-adjusted waist circumference,Osteosarcoma; Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio; Inguinal hernia,Bmi-adjusted waist circumference; Bmi-adjusted hip circumference; Waist-hip ratio; Bmi-adjusted waist-hip ratio,Interleukin 9 measurement,Waist-hip ratio; Bmi-adjusted waist-hip ratio; Triglyceride measurement,Snoring measurement,Sphingomyelin 22:0 measurement,Platelet component distribution width,Lymphocyte count,Total blood protein measurement,Hematocrit; Odontogenesis,Blood phosphate measurement,Platelet count,Reticulocyte count; Reticulocyte measurement,Reticulocyte measurement,Hemorrhoid,Anthropometric measurement; Brachial circumference,Bipolar disorder; Unipolar depression,Benign prostatic hyperplasia; Lower urinary tract symptom,Platelet-to-lymphocyte ratio,Eosinophil count; Eosinophil percentage of leukocytes,Total cholesterol measurement,Adolescent idiopathic scoliosis,-	KCNRG	ENSG00000286431
ENSG00000286443	ENSG00000286443	-4.42748588940411	0.0447242549118769	M1_vs_M0	HSALNG0116215	anti_sense	Q50	hsa-miR-4505,hsa-miR-4695-5p	-	RPL19	ENSG00000286443
ENSG00000286501	ENSG00000286501	5.45623797766662	0.00119999070908569	M1_vs_M0	HSALNG0029771	anti_sense	Q90	hsa-miR-619-5p,hsa-miR-3177-3p,hsa-miR-4269,hsa-miR-4472,hsa-miR-3972,hsa-miR-5587-3p	Total cholesterol measurement,T wave morphology measurement,Electrocardiography,Aging,Mosaic loss of chromosome y measurement,Sex hormone-binding globulin measurement,Myeloid white cell count,Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Adiponectin measurement,Bmi-adjusted waist-hip ratio,Bmi-adjusted hip circumference,Serum alanine aminotransferase measurement; Sex hormone-binding globulin measurement; Insulin measurement; Low density lipoprotein triglyceride measurement; Heel bone mineral density; Bmi-adjusted waist circumference; Apolipoprotein a 1 measurement; Body fat percentage; Waist-hip ratio; Bmi-adjusted hip circumference; Reticulocyte count; High density lipoprotein cholesterol measurement; Bmi-adjusted waist-hip ratio; Triglyceride measurement; Mean corpuscular volume; Erythrocyte count; Aspartate aminotransferase measurement,Open-angle glaucoma,Cognitive function measurement,Glaucoma; Open-angle glaucoma; Intraocular pressure measurement,Glaucoma,Hmg coa reductase inhibitor use measurement,Serum igg glycosylation measurement,Pulse pressure measurement; Sex hormone-binding globulin measurement; Cardiovascular disease; Waist-hip ratio; Hmg coa reductase inhibitor use measurement; Systolic blood pressure; Agents acting on the renin-angiotensin system use measurement; High density lipoprotein cholesterol measurement; Appendicular lean mass; Bmi-adjusted waist-hip ratio; Triglyceride measurement; Reticulocyte measurement,Self reported educational attainment,-	SERP1	ENSG00000286501
ENSG00000273272	ENSG00000273272	5.45644784232064	9.6342392216642e-4	M1_vs_M0	HSALNG0147331	integenic	Not conserved	NA	Monocyte count	KLHDC7B	ENSG00000286501
ENSG00000286654	ENSG00000286654	-7.13477572969977	3.0146121925992e-11	M1_vs_M0	HSALNG0146167	anti_sense	Not conserved	hsa-miR-6765-3p	Cortical thickness	CNNM3	ENSG00000286654
ENSG00000206344	HCG27	2.06376830161839	1.7048790539741e-4	M1_vs_M0	HSALNG0049246	integenic	Not conserved	hsa-miR-4640-3p,hsa-miR-6769b-5p	Sneeze,Multiple myeloma,Platelet-to-lymphocyte ratio,Bmi-adjusted waist-hip ratio,Squamous cell lung carcinoma; Peptic ulcer and gastro-oesophageal reflux disease (gord) drug use measurement; Upper aerodigestive tract neoplasm; Susceptibility to pneumonia measurement,Blood protein measurement,Intelligence; Diastolic blood pressure; Susceptibility to mycobacterium tuberculosis infection measurement,Cytokine measurement,Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Susceptibility to shingles measurement,Lymphocyte count,Bmi-adjusted waist circumference,Bmi-adjusted hip circumference,Serum igg glycosylation measurement,Coronary artery disease,Platelet count,Autism spectrum disorder; Parental longevity,Von willebrand factor measurement,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio,Autism spectrum disorder,High density lipoprotein cholesterol measurement,Lung carcinoma,Response to thioamide; Drug-induced agranulocytosis,Handedness,Lupus nephritis; Blood protein measurement,-	TCF19	ENSG00000286796
ENSG00000223485	LINC01615	-1.71869551225779	5.907122574129e-8	M1_vs_M0	HSALNG0055330	integenic	Q75	hsa-miR-4492,hsa-miR-4534,hsa-miR-4722-5p,hsa-miR-6514-3p,hsa-miR-6762-5p,hsa-miR-6848-3p	Response to diisocyanate,Central corneal thickness,-	THBS2	ACAD9-DT
ENSG00000258056	CD63-AS1	1.03777891075858	2.95059319849442e-9	M1_vs_M0	HSALNG0091431	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-3158-3p,hsa-miR-3195,hsa-miR-6792-3p	-	RDH5	ENSG00000287222
ENSG00000273473	ENSG00000273473	-5.8690617500471	1.3324756034763e-4	M1_vs_M0	HSALNG0150744	integenic	Not conserved	NA	-	WDR5	ENSG00000287264
ENSG00000287264	ENSG00000287264	-4.89369017546786	0.00995804929555761	M1_vs_M0	HSALNG0084413	integenic	Q50	hsa-miR-619-5p,hsa-miR-3612,hsa-miR-4430,hsa-miR-4481	Body height,-	OR4D9	ENSG00000287264
ENSG00000227467	LINC01537	-4.88317767167739	7.02524413414518e-10	M1_vs_M0	HSALNG0141635	anti_sense	Not conserved	NA	-	ATG16L2	ENSG00000287415
ENSG00000287485	ENSG00000287485	5.6920909100925	5.6205601646225e-4	M1_vs_M0	HSALNG0050410	integenic	Q75	NA	NA	TNFRSF21	ENSG00000287485
ENSG00000239213	NCK1-DT	-1.4051781930224	3.30729893522912e-12	M1_vs_M0	HSALNG0029189	anti_sense	Q90	hsa-miR-23a-5p,hsa-miR-135a-3p,hsa-miR-619-5p,hsa-miR-1268b,hsa-miR-4447,hsa-miR-3960,hsa-miR-6089	Lymphocyte count,Body mass index,-	STAG1	ENSG00000287557
ENSG00000222012	ENSG00000222012	-1.79545447761453	0.00358980712114458	M1_vs_M0	NA	NA	NA	NA	NA	DNAJB6	ENSG00000287616
ENSG00000287838	ENSG00000287838	-4.89332915685495	0.0264565472505616	M1_vs_M0	HSALNG0071161	integenic	Not conserved	hsa-miR-4650-5p	NA	SPATA31A1	ENSG00000287838
ENSG00000248673	LINC01331	-4.8936383720284	0.0111395061136332	M1_vs_M0	HSALNG0042682	integenic	Q50	NA	-	ENC1	ENSG00000287838
ENSG00000287991	ENSG00000287991	-5.08018655684128	0.00505866421989834	M1_vs_M0	HSALNG0144157	integenic	Q90	NA	-	CCNK	ENSG00000287991
ENSG00000254614	CAPN1-AS1	-1.9604288240909	2.9554151498024e-4	M1_vs_M0	HSALNG0084866	anti_sense	Not conserved	hsa-miR-4505,hsa-miR-5787	Bmi-adjusted hip circumference,-	SYVN1	ENSG00000287993
ENSG00000259668	ENSG00000259668	3.01924105377108	1.02787179740665e-8	M1_vs_M0	HSALNG0105911	anti_sense	Q75	hsa-miR-4443	C-reactive protein measurement,Body mass index,Self reported educational attainment,-,Waist-hip ratio; Smoking behavior; Body mass index,Body fat percentage	GLDN	ENSG00000288098
ENSG00000288753	ENSG00000288753	-2.95334119996476	0.0388480199484511	M1_vs_M0	HSALNG0111796	anti_sense	Q75	NA	-	KIFC3	ENSG00000288753
ENSG00000284734	ENSG00000284734	3.81660037152065	1.6444871463896e-7	M1_vs_M0	HSALNG0005052	anti_sense	Not conserved	NA	NA	GBP6	ENSG00000288765
ENSG00000269553	ENSG00000269553	-2.75123094208233	5.15536712718582e-5	M1_vs_M0	HSALNG0125598	intronic_sense	Not conserved	NA	NA	CD22	ENSG00000288778
ENSG00000288904	ENSG00000288904	-4.89406154731674	0.0190089181465097	M1_vs_M0	HSALNG0047687	integenic	Not conserved	hsa-miR-3178	NA	FAM217A	ENSG00000288904
ENSG00000288862	ENSG00000288862	-4.89417320037753	0.0267328677154386	M1_vs_M0	HSALNG0011323	integenic	Not conserved	hsa-miR-4290,hsa-miR-6728-3p	NA	RAB4A	ENSG00000288904
ENSG00000262089	ENSG00000262089	1.15918827595268	0.00575609415799311	M1_vs_M0	HSALNG0114242	integenic	Not conserved	hsa-miR-3944-5p	NA	SLC16A11	ENSG00000288919
ENSG00000278910	BANCR	6.45275150481003	5.2338937935035e-6	M1_vs_M0	HSALNG0071734	integenic	Not conserved	NA	-	APBA1	ENSG00000288954
ENSG00000270120	ENSG00000270120	4.49858009758022	1.56805169712246e-12	M1_vs_M0	HSALNG0111360	sense	Q50	NA	NA	NOD2	ENSG00000288954
ENSG00000251613	ENSG00000251613	2.02828372094498	0.0225223260343288	M1_vs_M0	HSALNG0042584	anti_sense	Q50	hsa-miR-766-5p,hsa-miR-3195,hsa-miR-3940-5p	Heel bone mineral density,Total cholesterol measurement,Low density lipoprotein cholesterol measurement,Reaction time measurement,Lung cancer,Handedness,Gut microbiome measurement,Femoral neck bone mineral density,Hemoglobin a1 measurement; Mean corpuscular hemoglobin; Mean corpuscular hemoglobin concentration,Apolipoprotein b measurement; Low density lipoprotein cholesterol measurement,Total cholesterol measurement; Low density lipoprotein cholesterol measurement,Serum gamma-glutamyl transferase measurement,Hematocrit,Aspartate aminotransferase to alanine aminotransferase ratio,Total blood protein measurement,Platelet count,Hemoglobin measurement,Eosinophil count,Platelet-to-lymphocyte ratio,Eosinophil count; Bone density; Heel bone mineral density,Digestive system infectious disease,-	ZNF366	ENSG00000288995
ENSG00000273124	ENSG00000273124	5.57941146412108	4.4289311809262e-4	M1_vs_M0	HSALNG0079637	integenic	Q50	hsa-miR-4650-5p,hsa-miR-6132,hsa-miR-6763-5p	Fibroblast growth factor basic measurement,-	ANKRD1	ENSG00000289005
ENSG00000289515	ENSG00000289515	-1.74818327727768	5.63591212687599e-7	M1_vs_M0	HSALNG0035305	anti_sense	Q90	NA	NA	CCDC158	ENSG00000289050
ENSG00000289173	ENSG00000289173	4.60617182465582	0.0323145424103348	M1_vs_M0	HSALNG0092178	integenic	Not conserved	hsa-miR-619-5p	-	CPM	ENSG00000289173
ENSG00000284693	LINC02606	-1.48461289405656	0.00114709007502354	M1_vs_M0	HSALNG0000694	integenic	Q75	hsa-miR-1237-5p,hsa-miR-4281,hsa-miR-4722-3p,hsa-miR-6089	Body height,Fev/fec ratio,Phosphatidylcholine 34:3 measurement,-	CLSTN1	ZNF496-DT
ENSG00000273855	ENSG00000273855	-2.65262425185491	6.10831352443904e-14	M1_vs_M0	HSALNG0105214	sense	Q75	hsa-miR-4293,hsa-miR-5088-3p	NA	PLCB2	ENSG00000289250
ENSG00000289194	ENSG00000289194	-1.8736086279557	7.7887681298768e-4	M1_vs_M0	NA	NA	NA	NA	NA	INCENP	ENSG00000289263
ENSG00000287687	ENSG00000287687	2.96460871397184	6.79657010523207e-9	M1_vs_M0	HSALNG0016092	integenic	Q50	hsa-miR-363-5p,hsa-miR-1268b,hsa-miR-5787	Pathological myopia,Eye measurement,-	M1AP	ENSG00000289268
ENSG00000230736	ENSG00000230736	3.88343925844352	1.9298182534979e-4	M1_vs_M0	HSALNG0135029	integenic	Not conserved	NA	NA	RFPL3	ENSG00000289384
ENSG00000277969	ENSG00000277969	2.31792449707273	1.24950223166878e-45	M1_vs_M0	HSALNG0116179	integenic	Q75	hsa-miR-1247-5p,hsa-miR-3620-5p,hsa-miR-4505,hsa-miR-1587,hsa-miR-6721-5p	NA	MLLT6	ENSG00000289407
ENSG00000177822	TENM3-AS1	7.61337608625878	7.65799649871448e-15	M1_vs_M0	HSALNG0038869	integenic	Q90	NA	NA	DCTD	ENSG00000289426
ENSG00000230149	ENSG00000230149	1.94312931900755	0.00428238310853502	M1_vs_M0	HSALNG0135439	anti_sense,sense	Q90	hsa-miR-1227-5p,hsa-miR-500b-3p	White matter microstructure measurement,-	GTPBP1	ENSG00000289470
ENSG00000249937	LINC02223	5.50645542688203	6.54730206959409e-27	M1_vs_M0	HSALNG0040447	integenic	Q50	NA	NA	TAF11L14	ENSG00000289588
ENSG00000289839	ENSG00000289839	5.58409573830616	0.0010122365505698	M1_vs_M0	HSALNG0047169	integenic	Q50	NA	Ovarian carcinoma,-	CNOT6	ENSG00000289839
ENSG00000290712	DSTNP2	1.90302295842645	8.32619624416492e-5	M1_vs_M0	NA	NA	NA	NA	NA	LRRC23	ENSG00000289939
ENSG00000260288	ENSG00000260288	2.37339990286099	0.0486726762241663	M1_vs_M0	HSALNG0107318	integenic	Not conserved	hsa-miR-676-5p,hsa-miR-4723-3p,hsa-miR-4734,hsa-miR-6763-5p,hsa-miR-7108-3p	Myopathy; Protein measurement; Response to simvastatin,Glaucoma,-	ODF3L1	ENSG00000289942
ENSG00000290034	ENSG00000290034	-2.28763877635065	9.614799039640571e-15	M1_vs_M0	HSALNG0049994	anti_sense	Q50	hsa-miR-6728-3p,hsa-miR-8485	C-reactive protein measurement,Isoleucine measurement; Leucine measurement,Supraventricular ectopy,Family history of alzheimers disease; Late-onset alzheimers disease,Late-onset alzheimers disease,Aortic stenosis; Aortic valve calcification,-	TREML4	ENSG00000289975
ENSG00000234506	LINC01506	4.326660268694	1.44469921986677e-6	M1_vs_M0	HSALNG0071693	integenic	Not conserved	hsa-miR-5787	NA	TMEM252	ENSG00000290041
ENSG00000245954	LINC02273	-5.96763671105185	1.4159878515082e-4	M1_vs_M0	HSALNG0037887	integenic	Q75	hsa-miR-504-3p,hsa-miR-6089	Systemic lupus erythematosus,Reaction time measurement,Smoking status measurement,Attention deficit hyperactivity disorder; Antisocial behaviour measurement; Substance abuse,Body mass index,-	FHIP1A	ENSG00000290357
ENSG00000258623	ENSG00000258623	-5.39360541156376	0.00115804837344043	M1_vs_M0	HSALNG0102098	anti_sense	Q50	hsa-miR-1227-5p,hsa-miR-4308,hsa-miR-6869-3p	Cognitive function measurement,Monoclonal gammopathy,Prostate carcinoma,Body height,Coronary artery calcification,Bmi-adjusted waist-hip ratio; Gut microbiome measurement,Waist-hip ratio; Bmi-adjusted waist-hip ratio; Balding measurement,High density lipoprotein cholesterol measurement,Diabetic nephropathy,-	ZFP36L1	ENSG00000290880
ENSG00000203446	SUGCT-AS1	5.3018426576973	5.15330531769192e-119	M1_vs_M0	HSALNG0057426	anti_sense	Q90	hsa-miR-6089,hsa-miR-6824-3p	-	MPLKIP	ENSG00000290956
ENSG00000180539	LINC02908	-2.41462993525911	1.22292115945659e-83	M1_vs_M0	HSALNG0075339	anti_sense	Q50	hsa-miR-210-5p,hsa-miR-619-5p,hsa-miR-4308,hsa-miR-4270,hsa-miR-6752-3p	Leukocyte count,Lymphocyte count,-	PAXX	ENSG00000291006
ENSG00000284678	LINC02811	-2.01872739742365	0.00903432949561299	M1_vs_M0	HSALNG0002808	integenic	Not conserved	hsa-miR-619-5p	Hemorrhoid	BMP8B	ENSG00000291015
ENSG00000291263	SMG1P7	2.09192866248407	1.82379059279711e-9	M1_vs_M0	NA	NA	NA	NA	NA	EXOSC6	ENSG00000291067
ENSG00000287189	ENSG00000287189	3.24177439534136	2.1878829430996e-4	M1_vs_M0	NA	NA	NA	NA	NA	CEP43	ENSG00000291131
ENSG00000253858	ENSG00000253858	-6.57620359139159	5.77223087722056e-7	M1_vs_M0	HSALNG0046523	anti_sense	Q75	hsa-miR-505-5p,hsa-miR-1301-3p,hsa-miR-4300,hsa-miR-4687-5p	Viral load,Abruptio placentae,Sclerosing cholangitis,Memory performance,-	KCNMB1	ENSG00000291137
ENSG00000236548	RNF217-AS1	-1.9700467158125	1.27772501950028e-7	M1_vs_M0	HSALNG0053257	anti_sense	Q50	NA	Calcium measurement,-	HDDC2	DPY19L2P2
ENSG00000277511	ENSG00000277511	3.29884612816475	2.8367970011194e-19	M1_vs_M0	HSALNG0115754	integenic	Not conserved	hsa-miR-6089,hsa-miR-7847-3p	-	RHOT1	ENSG00000291263
